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SUMMARY
The aim o f  the  s t u d i e s  d e s c r i b e d  in  t h i s  t h e s i s  was to
d e v e lo p  a v a c c i n e  a g a i n s t  f e l i n e  Leukaemia (FeLV) based on
i n a c t i v a t e d  v i r u s .  Previous attempts to produce an economical ,  
i n a c t i v a t e d  v i r u s  v a c c i n e  wh ich  would  p r o t e c t  k i t t e n s  a g a i n s t  
FeLV i n f e c t i o n  had not been successful .
In  the present  study a vaccine was prepared which p ro tec te d  
over  80% of  w e a n l i n g  k i t t e n s  a g a i n s t  a v i r a l  c h a l l e n g e  which  
induced p e r s i s t e n t  FeLV i n f e c t i o n  in  80-100% o f  u n v a c c i n a t e d  
k i t t e n s .  Among th e  reasons  f o r  th e  c o m p a r a t i v e  success o f  the  
vaccine described here were b e l ie v e d  to be:
1. The use of  FeLV of subgroup A produced in large  q u a n t i t i e s  by 
the F422 l i n e  of  f e l i n e  lymphosarcoma c e l l s .
2 .  I n a c t i v a t i o n  o f  t h e  v i r u s  w i t h  a c o n c e n t r a t i o n  o f
p a r a f o r m a l d e h y d e  w h i c h  p r e s e r v e d  o r  e n h a n c e d  t h e  
immunogenic i t y  of the an t igen .
3. The use o f  A l ( 0 H ) 3  F reund 's  i n c o m p l e t e  a d j u v a n t  i n  t h e
vacc in e ,
4. A s c h ed u le  f o r  v a c c i n a t i o n  and c h a l l e n g e  by FeLV which  
al lowed the e f f i c a c y  of  a vaccine to  be assessed c l e a r l y .
In  t h i s  t h e s i s ,  th e  G e n e r a l  I n t r o d u c t i o n  is  a r e v ie w  of  the  
b i o l o g y  o f  FeLV and o f  p r e v i o u s  a t t e m p t s  t o  p roduce  v a c c i n e s  
using FeLV ant igen s.  Chapter 1 describes the genera l  m a t e r i a ls  
and methods used throughout the study.
In Chapter 2 the condit ions  f o r  the p re p a r a t io n  of FeLV f o r  
use in v a c c in a t io n  are  described .  I t  was found t h a t  the optimum 
condit ions f o r  producing v i ru s  from F422 c e l l s  were to seed the
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c e l l s  a t  1.2 X 10*  ^ c e l l s  per  ml  o f  L -H  medium and h a r v e s t  t h e  
f l u i d  a f t e r  24 hours. In  the second experiment of t h is  chapter ,  
the conclusion was t h a t  v i r u s  product ion was b e t t e r  in L-M medium 
than RPMI and the amount of  v i ru s  harvested at  72 hours increased  
w ith  in c reas ing  PCS con cen t ra t io n .  In  the l a s t  exper im ent ,  i t  
was found t h a t  v i r u s  h a r v e s t e d  at 2 4 - 4 8  hours a f t e r  s u b c u l t u r e  
was of  optimum a n t i g e n i c i t y .
Chapter  3 descr ibes  the i n a c t i v a t i o n  of FeLV pseudotypesof  
murine sarcoma v i r u s  CMSV(FeLV)] w i th  severa l  chemica ls .  I t  was 
found that  f o r  complete i n a c t i v a t i o n  of v i r u s ,  paraformaldehyde  
(PF) should be used at 0.05%, a mix tu re  of  PF and g lu ta ra ld e hy d e  
at  0.004% ( o r  l e s s )  and a c e t y  l e t h y  l e n e i  mine (A E I )  a t  0.5%. An 
agent  which  s t a b i l i s e s  d i s u l p h i d e  bonds ( 2 , 2 - d i t h i o b i s ,  5 -  
n i t r o p y r i d i n e  (DTNP)) was also found to i n a c t i v a t e  v i r u s ,  but not 
c o m p l e t e l y  a t  t h e  c o n c e n t r a t i o n s  used.  In  t h i s  c h a p t e r ,  t h e  
adsorpt ion of  v i r u s  to Al(OH)^ was examined. Approximately 75% 
of v i r u s  was absorbed under condit ions employed.
Chapter  4 repor ts  the f i r s t  vac c in a t io n  experiment in which 
FeLV p r e p a r a t i o n s  i n a c t i v a t e d  w i t h  PF,  AEI o r  DTNP and PF w ere  
compared as v a c c i n e s .  A v a c c i n e  p r e p a r e d  w i t h  P F - i  nac t  i v a t e d
F422 c e l l s  was a l s o  used and AI (OH) 3  ^dd s a p o n in  w ere  used as 
a d j u v a n t s .  The r e s u l t  was t h a t  the most e f f e c t i v e  v a c c i n e  
appeared to  be t h a t  in a c t i v a t e d  w i th  PF and the leas t  e f f e c t i v e  
was th e  F422 c e l l u l a r  v a c c i n e .  A s c o r i n g  system was used t o  
assess e f f i c a c y  o f  t h e  v a c c i n e s .  T h ree  f u r t h e r  le ss o ns  were  
l e a r n e d  from t h i s  e x p e r i m e n t  and were i n c o r p o r a t e d  i n t o  th e  
second vaccine experiment (Chapter  7) .  F i r s t ,  the cha l lenge  dose 
of FeLV sh o u ld  be i n c r e a s e d  in  o r d e r  to  produce  v i r a e m i a  in a l l
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of the unvaccinated cats.  Secondly, a la r g e r  number of  cats per  
group should  be used t o  i n c r e a s e  th e  chance of  d e m o n s t r a t i n g  
d i f f e r e n c e  b e tw e en  v a c c i n a t e d  groups-  T h i r d l y ,  t h e  a d j u v a n t  
sapon in  should  be used at  a lo w e r  c o n c e n t r a t i o n  t o  a v o id  s i d e -  
e f f e c t s  found during i t s  use.
An innocuous dose of  s a po n in  was d e t e r m i n e d  in  C h ap te r  5.  
The dose o f  s a p o n in  wh ich  was h a r m le s s  was 100 ug pe r  c a t ,  
compared to 1500 ug which had been used p re v io u s ly  in Chapter 4.  
C h a p te r  6  d e a l s  w i t h  t h e  p r e p a r a t i o n  and d e t e r m i n a t i o n  o f  an 
ap propr ia te  chal lenge dose of  FeLV. The v i ru s  was prepared from 
f e l i n e  embryo c e l l s  i n f e c t e d  w i t h  F e L V - A /G la s g o w - 1  and was 
c o n c e n t r a t e d  by u l t r a c e n t r i f u g a t i o n .  Cats were i n f e c t e d  
o r o n a s a l l y  w i t h  a dose o f  6.5 X 10^ FIU and a l l  o f  t h e  c a t s  
became v i rae m ic .
C h a p te r  7 c o n t a i n s  th e  r e s u l t s  of  the  second v a c c i n a t i o n  
exper im ent ,  in c o rp o r a t in g  the im p r o v e m e n ts  d e s c r i b e d  ab o ve ,  i n  
which a comparison of adjuvants  was done, using P F - i n a c t i v a t e d  
FeLV. I n  t h i s  c h a p t e r  MSVCFeLV) was f i r s t  i n a c t i v a t e d  w i t h  
several  co ncentrat ions of PF at  25d to obta in  more in fo rm a t io n  on 
th e  opt imum c o n c e n t r a t i o n  o f  PF to  use.  S e c o n d ly ,  FeLV was 
i n a c t i v a t e d  in  th e  same way u s in g  the e s t a b l i s h e d  opt imum PF 
concentra t ion .  Traces of  the i n a c t i v a t i n g  agent were removed by 
u l t r a f i l t r a t i o n  and the i n a c t i v a t e d ,  washed an t igen  was used with  
two a d j u v a n t s ,  s a p o n in  and i n c o m p l e t e  F reund 's  a d j u v a n t .  The 
re s u l ts  of t h i s  experiment in d ic a te d  that  the vaccine using the  
incomplete Freund's adjuvant  was s l i g h t l y  super io r  to  the vaccine  
w ith  saponin.
x i i i
C h ap te r  8  c o n t a i n s  the  r e s u l t  o f  the f i n a l  v a c c i n a t i o n  
e x p e r i m e n t  in  w h ic h  a c o m p a r is o n  o f  a n t i g e n s  was done.  The 
ant igens and vaccines were prepared as in the previous experiment  
except  t h a t  two v i ruses  were used: F422 v i r u s  or FeLV-A/Glasgow-  
1,  grown in f e l i n e  embryo f i b r o b l a s t  c u l tu re s .  A comparison of  
F422 v i r u s  u s in g  unconcent  r a t e d  v i r u s  and v i r u s  c o n c e n t r a t e d  
t e n f o l d  was also  made. I t  was found tha t  the unconcent r a t e d ,  PF-  
i n a c t i  vated F422 v i ru s  p r o t e c t e d  5 / 6  k i t t e n s  f ro m  a c h a l l e n g e  
w i t h  FeLVwhich caused v i r a e m i a  in  6 / 6  o f  u n v a c c i n a t e d  k i t t e n s .  
The response  t o  c o n c e n t r a t e d  F422 v i r u s  was not  b e t t e r .  The 
FeLV-A/Glasgow-1 v i r u s  vaccine did not s i g n i f i c a n t l y  p ro tec t  the 
c a t s .  I n  t h i s  e x p e r i m e n t  i t  was a l s o  f o u n d  t h a t  4 o f  5 
v a c c i n a t e d  ca ts  wh ich r e s i s t e d  c h a l l e n g e  had a l a t e n t  FeLV 
i n f e c t i o n  in the bone marrow.
The r e s u l t s  in Chapter 9 are from experiments to at tem pt  to  
assess in v i t r o  the a n t i g e n i c i t y  of  FeLV exposed to four  types of  
c h e m i c a l  i n a c t i v a t i n g  a g e n t s  CPF, F o r m a l d e h y d e ,  AEI and 
b e t a p r o p i o l a c t o n e  CBPLH). T h i s  was a c h ie v e d  by m e a s u r in g  t h e  
b i n d i n g  o f  m o n o c lo n a l  a n t i b o d i e s  to  FeLV t r e a t e d  w i t h  th e s e  
a g e n t s ,  u s in g  an enzyme immunoassay .  These r e s u l t s  i n d i c a t e d  
t h a t ,  as expected,  the e f f e c t  of formaldehdye and PF was s i m i l a r  
but d i f f e r e n t  to  t h a t  of  AEI or BPL. At the concentra t ions  used,  
AEI and BPL had a le s s  h a r m f u l  e f f e c t  on a n t i b o d y  b i n d i n g  
c a p a c i t y  t h a n  f o r m a l d e h y d e  o r  PF. These tw o  l a t t e r  a g e n t s  
markedly reduced a n t i g e n i c i t y  at high co ncentra t ions ( 1 or 2 %) 
but enhanced a n t i g e n i c i t y  (by up t o  65%) a t  c o n c e n t r a t i o n s  
s i m i l a r  to  th o se  used in  th e  s u c c e s s f u l  v a c c i n e s  d e s c r i b e d  i n  
C h a p te rs  7 and 8 .
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P e r s i s t e n c e  o f  FeLV n e u t r a l i s i n g  a n t i b o d i e s  in  n a t u r a l l y  
in f e c t e d  cats was s tu d ied  in Chapter 10. These r e s u l t s  appeared 
to  show t h a t  the  t i t r e  o f  FeLV n e u t r a l i s i n g  a n t i b o d i e s  is  
m a i n t a i n e d  in  c a t s  f o r  a p e r i o d  o f  o v er  one y e a r  w h e t h e r  o r  not  
the cats are cont inuously  exposed to cats e x c r e t in g  FeLV. These 
r e s u l t s  in d ic a t e  th a t  f o l l o w i n g  contact  i n f e c t i o n  a cat  becomes a 
low or a high responder.
Chapter 11 is  a general  discuss ion  which reviews the r e s u l t s  
in  t h i s  t h e s i s  and compares t h e  r e s u l t s  w i t h  t h o s e  o f  p r e v i o u s  
experiments by o th e r s .  Suggest ions f o r  f u t u r e  work are proposed.
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X V I  1
GENERAL INTRODUCTION
F e l i n e  l e u k a e m ia  v i r u s  (FeLV) was d i s c o v e r e d  i n  1964
( J a r r e t t  ej^ a I ,  1 964a )  and has become the  s u b j e c t  of  much 
v e t e r i n a r y  and comparat ive i n t e r e s t  and research throughout the  
world.  FeLV i n f e c t i o n  is  common among cats in s i t u a t i o n s  where
contact  is  f requent  and may be a major cause of  death.  The v i r u s
is respons ib le  f o r  diseases of the haemopoiet ic system in c lud in g  
lymphoid and myeloid mal ignanc ies  and degenera t ive  diseases such 
as a n a e m i a ,  m a r r o w  a p l a s i a  and im m u n o s u p p r e s s io n .  FeLV 
t ransmiss io n  is by c o n ta c t  ( h o r i z o n t a l  t r a n s m i s s i o n )  (Hardy e t  
a l ,  1973; J a r r e t t  et  a I ,  1973) or c o n g e n i t a l l y  from the mother to  
her k i t t e n s  ( v e r t i c a l  t ran sm iss io n )  ( J a r r e t t  and R u s s e l l ,  1978) .  
S i n c e  some c a t s  w h i c h  a r e  e x p o s e d  t o  FeLV d e v e l o p  FeLV
n e u t r a l i s i n g  an t ib o d ies  and become n a t u r a l l y  r e s i s t a n t  t o  FeLV 
i n f e c t i o n ,  i t  is considered tha t  i t  may be poss ib le  to develop an 
e f f e c t i v e  vaccine.  Previous experiments led to  the development  
of  s e v e r a l  p r o t o t y p e  v a c c i n e s  but  none of  t h e s e  has y e t  been  
d e v e lo p e d  f o r  f i e l d  use .  The aim of  t h e  p r e s e n t  s t u d i e s  was t o  
p r e p a r e  a p o t e n t  and s a f e  FeLV v a c c i n e  in  th e  l i g h t  o f  p r e v i o u s  
experiments which would be simple  and inexpensive to  produce and 
would p ro tec t  cats aga inst  FeLV in f e c t i o n s  and l i m i t  FeLV disease  
spread.
1 .  Discovery of  FeLV
FeLV was f i r s t  d i s c o v e r e d  in  1964 in  a s s o c i a t i o n  w i t h  a 
c l u s t e r  o f  c a t s  t h a t  had lymphosarcoma (J a r r e t t  e t  a I ,  19 6 4 a ;  
1 96 4b ) .  The ob s e rv e d  c l u s t e r i n g  of  f e l i n e  lymphosarcoma cases 
l e d  to  e x t e n s i v e  r e s e a r c h  i n t o  th e  n a t u r e  o f  FeLV and t h e  means
1
by which i t  is  t r a n s m i t t e d  from cat to cat ,
2 .  FeLV r e l a t e d  diseases
Experimental  and e p id e m io lo g ic a l  studies have revealed that  
FeLV is  spread contag io us ly  between cats l i v i n g  in  t h e i r  n a t u r a l  
e n v i r o n m e n t ,  as d e s c r i b e d  b e lo w .  The v i r u s  has th e  a b i l i t y  to  
t ransform haemopoiet ic  c e l l s  in t o  tumour c e l l s  and can also  cause 
a number o f  f a t a l  n o n - n e o p l a s t i c  diseases main ly in vo lv in g  the  
haemopoiet ic system.
F e L V - i n f e c t e d  c a ts  which are a p p a r e n t l y  h e a l t h y  have an 
increased chance of  d e v e l o p i n g  F e L V - r e l a t e d  d i s e a s e s  (Hardy e t  
a I ,  1973). The in cubat io n  per iod  f o r  disease development a f t e r  
i n f e c t i o n  v a r i e s  f ro m  weeks to  y e a r s .  The main d is e a s e s  
associated w it h  FeLV i n f e c t i o n  are summarized in  Table 1.
The most common tum our  i n  c a ts  i s  lymphosarcoma o f  which  
t h e r e  a re  f o u r  main fo r m s  ( C r i g h t o n ,  1 9 6 8 ) .  These a re  t h y m i c  
l y m p h o s a r c o m a ,  m u l t i  c e n t r i  c l y m p h o s a r c o m a ,  a l i m e n t a r y  
lymphosarcoma and l y m p h a t i c  l e u k a e m ia .  The second ty p e  o f  
malignant  haemopoiet ic  diseases i n v o l v e s  t h e  m y e l o i d  c e l l s  and 
i n c l u d e s  m y e l o i d  l e u k a e m i a ,  e r y t h r o l e u k a e m i a  and a c u t e  
e r y t h r a e m i a  ( J a r r e t t  and M a c k e y ,  1 9 7 4 ) .  N on-m a I i g n a n t  
h a e m o p o i e t i c  d i s e a s e s  i n c l u d e  two types of  anaemia (haemolyt ic  
a n a e m i a  and e r y t h r o i d  h y p o p l a s i a )  m a r r o w  a p l a s i a  and  
immunosuppression. The second type of non-mal ignant  disease is  
i n f e r t i l i t y ,  main ly f o e t a l  reso rp t io n .
TABLE 1
Main Diseases Associated with  FeLV I n f e c t i o n
Mal ignant  haemopoiet ic diseases
Lymphoid tumours;
Myeloid tumours:
thymic Lymphosarcoma 
m u l t i c e n t r i c  " 
a l im e n ta ry  " 
myeloid leukaemia 
erythro leukaemia  
acute ery thraemia
Non-mal ig n an t  haemopoiet ic diseases
Anaemia: haemolyt ic  anaemia
e r y t h r o i d  hypoplasia  
Immunosuppression: thymic atrophy
Marrow a p la s ia
M y e lo f ib ro s is  and o s te o s c le r o s i s
Non-haemopoiet ic condi t ions
Reproduct ive f a i l u r e :  f o e t a l  re so rp t io n
ab o r t io n
Malignant  haemopoiet ic diseases  
Lymphosarcoma
Lymphosarcoma is the most common mal ignant  tumour of the cat  
and a c co u n ts  f o r  a p p r o x i m a t e l y  one t h i r d  o f  a l l  f e l i n e  tum ours  
( H a r d y ,1981 a ) .  The d i s e a s e  occurs  w i t h  an an n u a l  i n c i d e n c e  of  
a b o u t  45 p e r  1 0 0 , 0 0 0  c a t s  a t  r i s k  ( D o r n  ej^ a I ,  1 9 6 8 ) .  
Lymphosarcoma does not  have a p r e d i l e c t i o n  f o r  any p a r t i c u l a r  
b reed  or  s e x ,  but  o f t e n  o ccurs  in  young c a ts  l e s s  t h a n  3 y e a r s  
old.  Lymphosarcoma is  c l a s s i f i e d  according to the d i s t r i b u t i o n  
of the major gross les ions  in the f o l l o w i n g  4 groups (Mackey and 
J a r r e t t ,  1972; J a r r e t t  and Mackey, 1974 ):
a.  Al imentary  lymphosarcoma
This is the most common form of the tumour which is  u s u a l ly  
found e i t h e r  in  one s i t e  i n  t h e  i n t e s t i n a l  w a l l  or is a s s o c i a t e d  
witl i spread to  the mesenter ic  lymph nodes and kidneys .
b. Thymic lymphosarcoma
T h is  fo rm is  c h a r a c t e r i s e d  by a l a r g e  mass of  m a l i g n a n t  
lymphoid c e l l s  i n f i l t r a t i n g  the s i t e  of  the thymus gland in  the  
a n t e r i o r  m e d i a s t i n u m .  A l l  t h y m ic  lymphosarcoma c o n s i s t  of  T 
c e l l s .  Tumour c e l l s  are seldom found in the blood.
c. M u l t i c e n t r i c  Lymphosarcoma
This is the t h i r d  most common type of lymphosarcoma. Lymph 
nodes a l l  over the body are u s u a l ly  in vo lv ed ,  in  a d d i t i o n  to  the  
l i v e r  and s p l e e n .  M u l t i c e n t r i c  lymphosarcoma mostly occurs in 
young c a t s  ( a v e r a g e  age 4 y e a r s )  and i s  c h a r a c t e r i s e d  by gross  
enlargement of the lymph nodes due to i n f i l t r a t i o n  of mal ignant  
l y m phoid  c e l l s .  At  p o s t - m o r t e m  e x a m i n a t i o n  o r  b io p s y  t h e  
a f f e c t e d  lymph nodes a re  p a l e  w i t h  Loss o f  c o r t  i c o - m e d u l l a r y
d i f f e r e n t i a t i  on.
d. Lymphatic Leukaemia
This form may be considered as Lymphosarcoma which occurs in 
the bone marrow. Growth of mal ignant  c e l l s  in the marrow r e s u l t s  
i n  i m p a i r m e n t  o f  h a e m o p o i e s i s ,  so t h a t  a n a e m i a  and 
t h r o m b o c y t o p e n i a  a r e  o f t e n  seen.  The tu m our c e l l s  spread  t o  
o t h e r  organs by the  b l o o d ,  hence are  found in t h e  b l o o d ,  l i v e r  
and spleen.  This kind of  lymphosarcoma is  o f te n  ch a ra c te r is e d  by 
a great  increase  in the white blood c e l l  count .
Myeloid leukaemias
a.  Myeloid leukaemia
FeLV also causes a group of pr im ary  bone marrow n e o p la s t ic  
d i s o r d e r s  i n v o l v i n g  m y e l o i d  c e l l s .  In  m y e l o i d  l e u k a e m i a ,
mal ignant  myeloid c e l l s  in var ious degrees of d i f f e r e n t i a t i o n  are 
found in the bone marrow, l i v e r  and spleen and r e l a t i v e l y  mature  
granulocytes may be f r e q u e n t l y  found in the blood.
b. Erythro leukaemia
FeLV i n f e c t s  and r e p l i c a t e s  in  e r y t h r o i d  p r o g e n i t o r  c e l l s  
which  s t i l l  have n u c l e i  and causes both d e g e n e r a t i v e  and 
p r o l i f e r a t i v e  d i s e a s e s .  I n  e ry thro leukaem ia  both e r y t h r o id  and 
myeloid c e l l s  are invo lved  in the malignant  process,
c. Acute ery thraemia
In  t h i s  type of Leukaemia the major mal ignant  c e l l  type is  
an e a r ly  e r y t h r o i d  c e l l .
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Non-mal ig n a n t  haemopoietic diseases
I . Anaemias
a, Haemoly t ic  anaemia: Anaemia in cats is  more common than in  
other  pet  animals  because of  severa l  f a c t o r s ,  the most im por ta n t  
of which is FeLV. F eLV -re la ted  anaemia may be a pr im ary  e f f e c t  
of FeLV on haemopoiesis or an i n d i r e c t  consequence of  the e f f e c t s  
of e i t h e r  lymphoid or myeloid leukaemias on haemopoiesis(Mackey  
e ^ £ l_ ,  197 5 ) .
The main types of F eLV-re la ted  anaemia which are recognised  
a r e  e r y t h r o i d  h y p o p l a s i a  and h a e m o l y t i c  a n a e m i a .  O f t e n  
anaemias r e l a t e d  to FeLV i n f e c t i o n  remain undiagnosed u n t i l  the 
severe f i n a l  stages of  the co n d i t io n .  I t  has been suggested th a t  
one s ix th  of cats with  a h aem atocr i t  of less than 0 . 2 0  w i l l  have 
t h i s  type of  anaemia (Hardy, 1981b).
b. E ry th ro id  hypoplasia:  t h i s  anaemia is  f r e q u e n t l y  diagnosed 
in  c a t s  and i s  an a lo g ou s  t o  p u re  red c e l l  a p l a s i a  i n  man, in  
which o n ly  c e l l s  o f  th e  e r y t h r o i d  s e r i e s  a re  a f f e c t e d .  The 
numbers of  e r y t h r o b l a s t s ,  n o r m o b l a s t s  and r e t i c u l o c y t e s  in  t h e  
bone marrow and the blood e ry th rocy tes  r a p id ly  decrease,  w h i le  
th e  p r o d u c t i o n  o f  b lo o d  g r a n u l o c y t e s  and p l a t e l e t s  i s  s t i l l  
n o rm al  (Hoover  e t  a I ,  1974;  Mackey e t  a I ,  1975 ;  Onions e t  a I ,  
1982). A l l  these abnormal haem ato lo g ica I  processes happen due to  
a c o m p le t e  b lo c k  of  e r y t h r o p o i e s i s .  T h is  t y p e  of  anaem ia  is  
o f te n  termed "n o n - re ge n era t iv e"  anaemia.
I I .  Immunosuppression
FeLV is  r e s p o n s i b l e  f o r  s e v e r a l  s eco nd ary  d is e a s e s  which  
d e v e lo p  as a r e s u l t  o f  im m u n o s u p p re s s io n .  FeLV causes both
s p e c i f i c  C a n t i - v i r a L )  a n d  n o n - s p e c i f i c  ( g e n e r a l )  
immunosuppression. The mechanism of immunosuppression is complex 
and not yet  f u l l y  understood.
One c o n t r i b u t i n g  f a c t o r  may be th e  e f f e c t  of  the  v i r u s  on 
the thymus r e s u l t i n g  in thymic atrophy and hence de fec ts  in the  
m a t u r a t i o n  of  T l ym p h o cy tes  (Anderson et a l ,  1 9 7 1 ) .  A no th e r  
suggest ion f o r  immunosuppression development is  the e f f e c t  of the  
v i r a l  envelope p r o t e in  p15E which may act  d i r e c t l y  on lymphocytes 
prevent ing  t h e i r  p a r t i c i p a t i o n  in  immune responses  (P errym an  2 1  
2 L, 1972; Olsen et  198 0 ) .
I I I .  Marrow a p la s ia
This cond i t io n  is c h ara c te r ise d  by hypoplasia  of  myeloid and 
e r y t h r o id  c e l l s  in  the bone marrow which leads to  leukopaenia and 
an a em ia .  F o l l o w i n g  l e u k o p a e n ia  t h e r e  may be rap id  invas ion  of  
the i n t e s t i n a l  e p i t h e l iu m  by b a c t e r i a  c a u s in g  d y s e n t e r y .  T h i s  
condit ion  may be confus,ed c l i n i c a l l y  w ith  panleukopaenia but is  
o f te n  seen in  c a t s  v a c c i n a t e d  a g a i n s t  f e l i n e  p a n l e u k o p a e n i a  
v i ru s  (Hardy, 1931b) .
IV .  Other diseases
These diseases include condi t ions  of  the repro duct ion  system 
p a r t i c u l a r l y  re so r p t io n  o f  f o e t u s e s  and i n f e r t i l i t y  in  queens ,  
and less  f r e q u e n t l y  a b o r t i o n .  A n o th er  d is e a s e  thougt i t  to  be 
i n d i r e c t l y  r e l a t e d  t o  FeLV i n f e c t i o n  i s  g l o m e r u l o n e p h r i t i s  
(Anderson e t  a I ,  1971;  Mackey,  1975)  whi ch may be caused by the  
a c c u m u l a t i o n  o f  immune com ple xes  c o n t a i n i n g  FeLV a n t i g e n s  and 
complement in  t h e  g l o m e r u l i  of  some c a t s  w i t h  p e r s i s t e n t  FeLV 
v i ra e m ia  (Weksler et  a l ,  1975).
s t r u c t u r e  and b io logy  of  f e l i n e  leukaemia v i r u s  
V i r a l  s t r u c t u r e
FeLV is  a ty p e  C r e t r o v i r u s ,  s i m i l a r  in  s t r u c t u r e  to  o t h e r  
r e t r o v i r u s e s  which cause leukaemia in chickens,  c a t t l e  and mice 
( J a r r e t t  et  a I ,  1 964b ) ,  The v i r a l  p a r t i c l e  i s  a p p r o x i m a t e l y  
s p h e r i c a l  and 110 nm in  d i a m e t e r .  The v i r a l  genome i s  RNA and 
is  enclosed in an i n t e r n a l  p r o t e in  core. Surrounding the core is  
a phospho l ip id  envelope from which p r o je c t  sm al l  spikes (L a i r d  et.
1 9 6 3 a ) .
FeLV RNA is s in g le -s t r a n d e d  and two i d e n t i c a l  molecules are 
p r e s e n t  i n  t h e  v i r a l  core  (O. Jar r e t t  e t  a i  j 1 9 7 1 ) .  Bound t o  t h e  
RNA are severa l  molecules of a reverse t r a n s c r i p t a s e  enzyme which 
is  a RNA-dependent DNA polymerase. The RNA contains three  genes 
c a l l e d  gag ,  p o l  and env.  The gag gene codes f o r  t h e  v i r a l  
i n t e r n a l  p ro te in s  (g r o u p - s p e c i f i c  ant igens) .  The pol  gene codes 
f o r  the  r e v e r s e  t r a n s c r i p t a s e ,  and the env gene codes f o r  th e  
p ro te in s  of  the v i r a l  envelope.
The four i n t e r n a l  p ro te in s  which are the products of  the gag 
gene a r e  t e r m e d  pi 5 ,  pi 2 ,  p27 and piQ on a cco u n t  o f  t h e i r  
m o l e c u l a r  w e i g h t s  which a re  1 5 , 0 0 0 ,  1 2 , 0 0 0 ,  2 7 ,0 0 0  and 1 0 ,0 0 0  
r e s p e c t i v e l y  (Green  e t  a t ,  1 9 7 3 ) .  These p r o t e i n s  a re  found a t  
s p e c i f i c  s i t e s  in  t h e  v i r a l  p a r t i c l e .  Thus pi  5 i s  in  the  
e x t e r i o r  of  the v i r a l  core ,  p i 2  is  located j u s t  in s ide  the v i r a l  
envelope, p27 is  the major component of the v i r a l  core s h e l l  and 
p i 0 is  a n uc le o p ro te in  which is associated  w i th  the v i r a l  RNA.
The envelope p r o te in s  are gp70 which is  a g ly co p r o te in  wi th  
a m o l e c u l a r  w e i g h t  o f  about  7 0 , 0 0 0  and p15E which  i s  a non-
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g l y c o s y l a t e d  p r o t e i n  w i t h  a m o l e c u l a r  w e i g h t  o f  1 7 ,5 0 0  (bu t  
15 ,0 0 0  in  S D S - p o l y a c r y  l a m i d e  g e l  e l e c t r o p h o r e s i s )  ( N e i l ,  1978).  
The p15E is  very hydrophobic and is  s t ro n g ly  associa ted w i th  the  
envelope.  This molecule acts to anchor the gp70 to  the envelope 
by d is u lp h id e  bonds. The gp70 c o n s t i t u t e s  the v i r a l  spike which 
p ro je c ts  from the v i r a l  surface .  The spikes have th ree  important  
func t io ns ;  they conta in  the a n t ig e n ic  determinants  which induce 
the product ion of v i r u s  n e u t r a l i s i n g  a n t ib o d ies ;  and they car ry  
t h e  s i t e s  which  d e t e r m i n e  v i r a l  subgroup (A,  B or  C) and t h e  
a b i l i t y  to  i n f e c t  c e r t a i n  c e l l s  by b i n d i n g  to  t h e i r  s p e c i f i c  
sur face r e c e p t o r s .
Subgroups of  FeLV
F e l i n e  le u k a e m i a  v i r u s e s  occur in  3 su b g ro u p s .  A, B or C 
(Sarma and Log,  1 9 7 3 ) .  A l l  FeLV I s o l a t e s  made f rom c a t s  w i t h  
lymphosarcoma or  c l i n i c a l l y  h e a l t h y  c a r r i e r s  c o n t a i n  FeLV o f  
subgroup A (FeLV-A)  and i n  a d d i t i o n  a p p r o x i m a t e l y  h a l f  a l s o  
contain v i r u s  of subgroup B (FeLV-B) ( J a r r e t t  et  a l ,  1978; Sarma 
et  a l ,  1 9 7 3 ) .  V i r u s e s  o f  subgroup  C (FeLV-C)  a r e  r e l a t i v e l y  
r a r e ,  o c c u r r i n g  in  o n l y  1-2% o f  i s o l a t e s  ( J a r r e t t  e t  a I ,  1978)  
but are q u i t e  common (28%) in cats w i th  severe anaemia (Onions et  
a I ,  1 9 8 2 ) .  Thus ,  th e  p o s s i b l e  c o m p o s i t i o n  of  FeLV i s o l a t e s  is  
FeLV-A, FeLV-AB, FeLV-AC or FeLV-ABC.
S e v e r a l  reasons  have been put  f o r w a r d  f o r  the  a p p a r e n t  
dependence of  FeLV-B and FeLV-C on FeLV-A- Sarma and Log (1973)  
showed t h a t  th e  reason was not  because t h e s e  v i r u s e s  were  
d e f e c t i v e  and re q u i red  FeLV-A as a helper  v i r u s  since they could 
be s e p a r a t e d  and grown in  ca t  c e l l  c u l t u r e s  in t h e  absence of
 : :  '  _ ^
FeLV-Ao J a r r e t t  and R u s s e l l  (1 978 )  found t h a t  FeLV-B was not  
t r a n s m i t t e d  h o r i z o n t a l l y  to t r a c e r  k i t t e n s  which had been made 
v i ra e m ic  by e xper im en ta l  i n o c u l a t io n  w it h  FeLV-B alone.  However,  
both FeLV-A and FeLV-B were t r a n s m i t t e d  n a t u r a l l y  from cats which 
were v i ra e m ic  w i th  FeLV-AB. These authors suggested t h a t  FeLV-B 
i s  o n ly  t r a n s m i t t e d  w i t h i n  p h e n o t y p ic  m i x t u r e s  w i t h  FeLV-B 
because t a r g e t  c e l l s  f o r  o n l y  FeLV-A a r e  a v a i l a b l e  in  t h e  
oropharynx.
A d i f f e r e n t  reason was suggested f o r  the dependence of FeLV- 
C on FeLV-A by Russel l  and J a r r e t t  (1978b). This was t h a t  FeLV-C 
v iruses  a r is e  de novo in cats as recombinants of  FeLV-A, acquired  
by exogenous i n f e c t i o n ,  and endogenous F e L V - l ik e  DNA sequences in 
no rm al  ca t  c e l l  DNA (Okabe et  a l ,  1 9 7 6 ) .  R u s s e l l  and J a r r e t t  
(1978b) considered i t  u n l i k e l y  t h a t  FeLV-C v i ru s e s  were a c t u a l l y  
t r a n s m i t t e d  between cats in nature .
The subgroups of  FeLV a r e  d i s t i n g u i s h e d  by i n t e r f e r e n c e  
t e s t s  ( F i s c h i n g e r  and O'Connor,  1969;  Sarma and Log,  1 9 7 1 ) .  
T here  a re  a l s o  d i f f e r e n c e s  in  t h e  host  range o f  each subgroup.  
FeLV-A i n f e c t s  o n ly  c a t  c e l l s  w h i l e  FeLV-B and C have a w i d e r  
h o s t  r a n g e  ( J a r r e t t  e_l a 1,  1 9 7 3 ) .  A n t i g e n i c a l l y ,  by
n e u t r a l i s a t i o n  t e s t s ,  a l l  FeLV-A v iruses  are monotypic but th e re  
is  some a n t ig e n ic  v a r i a t i o n  between i n d i v i d u a l  i s o l a t e s  of  FeLV-B 
or  FeLV-C and t h e r e  i s  c o n s i d e r a b l e  c r o s s - r e a c t i v i t y  b e tw e e n  
subgroups (Russel l  and J a r r e t t ,  1978a ) .
R e p l ic a t io n  of  FeLV
I n f e c t i o n  of the host c e l l  by FeLV begins by the at tachment  
of the spikes of  the v i r u s  envelope surface to  s p e c i f i c  receptors
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on th e  host  c e l l  membrane.  The v i r u s  genome p e n e t r a t e s  i n s i d e  
th e  c e l l  by a method which  is  not c o m p l e t e l y  u n d e r s t o o d .  The 
reverse t r a n s c r i p t a s e  enzyme uses the RNA as a tem p la te  to make a 
s in g le -s t ra n d e d  DNA copy, A double-st randed DNA molecule is then 
s y n t h e s i s e d  w h ic h  i n t e g r a t e s  i n t o  c e l l u l a r  DNA to  fo rm  a 
p ro v ir us .  The p ro v i ru s  in the c e l l  chromosome can be a c t i v a t e d  
to produce v i r u s .
The p r o d u c t i o n  of  a progeny v i r u s  by th e  i n f e c t e d  c e l l s  
occurs  by s y n t h e s i s  o f  mRNA which  in  t u r n  pro duces  t h e  v i r a l  
p r o t e i n s  in  th e  c e l l  c y t o p l a s m .  Complete  i n f e c t i o u s  v i r u s  
p a r t i c l e s  a re  a s s e m b le d  f ro m  t h e  v i r a l  p r o t e i n s  and new RNA a t  
the c e l l  membrane and p a r t i c l e s  are made by budding through the  
membrane w i t h o u t  c a u s in g  damage,  hence t h e r e  is  no c y t o p a t h i c  
e f f e c t  ( L a i r d  _el a I ,  1 9 6 8 a ) .  T h is  occurs  both Jjn v i v o  and in  
in f e c t e d  c e l l  c u l t u r e s .  Whi le  FeLV has the a b i l i t y  to  t ransform  
i n f e c t e d  f e l i n e  c e l l s  in  v i v o  i t  does not  have t h i s  a b i l i t y  in  
v i t r o .
4 .  Transmission of  FeLV
FeLV is  t r a n s m i t t e d  contagious ly  among pet cats in two ways. 
The f i r s t  means of  t ran s m iss io n  is  h o r i z o n t a l  (Hardy et a l ,  1973;  
J a r r e t t  2 l  ^L,  1 9 73 )  by c lo s e  c o n t a c t  v i a  l i c k i n g  or b i t i n g  
b etw een  c a t s  by means o f  c o n t a m i n a t e d  s a l i v a  ( F r a n c i s  e t  a l ,  
1 9 7 7 ) .  T h i s  e n a b l e s  th e  v i r u s  to  i n f e c t  c a ts  th ro u g h  th e  o r a l  
and nasal  e p i t h e l iu m .
The second means of  t ransmiss io n  is e p ig e n e t ic  or congenita l  
t ra nsm is s ion  in which the v i ru s  is  t r a n s m i t t e d  from the in f e c t e d  
queen to  th e  d e v e l o p i n g  f o e t u s  across  th e  p l a c e n t a  d u r i n g
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pregnancy ( J a r r e t t  and R u s s e l l ,  1978) .
5.  Pathogenesis of  FeLV
P e r s i s t e n t l y  v i r a e m i c  c a ts  a re  th e  main source  of  FeLV 
i n f e c t i o n .  Subsequent to  d i r e c t  c o n t a c t  i n f e c t i o n ,  th e  v i r u s  
grows in  t h e  c e l l s  of  th e  o r o p h a r y n x  and is  t r a n s p o r t e d  to th e  
bone marrow v i a  t h e  b lo o d  in  m on o n u c le ar  c e l l s  (R o jk o  e t  a l ,  
1 9 7 9 ) ,  Bone marrow c e l l s  a re  v e r y  s u s c e p t i b l e  to  the  v i r u s  and 
large q u a n t i t i e s  of  FeLV are released in to  the blood. The v i r u s  
then  may s pread  haematogenous l y  t o  o t h e r  t i s s u e s  such as th e  
upper r e s p i r a t o r y  t r a c t  e p i t h e l i a l  c e l l s  and s a l i v a r y  glands and 
thus again to the mouth.
A l th o u g h  FeLV i s  d i s t r i b u t e d  in  t h i s  way a l l  over  th e  body 
o f  t h e  i n f e c t e d  c a t ,  i t s  p a t h o g e n i c  e f f e c t s  a r e  m o s t ly  on t h e  
haemopoiet ic c e l l s .
6 . Outcome of  FeLV i n f e c t i o n
Cats exposed t o  FeLV, e i t h e r  e x p e r i m e n t a l l y  or n a t u r a l l y ,  
become p e r s i s t e n t l y  i n f e c t e d  or  r e c o v e r  (Hard y  e t  a l ,  1 9 7 3 ) .  
Recovered cats e i t h e r  comple te ly  recover and e l i m i n a t e  t h e v i r u s  
or have a l a t e n t  i n f e c t i o n  i n  t h e  bone marrow (R o jko  2 l  a I ,  
1982).  There are two main f a c t o r s  which determine  the outcome 
o f  FeLV i n f e c t i o n .  These a re  t h e  age a t  w h ic h  th e  c a t  i s  
in f e c t e d  and the dose of the v i ru s  to which i t  is  exposed. Thus, 
developing foetuses  and newborn k i t t e n s  are most s u s cep t ib le  and 
have a g r e a t e r  chance of  becoming p e r s i s t e n t l y  i n f e c t e d  than  
a d u l t  c a t s  (Hoover e t  a I ,  1 9 7 6 ) .  The dose o f  v i r u s ,  under  
n a t u r a l  c o n d i t i o n s ,  is  dependent  of  the circumstances in which 
t h e . c a t s  l i v e .  As d e s c r i b e d  b e l o w ,  among f r e e  range  c a ts  t h e
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dose of  v i r u s  t r a n s m i t t e d  is  Low w h i le  in m u l t i c a t  households the  
degree of contact  is  high and the dose of v i ru s  is large .
I t  is  almost  c e r t a i n  t h a t  these f a c t o r s  in f lu e n c e  the immune 
response to  FeLV i n f e c t i o n  and hence th e  a b i l i t y  of  th e  ca t  to  
overcome the i n f e c t i o n .  Young k i t t e n s  do not mount an e f f e c t i v e  
immune response and unless p ro tec ted  by maternal  ant ibody (Hoover 
et  a I ,  1977a; J a r r e t t  e t  a I ,  1977)  a re  i m munosuppressed t o  FeLV.  
Older k i t t e n s  seem to be more i mmunologi ca I  Ly competent and the  
outcome depends on the balance between v i r a l  growth and ra te  of  
development of an immune response to the v i r u s .
Cats exposed to  FeLV have the f o l lo w in g  c h a r a c t e r i s t i c s -
a.  P e r s i s t e n t l y  i n f e c t e d  cats
A n im a ls  which  a re  i n f e c t e d  w i t h  FeLV and f a i l  to  mount an 
e f f e c t i v e  immune response develop a permanent i n f e c t i o n  w i th  a 
p e r s i s t e n t  v i ra e m ia -  These cats cont inuously  excre te  the v i ru s  
f rom  t h e  mouth and a r e  t h e  main source  o f  FeLV i n f e c t i o n  among 
t h e  cat  p o p u l a t i o n .  These  v i r a e m i c  c a t s  have a h igh r i s k  of  
developing F e L v - r e la t e d  diseases .  The s tu d ies  of McCle l land  2 I  
a l  ( 19 80 )  showed th e  outcome in  t h r e e  d i f f e r e n t  t y p e s  of  
households dur ing a 3 . 5  year  p e r io d .
In  the f i r s t  households which were F eL V - f re e ,  32 (17%) of  
191 u n i n f e c t e d  c a t s  d i e d  o f  d is e a s e  d u r i n g  t h e  o b s e r v a t i o n  
p e r i o d -  In  c o n t r a s t ,  159 (83%) were  s t i l l  a l i v e  a f t e r  t h e  same 
per io d .  The second households contained cats which were v i ra e m ic  
and those which were exposed but no n -v i raem ic .  The non-v iraemic  
cats were i s o l a t e d  from the v i r a e m ic  cats.  Of 46 in f e c t e d  cats  
which were i s o l a t e d  from the 233 u n in fec ted  c a ts ,  36 (83%) died
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of disease during the o bserva t ion  per iod  whereas only 29 (12%) of  
th e  233 u n i n f e c t e d  c a ts  d i e d  o f  d is e a s e  d u r in g  t h e  same p e r i o d .  
In  the t h i r d  type of  household which contained both i n f e c t e d  and 
u n i n f e c t e d  c a t s  l i v i n g  t o g e t h e r ,  of  th e  50 i n f e c t e d  c a t s ,  42 
(89%) d ie d  o f  d i s e a s e ,  in  c o n t r a s t  t o  o n ly  21 (24%) o f  t h e  8 8  
u n i n f e c t e d  c a ts  which d i e d  of  d i s e a s e  d u r i n g  t h e  o b s e r v a t i o n  
p e r io d .  T h i s  s tu d y  showed t h a t  t h e r e  was a f i v e - f o l d  h i g h e r  
m o r t a l i t y  r a t e  among F e L V - i n f e c t e d  c a t s  th an  among u n i n f e c t e d  
cats in  the households.
b. Recovered cats
R ecovered  c a t s  a re  o f  two t y p e s .  F i r s t ,  t h e  c a ts  may have 
completely e l i m i n a t e d  FeLV and in these th e re  is  no v i r a e m i a ,  no 
v i rus  may be i s o l a t e d  from the bone marrow c e l l s ,  no in f e c t io u s  
FeLV is  excreted from the mouth and th e re  is  a low r i s k  of  FeLV- 
r e l a t e d  d i s e a s e s  d e v e l o p i n g  (Hardy  e t  a I ,  1 9 7 3 ) .  S e c o n d ly ,  a 
s t a t e  o f  l a t e n t  i n f e c t i o n  may d e v e lo p  i n . w h i c h  t h e r e  i s  no 
v i r a e m i a  but  v i r u s  can be i s o l a t e d  from bone marrow c e l l s  in  
c u l t u r e  (Rojko et  a I ,  1982) . In  these cats no i n f e c t i o u s  FeLV is  
t r a n s m i t t e d  ( M a d e w e l l  and J a r r e t t ,  1 9 8 3 ) .  The r i s k  o f  FeLV-  
r e l a t e d  diseases in  these cats is  not yet  known.
c. T ra n s ie n t  v i raem ia
Some cats which recover from FeLV i n f e c t i o n  have a t r a n s i e n t  
v i r a e m ia  which may l a s t  f rom a day or two up to 8  weeks or longer  
( J a r r e t t  e t  a l , 1982a; Ped ers en  e t  a l ,  1 9 7 9 ) .  D u r in g  t h i s  p e r i o d  
t h e  c a t  may a l s o  e x c r e t e  t h e  v i r u s  f ro m  t h e  mouth and v i r a l  
a n t i g e n  and i n f e c t i o u s  v i r u s  may be f o u n d  i n  t h e  b l o o d .  
Fol lowing e xp e r im en ta l  oronasal  i n f e c t i o n ,  the peak of  t r a n s i e n t
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v i ra em ia  is  at  3 weeks a f t e r  i n f e c t i o n  and is  u s u a l ly  fo l lo w ed  by 
the d e v e lo p m e n t  o f  h ig h  t i t r e s  of n e u t r a l i s i n g  a n t i b o d i e s  
( J a r r e t t  et a l ,  1982a.). Under n a t u r a l  condit ions of  exposure the  
l e n g t h  o f  the t r a n s i e n t  v i r a e m i a  is  more v a r i a b l e  (Pedersen  e t  
2 1 ,  1 9 7 9 ) .
7 .  F e l in e  leukaemia v i r u s  immunity
The r e c o v e r y  o f  FeLV i n f e c t e d  c a t s ,  w h e t h e r  th ey  become 
l a t e n t l y  i n f e c t e d  or  e l i m i n a t e  FeLV, appears  t o  depend on both  
humoral and c e l l  mediated immunity (Madewell  and J a r r e t t ,  1983; 
Rojko et  a l ,  19 8 2 ) .
Serum of recovered cats conta ins two types of  FeLV-spec if ic  
ant ib od ie s :  v i r u s  n e u t r a l i s i n g  an t ibod ies  and a n t ib od ies  to  the
f e l i n e  o n c o r n a v i r u s - a s s o c i a t e d  c e l l  membrane a n t i g e n  (FOCMA) 
(Essex et  a I ,  1971).  V i ru s  n e u t r a l i s i n g  an t ib o d ies  are d i r e c t e d  
against  FeLV gp70 and i n a c t i v a t e  the v i ru s  in v i t r o  and in vivo  
(Hoover  e t  a I ,  1976 ;  J a r r e t t  e t  a I ,  1973;  R u s s e l l  and J a r r e t t ,  
1978a ) .  Also,  these a n t ib o d ie s  are presumably responsib le  f o r  the 
maintenance of  the l a t e n t  s t a t e  of  FeLV i n f e c t i o n  by t h e i r  ac t io n  
on F e L V - i n f e c t e d  c e l l s  in  the  bone marrow (Roj  ko e t  a I ,  1 9 8 2 ) .  
These an t ibod ies  p r o t e c t  the cats from FeLV i n f e c t i o n  and prevent  
v i r a e m i a  in  young k i t t e n s  (Hoover e t  a I , 1 9 7 7 a ;  J a r r e t t  e t  a l ,  
1977 ) .
FOCMA was o r i g i n a l l y  d e f in ed  as an an t igen  on the surface of  
the FL74 c e l l - l i n e  o f  f e l i n e  lymphosarcoma c e l l s  which reacted  
with  an t ibod ie s  in the sera of  cats recovered from f e l i n e  sarcoma 
v i r u s  i n f e c t i o n  (Essex et  a l ,  1971) or  exposed to FeLV X Rfgg ïV l
1971) . A n t i -FOCMA a n t i b o d i e s  appear  to  p r o t e c t  ca ts  from
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lymphosarcoma (Essex et  a l ,  1976) but not from FeLV i n f e c t i o n  and 
v i rae m ia  (Hardy a I ,  1977).
The m olecu lar  nature  of  FOCMA or i t s  genet ic  basis  have not 
y e t  been r e s o l v e d .  I n i t i a l l y  i t  was c l a i m e d  t h a t  FOCMA was a 
t u m o u r - s p e c i f i c  an t igen  which was encoded in the genome of f e l i n e  
sarcoma v i r u s  and induced in tumour c e l l s  by FeLV (Stephenson et  
a l , (1 9 7 7 9 j$ l i s k i  <5c Ess.ex,.(J979) and Hardy 0 9 7 7 )  s ug g e s te d
t h a t  FOCMA was not  a FeLV s t r u c t u r a l  a n t i g e n ,  m a i n l y  because  
p u r i f i e d  FeLV o r  FeLV p r o t e i n s  cou ld  not  absorb  an t i -FOC M A  
ant ibo d ies  from v i r a e m ic  cat  sera.  I t  should be noted,  however,  
t h a t  th e  FeLV which  was used in  th e s e  e x p e r i m e n t s  be lo n g ed  to  
subgroups A and B o n l y .  R u s s e l l  (197 7 )  showed t h a t  i n  t h e  s e r a  
o f  ca ts  exposed to  FeLV t h e r e  was a s t r o n g  c o r r e l a t i o n  b e tw een  
a n t i b o d y  t i t r e s  t o  FOCMA and n e u t r a l i s i n g  a n t i b o d y  t i t r e s  t o  
FeLV-C but  not  t o  t i t r e s  to  FeLV-A or  B, I n  t h e  l i g h t  of  th e s e  
r e s u l t s  he suggested t h a t  th e re  might be a r e l a t i o n s h i p  between  
FOCMA and FeLV-C e n v e l o p e  a n t i g e n s ,  and in de ed  showed t h a t  th e  
m a jo r  a n t i g e n  on F 174 c e l l s ,  which  a r e  t h e  t a r g e t  c e l l s  i n  t h e  
FOCMA t e s t ,  and r e l e a s e d  FeLV o f  subgroups A, B and C, was a 
FeLV-C an t igen .  Recent ly  Vedbrat  2 k  d 983) used both s e lec ted
cat sera and mouse monoclonal an t ib od ie s  to  FeLV-C to  show th a t  
t h e  d i s t r i b u t i o n  o f  FOCMA c o u ld  o n l y  be e x p l a i n e d  on t h e  b a s i s  
th a t  i t  was an a n t i g e n i c  de te rminant  r e l a t e d  to FeLV-C.
Recent s tu d ie s  have found t h a t  c e l l  mediated immunity may 
p l a y  an i m p o r t a n t  r o l e  in  r e c o v e r y  f rom FeLV i n f e c t i o n s .  The 
c e l l s  in volved  are lymphocytes which play  an im por tan t  p a r t  in  
m a in ta in in g  l a t e n t  i n f e c t i o n  in the bone marrow and lyse c e l l s
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which produce v i r u s  in bone marrow c u l t u r e s ,  de r ived  from cats  
with  l a t e n t  in f e c t i o n s  (Rojko et a l ,  1982).
8 . The epidemiology of  f e l i n e  leukaemia v i ru s
C h r o n ic a l ly  ( p e r s i s t e n t l y )  in fe c te d  cats are the main source 
of i n f e c t i o n  in cat  popula t ions .  FeLV is  spread main ly  by close  
c o n t a c t  b e tw e e n  c a t s  by means of  l i c k i n g  or  b i t i n g  i n  which  
s a l i v a  co nta in ing  v i r u s  is  t r a n s f e r r e d .  One m i l l i l i t r e  of  s a l i v a  
may c o n t a i n  5 X 103 t o  2 X 10^ i n f e c t i o u s  v i r u s  p a r t i c l e s  
(F ranc  i s e t  a I ,  1 9 7 7 ) .  I n  t h i s  way th e  v i r u s  i n f e c t s  th e  c a t  by 
way of the mouth and nose ( h o r i z o n t a l  t ran sm is s io n )  (Hardy et a I ,  
1973; J a r r e t t  et  a I ,  1973) .  The o ther  route of  spread of  FeLV is  
across the p lacenta  to the foetus.
The e p id e m io lo g ic a l  p a t t e r n  of FeLV i n f e c t i o n  is  re la t e d  to  
the housing s i t u a t i o n  in which cats are main ta ined  of  which th e re  
are two main types:  open houses and closed houses. In  the f i r s t  
typ e,  cats are u s u a l l y  kept s in g ly  or in smal l  numbers and range 
f r e e l y .  Thus, contact  between cats is  f requent  but i n t e r m i t t e n t  
and low doses o f  v i r u s  are t r a n s m i t t e d  from in f e c t e d  to hea l thy  
cats ,  hence the preva lence  of  exposure is  high (50-70%) ( J a r r e t t  
et  a I ,  1973) , By c o n t r a s t ,  p e r s is t e n t  i n f e c t i o n s  are in f re q u e n t  
(1%) (Rogerson e t  a I ,  1 9 7 5 ) .  I n  th e  second p a t t e r n ,  c a t s  a re  
g e n e r a l l y  kept  in m u l t i c a t  households in which sev era l  cats are  
kept to g e th er  and are is o la t e d  from the general  cat p opu la t ion .  
Since they are in  close contact  w i th  each o t h e r ,  the in t r o d u c t i o n  
of FeLV i n t o  t h e s e  househo lds  by means o f  a c a r r i e r  le a d s  t o  
w id e s p r e a d  d i s s e m i n a t i o n  o f  t h e  v i r u s .  In  t h i s  way a h ig h  
p r o po r t io n  of  the cats (about 40%) develops p e r s i s t e n t  i n f e c t i o n s
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(Hardy e t  a l ,  197 3 ;  J a r r e t t  2 I  2 l  197 8 ) .  The main f e a t u r e s  in  
both types of cats are shown in Table 2.
9.  F e l in e  leukaemia v i r u s  c o n t r o l
I n  the  l i g h t  of  e p i d e m i o l o g i c a l  s t u d i e s ,  i t  ap peared  t h a t  
c o n t r o l  o f  FeLV sh o u ld  be p o s s i b l e  by r em o v in g  t h e  so u rce  o f  
i n f e c t i o n  from the m u l t i c a t  households. Programmes of co n t r o l  to  
e s t a b l i s h  and m a i n t a i n  F e L V - f r e e  ca t  hou s eh o ld s  have been  
developed (Hardy et  a l ,  1976; W e i j e r  <5cE)aams, 1978) .  As described  
above ,  p e r s i s t e n t l y  v i r a e m i c  c a t s  a r e  t h e  main source  o f  
i n f e c t i o n ,  hence i s o l a t i o n  or  d e s t r u c t i o n  o f  t h e s e  c a ts  i s  th e  
f i r s t  i m p o r t a n t  s t e p  t o  c o n t r o l  th e  i n f e c t i o n  (Hardy e t  a I ,  
1976) .
Three  d i a g n o s t i c  methods a re  c u r r e n t l y  used to d e t e c t  
v iraemic  ca ts .
a. An im m u n o f l u o r e s c e n c e  ( I F )  method is  s i m p l e ,  r a p i d  and 
inexpensive (Hardy et  a l ,  1973) . FeLV ant igen  is  detected  in the  
cytoplasm of blood n e u t r o p h i ls  in a f i x e d  blood smear.
b. An e n z y m e - l i n k e d  im m u no s o rb en t  assay (ELISA) which  i s  
com m erc ia l l y  a v a i l a b l e  in k i t  form (Leukassay F) de tects  FeLV p27 
ant igen f r e e  in the plasma which is  presumably re leased by v i r u s -  
producing c e l l s  in the bone marrow.
c. V i r u s  i s o l a t i o n  ( V I )  i s  somewhat e x p e n s i v e  and t a k e s  6  days  
t o  c a r r y  o u t .  H o w e v e r ,  i t  i s  v e r y  r e l i a b l e  s i n c e  i t  d e t e c t s  
i n f e c t i o u s  v i r u s  i n  t h e  p las m a  ( J a r r e t t  et  a l ,  T968;  J a r r e t t  e t  
a i ,  1982b) .
The nex t  s t e p  in t h e  c o n t r o l  programme is  to  e f f e c t i v e l y  
d i s i n f e c t  th e  ca t  h o u s i n g ,  l i t t e r >  pans and f e e d i n g  b o w ls .  The
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TABLE 2
FeLV epidemioLogicaL s i t u a t i o n s
Closed m u l t i c a t  households
High exposure r a t e :  > 80% anti-FOCMA an t ib o d ie s
High v i raem ia  r a t e :  40% vi raemia
High in cidence  of  disease
Free-range cats
High exposure r a t e :
Low v i ra em ia  r a t e ;
Low inc idence  of  disease
50% anti-FOCMA a n t ib o d ie s  
1 % vi raemia
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t h i r d  step is to  r e t e s t  the cats at  Least 12 weeks a f t e r  removal  
of the v i raem ic  cats to  e s t a b l i s h  whether any p o s i t i v e  cats which 
have been r e t a i n e d  a r e  s t i l l  p o s i t i v e  and t h e r e f o r e  have a 
perm anent i n f e c t i o n .  More i m p o r t a n t l y ,  r e t e s t i n g  the negat ive  
cats is  done to ensure t h a t  they  are s t i l l  ne g a t iv e  and were not 
i n c u b a t i n g  an i n f e c t i o n  a t  the  i n i t i a l  t e s t ,  f u r t h e r  t e s t i n g  
p e r i o d i c a l l y  every 6  months ensures th a t  the negat iv e  cats remain 
so, and de tects  i f  there  are any new cases of i n f e c t i o n .  Also to  
p r o t e c t  a g a i n s t  r e - e n t r y  o f  FeLV, no new c a t s  s ho u ld  e n t e r  t h e  
house before t e s t i n g  and s a t i s f a c t o r y  quarant ine has been c a r r ie d  
out.
The measures have been very successful  in e r a d i c a t i n g  FeLV 
from many m u l t i c a t  households (Hardy et a l ,  1976; W e i je r  and 
Daams, 1978) .
10.  A n t i - f e l i n e  Leukaemia v i r u s  v acc in a t io n
To c o m p le t e  a FeLV d i s e a s e  e r a d i c a t i o n  programme an 
e f f e c t i v e  vaccine would be e x t rem ely  u se fu l .  In  a household from 
which v i r u s  had been e r a d ic a t e d ,  in t r o d u c t io n s ,  such as k i t t e n s  
born in t h e  house or  bought in from a n o t h e r  s o u r c e ,  co u ld  be 
p ro tec ted  aga inst  f u t u r e  exposure to FeLV a t ,  f o r  example,  stud 
or cat shows. From e p id e m io lo g ic a l  studies of FeLV i t  is  c le a r  
t h a t  many c a t s  fo r m  p r o t e c t i v e  t i t r e s  o f  v i r u s  n e u t r a l i s i n g  
ant ib od ies  as a consequence of a previous FeLV exposure and are 
known t o  be r e s i s t a n t  t o  r e i n f e c t i o n  w i t h  v i r u s  s u g g e s t i n g  t h e  
p o s s i b i l i t y  of  v a c c i n a t i o n .  A lso we know t h a t  most FeLV 
t ransm is s io n  occurs h o r i z o n t a l l y ,  by close c o n tac t ,  so t h a t  the  
t ransm is s ion  cycle might be broken by vacc in a t io n .
I  m munoprophy l a x  i s i s  one o f  the  m a jo r  ways o f  p r e v e n t i n g
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i n f e c t i o u s  d i s e a s e s  i n  a n i m a l s  and man. The main means o f  
a c h i e v i n g  a c t i v e  i m m u n i t y  i s  the use o f  p o t e n t ,  s a fe  and 
e c o n o m i c a l  v a c c i n e s -  The v i r a l  v a c c i n e s  in  c u r r e n t  use a r e  o f  
two main types ,  a t ten u a ted  (m odif ie d  l i v e )  or in a c t i v a t e d  (dead 
or k i l l e d ) .  In  a d d i t io n  subunit  vaccines co n s is t in g  of s u b v i r a l  
ant igens f r e e  of  n u c le ic  acid  have been developed fo r  a l i m i t e d  
number o f  v i r u s e s  ( B o l o g n e s i ,  1976 ;  S a l e r n o  e t  a l ,  1978;  
B a l c a r o v a  et  a I ,  1 9 8 1 ) .  A f o u r t h  type  of  v a c c i n e  which is  now 
being in v e s t i g a t e d  comprises sy n th e t ic  pept ides  which correspond 
to  the re le v a n t  a n t ig e n ic  determinants  of v i ru ses  ( B i t t l e  et  a I ,  
1982) .
M o d i f ied  l i v e  v i r u s  vaccines contain v iruses  which are non­
pat  h ogen ic  b u t  r e t a i n  t h e  a n t i g e n ( s )  o f  t h e  c o r r e s p o n d in g  
v i r u l e n t  v i r u s  w h i c h  i s ( a r e )  r e s p o n s i b l e  f o r  i n d u c i n g  a 
p r o t e c t i v e  immune response. These a t tenuated  v i ru se s  have been 
obta ined in s e v e ra l  ways, the most common of which are passage 
of v i ru s  f o r  long per iods in v i t r o ,  passage of v i r u s  in c e l l s  of  
a heterologous host or growth of a v i ru s  at  low tempera tures.  In  
the c a t ,  l i v e  vaccines are used f o r  immunisat ion ag ainst  f e l i n e  
panleukopaenia v i r u s ,  f e l i n e  c a l i c i v i r u s  and f e l i n e  herpesv irus.  
There  a r e  s e v e r a l  p o t e n t i a l  a d v a n t a g e s  o f  l i v e  v a c c i n e s .  
F i r s t l y ,  sm al l  doses of  v i r u s  may s t i m u l a t e  an e f f e c t i v e  immune 
response because the v i r u s  r e p l i c a t e s  in the host . Secondly,  the  
immune response  to  th e  v a c c i n e  may be s i m i l a r  in  ty p e  t o  t h a t  
produced f o l l o w i n g  n a t u r a l  exp osu re  t o  f i e l d  v i r u s .  T h i r d l y ,  
u s u a l l y  o n ly  one a d m i n i s t r a t i o n  of  v a c c i n e  i s  r e q u i r e d .  The 
major p o t e n t i a l  disadvantage of  l i v e  v i r u s  vaccines is th a t  the
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v i r u s  may r e v e r t  to  v i r u l e n c e  f o l l o w i n g  g ro w t h  in  v a c c i n a t e d  
animals and spread to oth er  animals.
I n a c t i v a t e d  v i r u s  v a c c i n e s  a re  t h e o r e t i c a l l y  s a f e r  than  
a t t e n u a t e d  v a c c i n e s  s in c e  th e y  cannot grow in  th e  a n i m a l  and 
t h e r e f o r e  cannot cause any disease or re v e r t  to  v i r u le n c e .  This  
assumes t h a t  th e  v i r u s  has been s u f f i c i e n t l y  w e l l  i n a c t i v a t e d .  
R e c e n t l y  i n a d e q u a t e  i n a c t i v a t i o n  o f  a f o o t - a n d - m o u t h  d i s e a s e  
v i ru s  vaccine led to in ocu la ted  pigs being in f e c t e d  in France and 
t h e  subsequent  sp rea d  o f  l i v e ,  v i r u l e n t  v i r u s  t o  th e  Channe l  
I s l a n d s  and the I s l e  o f  W ig ht  in 1981 (Donald son e t  a l ,  1 9 8 2 ) .  
In  c a ts ,  i n a c t i v a t e d  v iru se s  are used in a vaccine  against  f e l i n e  
p a n le 'ukopaen ia  v i r u s ,  f e l i n e  c a l i c i v i r u s  and f e l i n e  herpesvirus  
( V a x i ca t  P lu s :  Tasman V a c c in e  L a b o r a t o r i e s ) .  I n  p r a c t i c e ,  t h e  
main disadvantages of  in a c t i v a t e d  v i ru s  vaccines compared to l i v e  
v i r u s  v a c c i n e s  a r e  t h a t  s e v e r a l ,  u s u a l l y  t w o ,  i n o c u l a t i o n s  o f  
v a c c i n e  a re  r e q u i r e d  and a much l a r g e r  amount of  v i r u s  must be 
i n c o r p o r a t e d  i n t o  t h e  v a c c i n e  in  o r d e r  t o  p r o v i d e  s u f f i c i e n t  
a n t ig e n ic  mass fo r  immunisat ion.
The choice of the type of vaccine which could be used in  the  
f i e l d  f o r  immunisat ion aga inst  FeLV i n f e c t i o n s  is  r e s t r i c t e d  at  
p r e s e n t  t o  i n a c t i v a t e d  p r e p a r a t i o n s ,  f o r  t h r e e  main rea so n s .  
F i r s t l y ,  a t ten u a ted  FeLV s t r a i n s  have not yet  been developed and 
are u n l i k e l y  to be produced in the near f u t u re  since  t e s t i n g  FeLV 
f o r  non -p a th o g en ic i ty  would r e q u i r e  s e v e r a l  y e a r s  owing  t o  t h e  
long i n c u b a t i o n  p e r i o d s  of  most FeLV i s o l a t e s  (Mackey e t  a l ,
1 9 7 2 ) .  S e c o n d l y ,  s u b u n i t  v a c c i n e s  d e r i v e d  f ro m  p u r i f i e d  FeLV 
p a r t i c l e s  would be p r o h i b i t i v e l y  expensive ,  since large  amounts 
of p u r i f i e d  v i r u s  would have to be produced. T h i r d l y ,  vaccines
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based on s y n t h e t i c  pep t ides  are s t i l l  at the exper im en ta l  stage.  
Another,  n o n - s c i e n t i f i c ,  reason is tha t  i t  is very u n l i k e l y  t h a t  
p r o d u c t  l i c e n s i n g  a u t h o r i t i e s  would  p e r m i t  t h e  use o f  a l i v e  
vaccine f o r  a v i r u s  which is  oncogenic in a species which l i v e s  
c l o s e ly  w i th  human beings.
W. J a r r e t t  and h i s  c o l l e a g u e s  were t h e  f i r s t  to  a t t e m p t  t o  
develop a FeLV vaccine ( J a r r e t t  et  a I ,  1974). In  an i n i t i a l  study 
they in o cu la ted  cats with  l i v e  f e l i n e  lymphoblastoid c e l l s  of the  
FL74 l i n e  and o b t a i n e d  h ig h  t i t r e s  o f  an t  i -FOCMA a n t i b o d i e s .  
Some of  these in o c u la te d  cats were subsequently chal lenged w i th  
l i v e  FeLV o f  a h i g h l y  p a t h o g e n ic  s t r a i n  and r e s i s t é d  t h e  
i n f e c t i o n  w h i le  another group of cats given the cha l lenge  v irus  
became in f e c t e d  ( J a r r e t t  et. 2 1 /  1975). In the same experiments ,  
p u r i f i e d  v i r u s  r e l e a s e d  from FL74 c e l l s  was i n o c u l a t e d  i n t o  
a n o t h e r  group o f  c a t s .  I n  a d d i t i o n  c a t s  were v a c c i n a t e d  w i t h  
p a ra f o rm a ld e h y d e - in a c t iv a t e d  FL74 c e l l s .  The r e s u l t s  were t h a t  
p u r i f i e d  v i r u s  d i d  not  in d u ce  FOCMA a n t i b o d i e s  i n  c a t s ,  w h i l e  
c a ts  v a c c i n a t e d  w i t h  P F - i n a c t  i v a te d  FL74 c e l l s  developed FOCMA 
a n t i b o d i e s .  No v i r u s  c o u l d  be i s o l a t d  e i t h e r  f r o m  t h e  
i n a c t i v a t e d  v a c c i n e  or  f rom the  v a c c i n a t e d  cat  t i s s u e s .  The 
c o n c l u s i o n  f ro m  t h e s e  e x p e r i m e n t s  was t h a t  FL74 c e l l s  were  
immunogenic but released low i n f e c t i v i t y  v irus  and might be of  
value in de v is in g  vaccines aga ins t  FeLV.
A n o th er  FeLV v a c c i n e  p r e p a r a t i o n  was made by Pedersen  and 
h i s  c o - w o r k e r s  (Pede rsen  e t  a I ,  1979)  who v a c c i n a t e d  c a t s  w i t h  
l i v i n g  v i ru s  released from FL74 c e l l s ,  fo rm a ld e h y d e - in a c t iv a t e d  
v i ru s  from th e  same source or  fo rm a ld e h y d e - in a c t iv a t e d  FL74 c e l l s
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and ch aL te n ge d  t h e  c a t s  w i t h  v i r u l e n t  FeLV by c o n t a c t .  T h e i r  
r e s u l t s  were  t h a t  n e i t h e r  i n a c t i v a t e d  v a c c i n e  produced a 
measurable anti-FOCMA or v i r u s  n e u t r a l i s i n g  ant ibody response nor  
c o m p l e t e l y  p r e v e n t e d  n a t u r a l  i n f e c t i o n  w i t h  v i r u l e n t  FeLV. 
H o w e v e r ,  t h e  l i v e  v i r u s  v a c c i n e  d r a m a t i c a l l y  d e c r e a s e d  t h e  
p r o p o r t i o n  of  i n f e c t e d  k i t t e n s .  The c e l l  v a c c i n e  d id  not  
p r o t e c t  aga in st  cha l lenge .
A t h i r d  a t t e m p t  t o  d e v e lo p  a FeLV v a c c i n e  was made by 
S a l e r n o  and h i s  c o - w o r k e r s  ( S a l e r n o  _et. a I ,  1 9 7 8 ) .  T h ey  
apparent ly  pursued the development of  a subunit vaccine aga inst  
FeLV as a g u i d e l i n e  t o  p r e p a r i n g  s i m i l a r  v a c c i n e s  f o r  human 
beings in the event th a t  r e t r o v i r u s e s  were found to be causes of 
leukaemia in man, A subunit  vaccine was chosen to  avoid the use 
of  a l i v e  o n co g e n ic  v i r u s  or  the  o n cogen ic  v i r a l  RNA. The 
ant igen  s e lec te d  f o r  subuni t  v a c c i n e  p r e p a r a t i o n  was t h e  v i r a l  
envelope g ly c o p r o t e i n ,  gp70. The g lyc o p ro te in  was p u r i f i e d  from 
FeLV-AB v i r u s  and was g i v e n  t o  c a t s  and g u in e a  p ig s  w i t h  and 
w i t h o u t  a d j u v a n t .  An aqueous v a c c in e  in duced  n e u t r a l i z i n g  
ant ibody in  only 50% of  guinea pigs w h i le  an adjuvanted  vaccine  
induced h i g h e r  l e v e l s .  I n  c o n t r a s t  to  g u in ea  p i g s ,  c a ts  
im m unised  w i t h  t w i c e  t h e  g u in e a  p ig  dose produced  l i t t l e  o r  no 
response  w i t h  t h e  aqueous v a c c i n e  and even le s s  of  an immune
resp onse  t h a n  g u in e a  p i g s  when v a c c i n a t e d  w i t h  an A l ( 0 H) 3  
a d j u v a n t e d  v a c c i n e -  At the  same t i m e  t h i s  g l y c o p r o t e i n  was 
in o cu la ted  in t o  goats and induced a high t i t r e  of  ant ibody which 
s p e c i f i c a l l y  n e u t r a l i s e d  FeLV.
F i n a l l y ,  Olsen and his  co-workers have prepared severa l  FeLV 
vaccines.  F i r s t ,  they immunised cats w i th  t h e r m a l l y  in a c t i v a t e d
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FL74 c e l l s  and t h e s e  c a t s  p roduced h ig h  t i t r e s  o f  a n t i b o d y  to  
FOCMA and were p r o t e c t e d  from o ncogen ic  f e l i n e  sarcoma v i r u s  
c h a l l e n g e .  H o w e v e r ,  t h e  v a c c i n e  d i d  n o t  i n d u c e  v i r u s  
n e u t r a l i s i n g  an t ib ody ,  nor did i t  prevent  FeLV v i r a e m ia  f o l l o w i n g  
c h a l l e n g e  (O lse n  e t  a I ,  1 9 7 6 ) .  A second a t t e m p t  t o  p r e p a r e  a 
FeLV vaccine was made by g iv in g  the cats a dual vaccine composed 
o f  k i l l e d  FL74 c e l l s  and k i l l e d  FeLV ( f o r m a  I i  n - t  r e a t e d  o r  
u l t r a v i o l e t  l i g h t  i n a c t i v a t e d )  in  an a t t e m p t  t o  p r e v e n t  both  
v i ra e m ia  and ensuing n e o p la s t ic  disease.  The unexpected r e s u l t  
of using t h i s  vaccine was th a t  the cats became more su scep t ib le  
to  FeSV c h a l l e n g e  t h a n  t h e  u n v a c c i n a t e d  c o n t r o l  c a t s .  I t  was 
c o n s i d e r e d  t h a t  t h e  c o m b i n a t i o n  of  both  FeLV and tumour  c e l l  
vaccine abrogated p r o t e c t i v e  tumour immunity. T h e i r  exp lana t io n  
of  t h i s  r e s u l t  was t h a t  a s m a l l  m o l e c u l a r  p r o t e i n  (p15E) f ro m  
FeLV which was i n  t h e  v a c c i n e  was im m u n o t o x ic  and led  t o  
s u p p r e s s i o n  of  t h e  c a t s '  lym p h o c y te  f u n c t i o n s  r e n d e r i n g  th e  
vacc inated cats more s u s c e p t ib le  than the c o n t ro ls .  At the same 
t i m e  th e s e  w o r k e r s  v a c c i n a t e d  c a ts  w i t h  k i l l e d  FeLV or k i l l e d  
FL74 c e l l s  w i t h  t h e  r e s u l t  t h a t  v i r u s  n e u t r a l i s i n g  a n t i b o d i es 
were induced  in  a d u l t  c a t s ,  but  not  in  young k i t t e n s  a t  f i r s t  
v a c c i n a t i o n .  P r o t e c t i v e  i m m u n i t y  a g a i n s t  t h e  s u b s e q u e n t  
n eo p la s t ic  disease was e v i d e n t ,  but the vaccine did not prevent  
FeLV v i r a e m ia  (Olsen et  a I ,  T980 a ) ,
In  the l i g h t  of these exper iments ,  Olsen and his co-workers  
subsequently developed a so lub le  tumour c e l l  vaccine co nta in ing  
v i r a l  p ro te in s  and "FOCMA", which was prepared from concentrated  
spent  media  o f  FL74 c e l l s  grown i n  s e r u m - f r e e  medium. T h i s
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m a t e r i a l  was n o n - i n f e c t i o u s  and was used w i t h  c o m p le te  or  
incomplete Freund's ad ju v an t ,  or AKQH)^ to vacc in a te  cats.  The 
v a c c in a t io n  r e s u l t s  were th a t  potent  anti-FOCMA an t ib o d ies  were 
in duced and a h ig h  p r o p o r t i o n  (80%) o f  th e  c a ts  were p r o t e c t e d  
from FeLV v i r a e m ia  and r e l a t e d  diseases a f t e r  chal lenge  w i th  the  
Rickard s t r a i n  of FeLV. In  contras t  a l l  c o n t ro l  cats developed  
FeLV v i r a e m i a  a f t e r  c h a l l e n g e  ( O l s e n  eJl a I ,  19 8 0 a ) .  The  
v a c c i n a t e d  ca ts  made a n t i b o d y  to  FeLV g p 70 ,  FeLV pH7 and FeLV 
pi 5 ,  as shown by i m m u n o p r é c i p i t a t i o n  o f  r a d i o l a b e l i e d  v i r a l  
p r o t e in s .
The present  study
The pr im ary  aim of the stud ies described in t h i s  th e s is  was
to develop a vaccine aga in st  FeLV i n f e c t i o n  based on ch em ica l ly
i n a c t i v a t e d  whole v i r u s .
I n  th e  t h e s i s .  C h a p te r  1 d e a l s  w i t h  t h e  g e n e r a l  m a t e r i a l s  
and methods used in  these s tud ies  w h i le  s p e c i f i c  m a t e r i a ls  and 
methods are descr ibed  in the i n d i v i d u a l  chapters .  Chapter 2 is  
an acco u n t  o f  s t u d i e s  t o  f i n d  t h e  opt im um c o n d i t i o n s  f o r  
producing c e l l s  and v i r u s  f o r  use in the p r e p a ra t io n  of vaccines.  
Chapter  3 descr ibes  the r e s u l t s  of  stud ies  on the i n a c t i v a t i o n  
of FeLV pseudotypes of mouse sarcoma v i ru s  to f i n d  the condit ions
to i n a c t i v a t e  FeLV. Using these r e s u l t s ,  s ev e ra l  FeLV vaccines
were prepared w i th  these agents and compared f o r  e f f i c a c y  in an 
experiment descr ibed  in Chapter  4. Some problems in vo lv in g  s id e -  
e f f e c t s  of  the  a d j u v a n t  and th e  c h a l l e n g e  dose of  v i r u s  were  
encountered in t h i s  exper im ent ,  and Chapters 5 and 6  present  the  
re s u l t s  of experiments to overcome these problems,
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C h a p t e r  7 and 8  d e s c r i b e  t w o  f u r t h e r  v a c c i n a t i o n  
e x p e r i m e n t s .  I n  th e  f i r s t ,  a co m p a r iso n  was made of  two  
d i f f e r e n t  a d j u v a n t s ,  s a p o n in  and i n c o m p l e t e  Freund 's  a d j u v a n t .  
In  the second, Freund's ad juvant  was used and FeLV produced from 
two s o u r c e s ,  s u s p e n s io n  c u l t u r e s  or  mono l a y e r  c u l t u r e s ,  was 
compared as an an t igen .  Chapter  9 is  an account of  experiments  
in  which  a t t e m p t s  were  made t o  d e v e lo p  an in  v i t r o  t e s t  o f  
a n t i g e n i c i t y  of FeLV an t ig en  t r e a t e d  w i th  chemical i n a c t i v a t i n g  
agents.  F i n a l l y ,  in  Chapter 10 an experiment is  described which 
examined  the  p e r s i s t e n c e  o f  FeLV a n t i b o d i e s  in  ca ts  which had 
recovered from n a t u r a l  FeLV i n f e c t i o n .
25
 : ^ : .
' : ;: , . . . ■ . •: ^, . -  ^, ' - ,- v ■ ' .„. ' . '. - ■ -^ v . '•'•■■„' ■.■•■,• • ■ -■ _ ' . : : - - -. ' v ^  ._ yf  ^ ..-
CHAPTER 1 
MATERIALS AND METHODS
M a t e r i a l s
1.  Media
The G l a s g o w  (B H K 21)  m o d i f i c a t i o n  o f  E a g l e 's  M i n i m a l  
E s s e n t ia l  Medium (MEM) was suppl ied  by the I n s t i t u t e  of  V i r o lo g y ,  
U n iv e r s i t y  of Glasgow, Growth medium (EFC) was Eagle's MEM wi th  
10% f o e t a l  c a l f  serum (FCS),  O c c a s i o n a l l y  medium w i t h  20% FCS 
was used (EFC20) ,  FCS was purc h ase d  from G ib c o - E u r o p e  L t d  and 
batches were s e le c te d  f o r  t h e i r  capac i ty  to support  the growth of  
FeLV pseudotypes of murine sarcoma v i ru s  (MSV(FeLV)).
L e ib o v i t z  L - 1 5 medium was purchased from Gibco-Europe Ltd.  
T h is  medium is  in d e p e n d e n t  of  CO^ f o r  b u f f e r i n g  and f o r  t h i s  
reason was used t o  make d i l u t i o n s  o f  v i r u s e s  and se ra  d u r i n g  
assays.
McCoy's 5a medium (Gibco-Europe Ltd)  was used with  an equal  
volume o f  L e i b o v i t z  L-1 5 medium and 15% FCS t o  grow s u sp en s io n  
c e l l  c u l t u r e s .  T h is  g ro w t h  medium was te rm e d  L-M medium.  
P e n i c i l l i n  (100 u n i t s / m l )  and s t r e p t o m y c i n  (100  u n i t s / m l )  were  
used in a l l  media.
2,  C e l l  cu l tu re s
The fo l lo w in g  c e l l s  were used,
a. FEA c e l l s :  These f e l i n e  embryonic f i b r o b l a s t  c e l l s  were used
between passage 15 and 35 ( J a r r e t t  et  a I ,  1973 0 .  The c e l l s  were 
r o u t i n e l y  grown in 250 ml glass b o t t l e s  w i t h  12 ml of  EFC medium 
and one q u a r t e r  of  t h e  t o t a l  c e l l s  were s u b - c u l t u r e d  t w i c e  a 
week.
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b. C81 c e l l s :  The clone 81 c e l l s  were o r i g i n a l l y  der ived  from 
the Crande l l  f e l i n e  kidney f i b r o b l a s t  c e l l  l i n e  CCCC) and conta in  
t h e  genome o f  Moloney  mouse sarcoma v i  rus (MSV) ( F i s c h i n g e r  e t  
a l ,  1974 ) .  These c e l l s  were grown and su b -cu l tu red  as above.
c. FL74 c e l l s :  These are n e o p la s t ic  lymphoid c e l l s  der ived  from 
a lymphosarcoma tumour of the kidney of a cat in f e c t e d  with  FeLV 
(T h e i  len  e t  a l ,  1 9 6 9 ) .  The c e l  ls  were  grown in  susp en s io n  and 
were s u b-cu lt u red  w i th  L-M medium at 1 X 10 & per ml dens ity  and 
were s u b -c u l tu re d  t w ic e  a week. The c e l l s  cont inuously  re lease  
FeLV-ABC/KT s t r a i n  in la rge  q u a n t i t i e s .
d. F422 c e l l s :  T h i s  c e l l  l i n e  was e s t a b l i s h e d  f rom a t h y m i c  
lymphosarcoma of a k i t t e n  in o cu la ted  with  the second passage of 
the Rickard s t r a i n  of  FeLV (Rickard  et a I ,  1969) . The c e l l s  grow 
in suspension c u l t u r e  w i th  L-M medium and re le ase  FeLV of  sub­
group A.
3 .  F e l in e  leukaemia v iru s es
The fo l lo w in g  f e l i n e  leukaemia v iruses  were used.
a. F e L V - A /G la s g o w - 1  was o r i g i n a l l y  i s o l a t e d  f ro m  a c a t  w i t h
a l i m e n t a r y  l y m p h o s a r c o m a .  The v i r u s  was r e l e a s e d  f r o m
c h r o n i c a l l y  i n f e c t e d  FEA c e l l  c u l tu r e s  ( J a r r e t t  et a I ,  1973).
b.  FeLV-A/F422 was re leased from F422 suspension c u l t u r e s .
c.  FeLV-ABC/FL74 was produced from FL74 c e l l s .
4 .  FeLV pseudotypes of  mouse sarcoma v i rus
A FeLV-A/Glasgow-1 pseudotype of Moloney mouse sarcoma v i r u s
was used (MSV (FeLV-A /G  la sg o w -1  ) .  The Moloney mouse sarcoma 
v i r u s  was rescued from C81 c e l l s  by FeLV-A/Glasgpw-1 (Russe l l  and 
J a r r e t t ,  1976).
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5,  Experimental  cats
The e x p e r i m e n t a l  k i t t e n s  were o b t a i n e d  from th e  s p e c i f i c  
p ath og en  f r e e  ca t  c o lo n y  o f  t h e  V e t e r i n a r y  School  o f  Glasgow  
U n i v e r s i t y ,  G e n e r a l l y  th e s e  k i t t e n s  were  8  weeks o ld  at th e  
beginning of the experiments .
Methods
1.  C e l l  growth and s u b -c u l tu re s
A l l  c e l l s  g r o w in g  in  su s p en s io n  c u l t u r e  were at  a c e l l  
de n s i ty  of  1 X 10^/ml in  8  ounce glass b o t t l e s  or 25 cm^ p l a s t i c  
f l a s k s  (Nunc) w i th  12 ml L-M medium and were su b-cu ltu red  every  
3-4  days. Seeding of  these c e l l s  was r e s t r i c t e d  to  l i v i n g  c e l l s  
which were in d ic a t e d  by using Trypan blue (1%) to s t a in  the dead 
c e l l s .  I n  some cases where  t h e r e  was a h igh p e r c e n t a g e  o f  dead  
c e l l s ,  a F ico l l -Hypaque s o lu t io n  was used to remove these c e l l s  
f rom t h e  c u l t u r e .  A vo lume o f  15 ml o f  su s p en s io n  c u l t u r e  was 
layered g e n t ly  on top of  20 ml of F icol l -Hypaque  (Pharmacia)  in  a 
50 ml c e n t r i f u g e  tube which was spun at 2000 rpm f o r  10 minutes.  
The l i v e  c e l l s  which c o l l e c t e d  in  a band at  t h e  i n t e r f a c e  were  
removed, resuspended in 20 ml L-M medium and spun again at  1000 
rpm f o r  10 m i n u t e s .  The c e l l s  were f i n a l l y  resuspended  in  L-M 
medium at the a p p r o p r ia te  d ens ity  and were incubated at 37°-
To make s u b -c u l tu r e s  of  FEA c e l l s  growing as monolayers in 8  
ounce glass  b o t t l e s ,  the old medium was removed, the monolayer  
was washed w i th  5 ml of  t r y p s in -v e r s e n e  prepared by adding 5 ml 
0.01% t r y p s i n  t o  20 ml 0.02% v e r s e n e  (EDTA). The wash in g  was 
repeated and then 1 ml of  the t r y p s in -v e r s e n e  s o lu t io n  was added
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to  t h e  b o t t l e  which  was i n c u b a t e d  a t  37 °  f o r  5 m in u t e s .  Then 
th e  d e ta ch ed  c e l l s  were  suspended in medium, were  c a r e f u l l y  
d i s p e r s e d  and o n e - f o u r t h  o f  th e  c e l l s  was seeded i n  12 ml EFC 
medium in 8  ounce glass b o t t l e s .  A mix ture  of  5% CO^  in a i r  was 
added and the c u l t u r e  was incubated at  37° .  S ub -cu l tu res  were 
made twice  a week.
2.  P re p a ra t io n  of  FeLV
Two FeLV s t o c k s  were  p r e p a r e d  by d i f f e r e n t  methods.  The 
f i r s t  method was to  seed FeLV-A/Glasgow-1 i n f e c t e d  FEA c e l l s  in 9 
cm p l a s t i c  p la t e s  at  a c e l l  d ens ity  of 6  X 10^ per p l a t e  w it h  10 
ml EFC2Q medium and t o  h a r v e s t  t h e  c u l t u r e  f l u i d  3 days l a t e r .  
The f l u i d  was spun at 2000 rpm f o r  10 minutes and the supernatant  
f l u i d  was s tored at  - 7 0 °  in volumes of  5 ml or  1 ml. The stock  
p r e p a r e d  in  t h i s  way had a t i t r e  of  1.8 X 1 0  ^ f o cu s  in d u c in g  
u n i t s  CFIU) per  ml.
The second method was s i m i l a r  except t h a t  McCoy's 5a medium 
w ith  10% FCS was used and the c u l t u r e  f l u i d  was harvested 2 days 
a f t e r  s e e d i n g .  The t i t r e  o f  t h i s  v i r u s  was 9.4  X 10^ F l U / m l  
a f t e r  con ce n t ra t io n  by u l t r a f i l t r a t i o n  as descr ibed in d e t a i l  - in  
Chapter 7 .
3 .  Assay of  FeLV
a.  One-stage assay
F iv e  cm p l a t e s  were  seeded w i t h  3 X 10^ c e l l s  o f  FEA/G81 
m i x t u r e  a t  a 10:1 r a t i o  in  4 ml EFC. T w e n ty  f o u r  hours l a t e r  
each p l a t e  was in o cu la ted  w ith  1.0 ml of  a v i r u s  d i l u t i o n  in EFC 
w ith  4 ug /ml polybrene a f t e r  removing the old medium. The c e l l s
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were incubated a t  3 7 °  f o r  two hours and the inoculum was replaced  
w i t h  4 ml EFC. T h ree  days a f t e r  i n o c u l a t i o n  the  medium was 
r e p l a c e d  w i t h  4 ml f r e s h  EFC and the  r e s u l t s  were  sco red  f o u r  
d ay s  l a t e r .  V i r u s  t r a n s f o r m e d  c e l l  f o c i  w e r e  c o u n t e d  
mi croscopi c a l l y .
b. Two-stage assay
Clone 81 c e l l s  were seeded in 4 ml EFC c o n t a i n i n g  8  X 10^ 
c e l l s  and were i n c u b a t e d  a t  3 7 °  in  5% COg a i r .  A f t e r  24 
hours d i l u t i o n s  o f  v i r u s  were made in  EFC c o n t a i n i n g  4 u g / m l  
p o l y b r e n e  (PB).  The o l d  c u l t u r e  medium was removed and 1 ml of  
d i l u t e d  v i ru s  was added to each p la te -  The p la t e s  were incubated  
at  37°  f o r  90 minutes.  The inoculum was then rep laced w i t h  4 
ml EFC and th e  p l a t e s  were  r e i n c u b a t e d .  T h ree  days l a t e r  th e  
medium was r e p l a c e d  w i t h  4 ml EFC c o n t a i n i n g  1 X 10^ FEA c e l l s  
and th e  p l a t e s  were r e i n c u b a t e d  at  3 7 ° .  Foci  were counted  
m ic ro s c o p ic a l ly  a f t e r  a f u r t h e r  4 days. The number of  fo c i  in  a 
p l a t e  m u l t i p l i e d  by the d i l u t i o n  f a c t o r  gave the t i t r e  in FIU per  
ml.  The t i t r e  was u s u a l l y  c a l c u l a t e d  f rom counts  o f  p l a t e s  
conta in in g  about 20-30 f o c i .
4 .  P re p a ra t io n  of  MSV (FeLV)
F iv e  cm p l a s t i c  p l a t e s  were seeded w i t h  8  X 10^ c81 c e l l s  
p e r  p l a t e  i n  4 ml EFC and were,  i n c u b a t e d  a t  3 7 °  i n  5% COg 
a i r .  On the  n ex t  day th e  p l a t e s  were i n o c u l a t e d  w i t h  1 ml of  
FeLV d i l u t e d  i n  EFC c o n t a i n i n g  4 u g /m l  PB, The p l a t e s  w ere  
incubated fo r  90 minutes at 37° .  The inoculum was then replaced  
with  4 ml EFC and the p l a t e s  were re incubated .
T h re e  days l a t e r  th e  medium was removed and r e p l a c e d  w i t h
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1 X 10^ of  FEA c e l l s  in 4 ml EFC. The p la t e s  were re in cu b a ted [a t  
3 7 ° .  Two days l a t e r  th e  f l u i d  was h a r v e s t e d ,  c e n t r i f u g e d  at  
2 0 0 0  rpm f o r  1 0  m in u t e s  and t h e  f  l u i d  was s t o r e d  i n  g l a s s  v i a l s  
in 0 .2  ml volumes at  - 7 0 ° ,
The t i t r e  o f  v i r u s  p r e p a r e d  by t h i s  p r o c e d u r e  was 4 X 10^ 
focus forming u n i ts  (F FU) /m l .
5 .  Assay of  MSV (FeLV)
The method o f  R u s s e l l  and J a r r e t t  ( 1976 )  was f o l l o w e d .  In  
the assay of  MSV (FeLV-A) 3 X 10^ c e l l s  c h r o n i c a l l y  i n f e c t e d  w ith  
FeLV-B were seeded in  4 ml EFC in  5 cm p l a s t i c  p l a t e s  and were  
i n c u b a t e d  a t  3 7 ° .  A f t e r  24 hours  t e n f o l d  d i l u t i o n s  o f  MSV 
(FeLV) were  made i n  EFC20 w i t h  4 u g / m l  PB. The o l d  medium was 
removed and 2  ml o f  each d i l u t i o n  was i n o c u l a t e d  on t o  each 
c u l t u r e  p l a t e  which  was i n c u b a t e d  o v e r n i g h t  a t  3 7 ° .  Next  day 
the medium was removed and each in f e c t e d  c u l t u r e  was seeded w i th  
1 - 1 . 2  X 10^  FEA c e l l s  i n  4 ml EFC20 and t h e  p l a t e s  w e r e  
reincubated .  A f t e r  a f u r t h e r  3 days the p l a t e s  were s ta in ed  w i th  
0.5% c r y s t a l  v i o l e t  in  5% m ethano l  and 10% f o r m a l i n  f o r  15 
m i n u t e s .  The p l a t e s  w ere  t h e n  washed i n  w a t e r y  d r i e d  and t h e  
f o c i  were counted  mac r o s c o p i  c a l l y .  The t i t r e  was expressed in  
focus forming u n i t s  (FFU) per ml.
6 . I s o l a t i o n  of  FeLV from plasma
FeLV was i s o l a t e d  f ro m  h e p a r i n i s e d  p lasma as d e s c r i b e d  by 
J a r r e t t  ±1. ( 198 2b ) .  C e l l s  were  seeded a t  4 X 10^ c e l l s  p e r  
w e l l  in 24 w e l l  p l a s t i c  c l u s t e r  p la t e s  (Nunc) in 0.5 ml EFC with  
4 u g / m l  PB. The p l a t e s  w ere  i n c u b a t e d  a t  3 7 °  f o r  24 h o u rs .  A 
volume of 0 . 1  ml plasma was then added to each w e l l  and incubated
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f o r  2 hours. The o ld  medium w i th  the inoculum was then replaced  
w it h  a fresh 1 ml of EFC medium. Three days l a t e r  the medium was 
removed and the in o c u la te d  c u l t u r e  was seeded w i th  1 X 10^ FEA 
c e l l s  in 1 ml f r e s h  EFC per w e l l  and r e i n c u b a t e d .  A f t e r  4 days  
the w e l l s  were examined m ic r o s c o p ic a l ly  f o r  c e l l  t r a n s f o r m a t io n  
and were scored as p o s i t i v e  or negat ive fo r  FeLV.
7.  FeLV n e u t r a l i s a t i o n  t e s t
To e s t a b l i s h  the presence of v i ru s  n e u t r a l i s i n g  an t ib o d ies  
t o  FeLV-A i n  t h e  s e r a  o f  t h e  c a t s  used i n  t h e  e x p e r i m e n t s ,  t h e  
f o l l o w i n g  assay was used which was a m o d i f i c a t i o n  of  the method 
o f  R u s s e l l  and J a r r e t t  ( 1 9 7 8 a ) .  FEA c e l l s  i n f e c t e d  w i t h  FeLV-B  
were seeded a t  4 X 10^ c e l l s  per  w e l l  in  0.5 ml EFC20 w i t h  4 
u g / m l  PB in  2 4 - w e l l  p l a s t i c  p l a t e s  and i n c u b a t e d  a t  3 7 ° .  Nex t  
day a vo lume o f  50 u I  serum d i l u t e d  in L - 1 5 c o n t a i n i n g  10% FCS 
medium was m ix ed  w i t h  an e q u a l  volume o f  MSV (FeL V-A)  d i l u t e d  
w ith  the same medium in 96 w e l l  U-bottomed p l a s t i c  p l a t e s .  The 
m i x t u r e  was i n c u b a t e d  a t  3 7 °  f o r  90 m in u te s  and 25 u I  o f  each  
r e a c t i o n  was then  i n o c u l a t e d  i n t o  one w e l l  o f  t h e  FEA/FeLV-B  
c e l l s .  Next day the i n f e c t e d  c u l t u r e  was seeded w i t h  1 ml EFC20 
c o n t a i n i n g  1 X 10^ FEA c e l l s  per  w e l l  a f t e r  re m ov in g  t h e  o l d  
medium. The p l a t e  was r e i n c u b a t e d  un der  th e  same c o n d i t i o n s .  
Three days l a t e r  the p la t e s  were sta ined  w ith  0.5% c r y s t a l  v i o l e t  
as above, washed w i th  tap w a t e r ,  d r ie d  and the f o c i  were counted.  
P o s i t i v e  n e u t r a l i s a t i o n  was scored when the number of fo c i  was 
reduced  t o  le s s  t h a n  25% o f  t h e  number i n  t h e  v i r u s  c o n t r o l  
w ithout  serum. Appro ximately 30 fo c i  were present  in the v i ru s  
cont r o l -
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CHAPTER 2
CONDITIONS FOR PREPARATION OF FeLV FOR VACCINES 
I n t r o d u c t i o n
To b e g in  t o  p r e p a r e  an e f f e c t i v e  v a c c i n e  an a p p r o p r i a t e  
a n t i g e n  should  be i d e n t i f i e d  and methods f o r  i t s  p r o d u c t i o n  
establ ished» Previous re s e a r c h  w o r k e r s  used e i t h e r  l i v e  who le  
FeLV, i n a c t i v a t e d  whole  FeLV, FeLV gp70 or  i n a c t i v a t e d  FeLV-  
in f e c t e d  c e l l s  ( J a r r e t t  e t  a l , 1974; 01sen,<Sc Lewi s , ( 1981 ) ; Pedersen e t  a l  
1979;  S a l e r n o  et  a l ,  1 9 7 8 ) .  I n  each case the  source  of  a n t i g e n  
was FL74 lymphoblas to id  c e l l s  or  the FeLV of subgroups A, 8  and C 
which is  r e l e a s e d  by t h e s e  c e l l s .  Some o f  th e  r e s u l t s  were not  
c o m p l e t e l y  s a t i s f a c t o r y  f o r  t h e  reasons w h ic h  were  d e s c r i b e d  
above and are discussed f u r t h e r  in Chapter 11»
For t h e  p r e s e n t  s e r i e s  o f  e x p e r i m e n t s  i t  was d e c id e d  to  
concent rate on FeLV of  subgroup A as the an t ig en .  There were two 
main reasons  f o r  t h i s  c h o i c e .  F i r s t ,  i t  ap p e a r e d  t h a t  FeLV-A  
v i ruses  are monotypic based on n e u t r a l i z a t i o n  t e s t s  in vo lv in g  
19 i n d i v i d u a l  i s o l a t e s  ( R u s s e l l  and J a r r e t t ,  1978a )  so t h a t  an 
immune resp onse  induced  by one i s o l a t e  m ig h t  be e x p e c t e d  to  be 
e f f e c t i v e  a g a i n s t  any o t h e r  FeLV-A.  S e c o n d l y ,  s i n c e  t h e  
h o r i z o n t a l  t r a n s m i s s i o n  of  FeLV-B and the appearance of FeLV-C 
a re  dependent on FeLV-A ( J a r r e t t  and R u s s e l l , 1978;  R u s s e l l  and 
J a r r e t t ,  1978b)  i m m u n i t y  t o  FeLV-A s h ou ld  a l s o  p r o t e c t  a g a i n s t  
contact  i n f e c t i o n  by v i ru s e s  of  the other  two subgroups.
The so u rces  of  FeLV-A which  were c o n s i d e r e d  were t h e  
lymphosarcoma s u s p e n s io n  c e l l  l i n e ,  F422 ( R i c k a r d  e t  a l ,  1969)  
and FEA monolayer c e l l s  c h r o n i c a l l y  in fe c te d  w i th  FeLV-A/Glasgow-
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1 ( J a r r e t t  et  a l ,  1 9 7 3 ) .  The a d v a n ta g e  o f  F422 c e l l s  i s  t h a t  
l a r g e  q u a n t i t i e s  o f  v i r a l  p a r t i c l e s  a re  re le a s e d  which may be 
u s e f u l  i n  p r o v i d i n g  s u f f i c i e n t  a n t i g e n i c  mass f o r  v a c c i n e  
p r e p a r a t i o n .  About 5 mg of  v i r a l  p r o t e i n  is  r e c o v e r e d  from 1 
l i t r e  of c u l t u r e  f l u i d  ( N e i l ,  1978).  A poss ib le  disadvantage of  
us ing  these  c e l l s  is  t h a t  th e  v i r u s  which is  r e l e a s e d  has a low 
s p e c i f i c  i n f e c t i v i t y ,  compared to  v i r u s  grown in  mono l a y e r  
c u l t u r e s .  T h is  may i n d i c a t e  a d e f e c t  in  F422 v i r a l  gp7Q which  
may not  be e f f i c i e n t  as an immunogen. I n  c o n t r a s t ,  u s in g  
i n f e c t e d  FEA c e l l s  has th e  ad v a n ta g e  t h a t  FeLV r e l e a s e d  from  
these c e l l s  is  more i n f e c t i o u s  and perhaps more immunogenic, but 
at  the  same t i m e  has t h e  d i s a d v a n t a g e  t h a t  t h e r e  is  a low v i r a l  
mass (about 500 ug of  v i r a l  p r o t e i n  in I l i t r e  of  c u l t u r e  f l u i d ) .
The p r e s e n t  c h a p t e r  d e s c r i b e s  3 e x p e r i m e n t s  d es ig n ed  to  
e s t a b l i s h  the optimum condit ions  f o r  the growth of  these c e l l s  
and viruses  before  they were used in the p re p a ra t io n  of Vaccines.
Results
E x p e r i m e n t  I :  Opt imum c o n d i t i o n s  f o r  t h e  p r o d u c t i o n  o f  F422
c e l l s  and v i r u s
F422 c e l l s  were grown in p l a s t i c  f l a s k s  (25 cm2) g ^1 of 
LhM,medium in  each f l a s k .  F i v e  d i f f e r e n t  c e l l  d e n s i t i e s  were  
used with  2 f l a s k s  f o r  each dens it y .  The d e n s i t i e s  were 3 X 10^,  
6  X 1 0^ ,  9 X 1 0 ^ ,  12 X 10^ and 24 X 10^ p er  ml .  The c u l t u r e s  
were incubated at  37°  and c u l t u r e  samples were c o l l e c t e d  at 24,  
4 8 ,  7 2 ,  96 and 12 0  h o u r s  a f t e r  s e e d i n g .  The f l u i d  was  
c e n t r i f u g e d  a t  2 0 0 0  rpm f o r  1 0  m in u t e s  and th e  s u p e r n a t a n t  was
34 I
s t o r e d  a t  - f O °  f o r  FeLV assay L a t e r .  At th e  same t i m e  a v i a b l e  
c e l l  count was made. The re s u l ts  of c e l l  counts, v i rus  t i t r a t i o n  
and r a t i o  of i n f e c t i v i t y  per c e l l  are shown in Table 2.1 and Fig.  
2 .1 .
From th e s e  r e s u l t s  i t  i s  seen t h a t  th e  h i g h e s t  v i ru s  ti t  res 
were in th e  samples c o l l e c t e d  from the c u l tu re s  seeded at  a c e l l  
d e n s i t y  o f  12 X 1 0 ^ / m l ,  24 and IZ  h o u r s  a f t e r  s e e d i n g
C5 X 1 0 ^ F I U / m l ) .  The h i g h e s t  c e l l  count  was in  th e  sample  
c o l l e c t e d  from the c u l t u r e  at 24 X 1 0 ^ / m l ,  120 hours a f t e r  
s e e d in g  (1.0 X 1 0 ^ / m l ) .  The h i g h e s t  r a t i o  o f  v i r u s  t o  c e l l  was 
obtained from the c e l l  c u l t u r e  seeded at 12 X 1 0 ^ /m l ,  24
hours a f t e r  seeding (34 X 10”^).
E x p e r i m e n t  2: Growth  o f  F422 c e l l s  in  d i f f e r e n t  media and FCS
concentra t io ns
The F422 c e l l s  were grown in 25 cm^ p l a s t i c  f l a s k s  w i th  10 
ml of growth medium supplemented w i th  FCS at  5%, 10% or 15%. Two 
mediavcere compared:  L-M and RPMI 1640 .  T h re e  25 cm^ p l a s t i c
f l a s k s  were seeded w i th  F422 c e l l s  at  a d en s i ty  of  7 X 10^ /m l in 
10m l L-M medium. Each f l a s k  c o n t a in e d  5%, 10% or 15% FCS. 
Another 3 f l a s k s  were set  up in the same manner using RPMI 1640 
medium, but  in  t h i s  case a l l  f l a s k s  were gassed w i t h  5% CO^ in  
a i r  b e f o r e  i n c u b a t i o n .  S u b s e q u e n t l y ,  2 4 ,  4 8 ,  72 and 96 hours  
l a t e r ,  the c e l l  concentra t ion  in each c u l t u r e  was determined by 
t ak in g  two 0.5 ml volumes from each f l a s k ,  d is p e rs in g  the c e l l s  
and mixing 0 , 1  ml w ith  an equal volume of 1 % trypan blue f o r  c e l l  
counting. C u l tu re  f l u i d s  were c o l le c t e d  from a l l  the f l a s k s  72 
hours a f t e r  seeding,  c e n t r i fu g e d  at 2 0 0 0  rpm fo r  1 0  minutes and
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I ABLE 2.1
Optimum co nd it io ns  f o r  the growth o f  F422 c e l l s  and v i ru s
S t a r t i n g  c e l l  
concentra t ion
Time a f t e r  seeding (hours)  
24 48 72 96 120
3 X 10' c e l l s
v i ru s
v:c
3 , 8
0.2
6
4 . 4
0.6
14
6 .6 
0.8  
12
10.2
0 .3
3
9 .8
0.2
2
6  X 10- c e l l s
v i ru s
v:c
7 . 8
2 .5
32
10.2
1 .9
18
16 .8
2 .5
14
22 .7
2.0
9
27 .3
1.3
5
9 X 10- c e l l s
v i ru s
v:c
11.0
3 . 0
29
14 .8
3 . 0
20
27 .2
2 .5
9
35 .2
2.0
6
32 .6
1.0
3
1.2  X 10 c e l l s
v i ru s
v : g
14 .6
5 .0
34
19 .2
4 , 5
23
36 .3
5 .0
14
45 .3
2.0
4
57 .2
2 .5
4
2 . 4  X 10' c e l l s
v i r u s
v:c
2 8 .0
4 . 5
15
35 .2
3 . 8
11
77.1
4 . 5
6
97 .8  107*8
4 . 3  3 .8
4 4
C e l ls :  X
Vi rus:  X
V i r u s / c e l l  r a t i o
1 0 , c e l l s  per  ml 
10 FIU per m l ^
X 10
__
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the supernatant  f l u i d  was s t o r e d  a t  - 70® b e f o r e  b e i n g  assayed  
f o r  FeLV.
The r e s u l t s  of  c e l l  counts and v i r us  t i t r a t i o n s  f o r  a l l  6  
c u l t u r es  are shown in Table 2.2.
The r e s u l t s  obta ined from t h i s  exper iment  i n d i ca t ed  t hat  L-M 
medium w i t h  15% FCS was b e t t e r  t han  RPMI 1640 medium f o r  both  
c e l l  growth and v i r u s  product ion.  The highest  c e l l  count was in 
the sample c o l l e c t e d  f rom the L-M c u l t u r e  w i t h  15% FCS, 96hours  
a f t e r  seeding and the highest  v i r us  t i t r e  was obtained from the 
same sample.
Exper iment  3: Condi t ions f o r  the  optimum growth of  FEA/FeLV-A
c e l l s  and v i r u s
Eight  5 cm p l a s t i c  p l a t e s  were seeded wi t h  FeLV-A i n f ec t ed  
FEA c e l l s  at  3 X 10^ c e l l s  per p l a t e  in 4 ml EFC medium and were
incubated at 37® in 5% COg in a i r .  A f t e r  24 hours cu l t u r e  f l u i d  
samples were c o l l e c t e d  and c e l l s  counted from the f i r s t  2  p l a t es .  
These sampl es  were c e n t r i f u g e d  at  2000 rpm f o r  10 mi nut es  and 
s t o r e d  a t  - 7 0 ® .  T h i s  p r o c e s s  was r e p e a t e d  a f t e r  4 8 ,  72 and 96  
hours using 2 p l a t e s  each t i me .  The stored c u l t u r e  f l u i d  samples 
were  assayed f o r  FeLV.
The second par t  of  the exper iment  was done in the same way 
except  t h a t  media f o r  a l l  p l a t es  was changed d a i l y .  In the t h i r d  
p a r t  of  t he  e x p e r i m e n t  c e l l  count s  and c o l l e c t i o n  of  c u l t u r e  
f l u i d  were done 72 and 96 hours a f t e r  seeding and the medium was 
changed every other  day.
C e l l  count s  and r e s u l t s  o f  v i r u s  t i t r a t i o n s  of  a l l  3 p a r t s  
o f  t h e  e x p e r i m e n t  a r e  shown i n  F i g ,  2.2 and T a b l e  2 .3 .  From
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TABLE 2 . 2
Growth o f  F422 c e l l s  and v i r u s  i n  d i f f e r e n t  media
Medium FCS
(%)
C e l l  count  a t  (hours)^:  
24 48 72 96
Vi rus^ ( F l U / ml )
LM 5 1 1 . 0 2 0 . 0 2 9 . 0 30.8 1 . 2 X 1 0 ^
1 0 12 . 4 2 0 . 8 30.5 42.1 2 . 3 X 1 0 ^
15 14.1 2 0 . 2 37 .2 46 .0 2 . 2 X 1 0 ^
RPMI 5 13.1 2 0 . 7 2 1 . 8 25.5 0 . 7 X 1 0 ^
1 0 14.0 17 . 3 23 . 4 29 .2 1 .7 X 1 0 ^
15 13.5 23.1 28 ,5 32 .5 2 . 0 X 1 0 ^
a Ce l l s  X 1 0
b Vi rus sampled *at 72 hours.
   \  :
= 5 x 1 0
<Da
zo
H<cr
Hz
UJ 
Üz o o
- J
mo
1 x 1 0
5 x 1  0
Fig 2. 2  
G R O W T H  OF F E A C E L L S
I N F E C T E D  W I T H  F e L V - A
T
X
T
X
0 2 4  4 8  9 6
H O U R S  A F T E R  S E E D I N G
( 1 )  M E D I U M  C H A N G E D  AT  4 8  H O U R S
( 2 )  M E D I U M  C H A N G E D  D A I L Y
( 3 )  C O N T I N U O U S  M E D I U M
__ —  :   : :_________
TABLE 2 .3
Growth o f  FEA/FeLV-A c e l l s  and v i r u s
Condi t ions o f  
medium
Time a f t e r  seeding (hours)  
24 48 72 96
Continuous c e l l s  6 . 8  14 .3  16 .9  21.7
v i r u s  4 . 5  5.1 4.1 3 . 0
V:C 65 36 24 14
Changed
d a i l y
c e l l s
v i r u s
V:C
16.6  29 ,3  29 ,6
5 . 8  7.1 8 . 6
34 29 29
Changed 
every other  
day
c e l l s
v i r u s
V:C
35 .7  34 .9
6 . 4  5.1
18 15
CELLS: X 10
VIRUS: X 10^ FIU per  ml
VIRUS :CELLS' ' X1 0 "^
these r e s u l t s ,  the highest  c e l l  count and v i r us  t i t r e  were found 
i n  sampl es  c o l l e c t e d  96 hours a f t e r  seed i ng  in the  c u l t u r e s  in  
which medium was changed d a i l y  ( 8 . 6  X 10^ FlU/ml )  and the h i g h e s t ,  
c e l l  count  was i n  t he  72 hour  c u l t u r e  i n  medium changed e v e r y  2 
days <3.6 X 10^ ) -  The g r e a t e s t  r a t i o  o f  i n f e c t i o u s  v i r u s  pe r  
c e l l  was in the sample c o l l e c t e d  24 hours a f t e r  seeding (65 X 10"^)
Discussion
Three types of  exper iments were done to s e l ec t  the best  way 
of ob t a i n i ng  good q u a n t i t y  and q u a l i t y  of c e l l s  and v i r us  which 
might be used f o r  FeLV vaccine product ion.  The q uan t i t y  of v i r us  
in a c e l l  c u l t u r e  is  obviously  impor tant  for  vaccine pr epar a t i on  
because an i n a c t i v a t e d  vaccine must contain s u f f i c i e n t  a n t i ge n i c  
mass t o  i mmu n i s e .  Ho we v e r ,  t he  q u a l i t y  of  t he  v i r u s  may be 
equa l l y  i mpor t an t .  Wi th r e t r o v i r u s e s ,  the a n t i gen i c  det erminant s  
of the gp70 are c r u c i a l  in immuni ty.  Al though i t  is not known i f  
the a n t i g e n i c i t y ,  or  immunogenic i t y ,  of  the gp70 of  FeLV dec l i nes  
a f t e r  t h e  v i r u s  i s  produced  f rom t he  s u r f a c e  of  t he  c e l l ,  t h e r e  
i s  e v i d e n c e  f r o m e l e c t r o n  mi c r o s c o p y  t h a t  t he  e nve l op e  s p i k e s  
which are composed of gp70,  are prominent  when the v i rus  is f i r s t  
produced but  become l e s s  obv i ous  as t h e  v i r a l  p a r t i c l e  ma t ur e s  
(La i r d  and J a r r e t t ,  personal  communicat ion) .  The i n f e c t i v i t y  of  
t he  v i r u s  a l s o  d e c l i n e s .  T h i s  may i n d i c a t e  a l s o  a l oss  o f  
a n t i g e n i c  s t r u c t u r e .  T h e r e f o r e ,  in t hese  e x p e r i m e n t s  i t  was 
c o n s i d e r e d  t h a t  t h e  amount  o f  i n f e c t i o u s  v i r u s  pr educed  by t h e  
c e l l s  might be an i mpor tant  i n d i c a t o r  of i t s  immunogenic i t y ,  and
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that  the r a t i o  of  c e l l s  to v i rus  in a cu l t u r e  might give a guide  
to the e f f i c i e n c y  of  the c e l l  c u l t u r e .
In the f i r s t  exper iment  i t  was found t hat  F422 c e l l s  grew at  
the same rate  for  each s t a r t i n g  concent rat ion (Fig,  2.1 ) and that  
in the range of  s t a r t i n g  concent rat ions between 3 X 1 0  ^ and 1,2 X 
1 0  ^ c e l l s  per  .ml t h e r e  was a r e a s o n a b l e  c o r r e l a t i o n  at  a l l  
sampl ing t imes between the concent rat ion of  c e l l s  and the amount  
of  i n f e c t i o u s  v i r u s  in t he  c u l t u r e  f l u i d .  However ,  w i t h  
i n c r e a s i n g  t i m e  t h e  amount  o f  v i r u s  per  c e l l  d e c l i n e d  whi ch  
probably r e f l e c t s  a decrease in the product ion of v i r us  wi th  t i me  
as w e l l  as i n c r e a s i n g  a c t i v a t i o n  of  v i r u s  due,  p e r h a p s ,  t o  t he  
act ion of proteases and nucleases released from the c e l l s .  This  
e x p e r i m e n t  a l s o  showed t h a t  i n  a l l  c u l t u r e s  w i t h i n  t h e  range  
Ô X 10^ to 2.4 X 10^,  the highest  r a t i o  of  v i rus  to ce l l s  was at  
24 hours a f t e r  s e e d i n g .  T h i s  p r o b a b l y  i s  because a h i g h e r  
p r o p o r t i o n  of  t he  c e l l s  a re  i n  m i t o s i s  d u r i n g  t h i s  i n t i t i a l  
p e r i o d  compared t o  l a t e r  t i m e s  and i t  i s  known t h a t  FeLV i s  
produced by the  c e l l s  p r i n c i p a l l y  d u r i n g  m i t o s i s  ( T o t h ,  1 9 80 ) .  
Thus the main conclusion from these r esu l t s  was t h a t  the optimum 
condi t ions f o r  producing v i r u s  from F422 c e l l s  were to seed the 
c e l l s  a t  1.2 X 10^ c e l l s  per  ml and h a r v e s t  t h e  f l u i d  a f t e r  24 
hours .  Th i s  would  appear  t o  be the most e c o n o m i ca l  way of  
p r o d u c i n g  a l a r g e  amount  o f  v i r u s ,  s i n c e  t h e  v i r u s  i s  o f  
r e l a t i v e l y  high i n f e c t i v i t y  and i t  i s ,  t h e r e f o r e ,  most l i k e l y  to 
be a n t i g e n i c a l l y  a c t i v e .
I n  the second e x p e r i m e n t  the aim was t o  f i n d  i f  RPM 1 - 16 4 0  
medium was a d e q u a t e  f o r  g r o w i n g  F422 c e l l s  compared t o  L-M
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medium. RPMI-1640 is w i de l y  used for  the growth of  suspension 
c u l t u r e s  of  l eu k a e m i a  c e l l s  ( Cr eemer s  et  a l ,  1978)  and i s  l ess  
e x p e n s i v e  t han  L-M medium whi ch  i s  a ma j o r  c o n s i d e r a t i o n  in  
vaccine product ion.  The f i r s t  conclusion of t h i s  exper iment  was 
t h a t ,  w i t h  each medium, i ncreas i ng  FCS concent ra t ion gave b e t t e r  
gr o wt h  p r es u m a b l y  by s u p p l y i n g  g r e a t e r  q u a n t i t i e s  of  e s s e n t i a l  
gr o wt h  f a c t o r s .  S e c o n d l y ,  i t  was f ound t h a t  F422 c e l l s  grew 
r e a s o n a b l y  w e l l  i n  R P MI - 1 6 4 0  but  not  as w e l l  as in  L-M medium.  
For exampl e  a c o n c e n t r a t i o n  o f  15% FCS was r e q u i r e d  w i t h  RPMI -  
1640 to  give the same growth ra t e  as L-M wi th  5% serum. T h i r d l y ,  
in gener a l ,  v i r u s  product ion was b e t t e r  in L-M than in RPMI and 
t he  amount  of  v i r u s  h a r v e s t e d  at  72 hours i n c r e a s e d  w i t h  
i ncreas i ng FCS concent ra t i on .  The main conclusion was t ha t  L-M 
wi th 10 or 15% FCS should be used f o r  F422 v i r u s  product ion.
In the t h i r d  exper iment  i nvo l v i ng  a monolayer of  FEA c e l l s  
i n f e c t e d  wi th  FeLV-A the r e s u l t s  of the f i r s t  par t  in which the 
c e l l s  were grown wi t hout  medium change i nd i ca t ed  t h a t  the i n i t i a l  
i n c r e a s e  in c e l l  g r o wt h  s l owed  a f t e r  48 h o u r s ,  perhaps  due t o  
exhaust ion of  n u t r i e n t s  and growth f ac t or s  in the medium, since  
c e l l s  in cu l t u r e s  in which the medium was changed d a i l y  cont inued  
t o  i n c r e a s e  i n  number .  I n  t h i s  case t h e  c e l l  numbers r eached a 
pla teau a f t e r  72 hours.  The cont inued st i mul us  of  medium changes 
appeared to lead to  the product ion of  l arge amounts of  v i r us  and 
t he  v i r u s z c e l l  r a t i o  d i d  not  a l t e r  much f rom 48^-96 hours .  I t  
a p p e a r e d ,  t h e r e f o r e ,  f r om t h i s  e x p e r i m e n t  t h a t  i n  c o n t i n u o u s  
medium, the ra t e  of  i n a c t i v a t i o n  of  v i rus  was balanced by ra t e  of  
product ion.  In c u l t u r e s  in which the medium was changed d a i l y ,  
t h e r e  was a h i g h e r  r a t e  o f  v i r u s  p r o d u c t i o n ,  or  l o we r  r a t e  of
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i n a c t i v a t i o n ,  perhaps due to removal  of  proteases and nucleases.
F i n a l l y  i n  t he  t h i r d  p a r t  of  t h i s  e x p e r i m e n t  in which t he  
medium was changed two days a f t e r  s e e d i n g ,  t he  c e l l  counts  and 
i n f e c t i o u s  v i r us  as w e l l  as the v i r u s : c e l l  r a t i o  were e s s e n t i a l l y  
t h e  same a t  72 and 96 hour s .  I n  s p i t e  of  t h e  r a p i d  i n c r e a s e  i n  
c e l l  numbers between 48 and 72 hours in these c u l t u r e s ,  the c e l l s  
q u i c k l y  became c o n f l u e n t  and t h e r e  was not  a c o r r e s p o n d i n g  
i ncrease in the product ion of  v i r us .  Also the r a t i o  of c e l l s  to 
i n f e c t i o u s  v i r u s  r e m a i n e d  r a t h e r  low compared to  c u l t u r e s  i n  
which there was cont inuing growth of  c e l l s .
The c o n c l u s i o n  o f  t h i s  e x p e r i m e n t  was t h a t ,  as f o r  F422 
c e l l s ,  the h i g h e s t  v i  r u s : ce IL r a t i o  i s  at  2 4 - 4 8  hours .  Thus i t  
is l i k e l y  t h a t  v i r u s  harvested at  24-48 hours a f t e r  subcul ture is  
of  good a n t i g e n i c i t y .
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CHAPTER 3
INACTIVATION OF FeLV PSEUDOTYPES OF MURINE SARCOMA VIRUS
I n t r o d u c t i o n
The a ims o f  t h i s  s t u d y  were  t o  ga i n  i n f o r m a t i o n  on t he  
i n a c t i v a t i o n  of  FeLV by severa l  chemical  agents,  and t o  examine
the binding of  v i r u s  to the ad j u v a n t ,  AI (OH ) 3  9^1.
The i n i t i a l  choice of  v i r u s  f o r  studies on i n a c t i v a t i o n  of  
FeLV was not  FeLV i t s e l f  but  MSV (FeLV) .  These pseudot ype  
v i ruses have been wi d e l y  used in studies on FeLV because they can 
be obtained w i t h  p a r t i c u l a r  FeLV e n v e l o pe  a n t i g e n s  ( F i s c h i n g e r  
and O'Connor, 1969) and so can be used in FeLV subgrouping using 
i n t e r f e r e n c e  t e s t s  (Sarma and Log, 1973) ,  in det ermi n i ng  the host  
range of FeLV s t r a i n s  (F i sch i nger  and O'Connor, 1970; J a r r e t t  et  
a l ,  1973)  and i n  d e t e c t i n g  and t i t r a t i n g  v i r u s  n e u t r a l i s i n g  
ant i bodi es  (Sarma 6 c Log,  1973; Russel l  and J a r r e t t ,  T978a).  This  
wide range of  uses of  MSV (FeLV) is mainly because the v i r us  can 
be assayed more e a s i l y  and w i t h  g r e a t e r  p r e c i s i o n  t han  FeLV 
(Russel l  and J a r r e t t ,  1976) .  I n  t h i s  study,  i n a c t i v a t i o n  of  MSV 
(FeLV)  r a t h e r  t h a n  FeLV was used f o r  t hese  reasons and a l s o  
because the MSV (FeLV) assay can be read macroscopi ca l l y  a f t e r  4 
days ( R u s s e l l  and J a r r e t t ,  1976)  w h i l e  t he  FeLV assay  t a k e s  6 - 7  
days and has to be read mi c r o s c o p i c a l l y  ( J a r r e t t  et  a 1,1982b) .
I t  is very l i k e l y ,  however ,  that  the i n a c t i v a t i o n  k i n e t i c s  
of  MSV (FeLV) and FeLV are very s i m i l a r  since the envelope of  the  
pseudotype v i r us  is  i d e n t i c a l  to t ha t  of FeLV and should react  in  
t h e  same way w i t h  p r o t e o t r o p i c  i n a c t i v a t i n g  a g e n t s .  A l s o ,  t h e  
RNA genomes of  the two v i ruses  are s i m i l a r  in s i z e  and would be
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expected to have s i m i l a r  responses to nucLeotropic i n a c t i v a t i n g  
agents.
The reasons f o r  the choice of paraformaldehyde (PF),  PF and 
g l u t a r a  Idehyde  (GA) t o g e t h e r  (PF + GA),  a c e t y l e t h y l e n e i m i ne 
(AEI ) ,  and 2,  2 - d i t h i o b i s ,  5 - n i t r o p y r i d i n e  (DTNP) as i n a c t i v a t i n g  
agent s  were as f o l l o w s .  PF was used p r e v i o u s l y  by J a r r e t t  e t  al  
( 1975)  w i t h  success in i n a c t i v a t i n g  FL74 c e l l s  f o r  use as a 
c e l l u l a r  v a c c i n e  a g a i n s t  FeLV.  PF + GA i s  w i d e l y  used as a 
f i x a t i v e  in e l e c t r o n  mi cr o s c o p y  and g i v e s  good m o r p h o l o g i c a l  
pr eser va t i on  of  the envelope spikes of  FeLV ( La i rd  et a I ,  1967) ,  
so i t  mi ght  be e x p e c t ed  a l s o  t o  p r e s e r v e  a n t i g e n i c i t y .  The 
act i on  of  DTNP is to s t a b i l i s e  d i su l ph i de  bonds between prot e i ns  
and in p a r t i c u l a r  has been shown t o  c r o s s - l i n k  r e t r o v i r a l  gp7Q 
and p15E ( P i n t e r  <5cFleissner, ,1971.. Th i s  ac t i onrmi ght  have advantages 
i n  t he  p r e p a r a t i o n  of  a FeLV v a c c i n e  in t wo ways.  F i r s t ,  i t  
might preserve the s t r u c t u r e  of  gp70 on the v i r a l  envelope since  
i t  i s  anchored  by t he  p15E i n t o  t he  l i p i d  o f  the enve l op e  
( Bo l o g n e s i  e_t_ a I ,  1 9 7 8 ) .  S e c o n d l y ,  i t  mi g h t  p r e v e n t  t he  
breakdown of  t he  e n v e l o p e  and r e l e a s e  of  p15E which may be 
immunosuppressive (Olsen et  a I ,  1980) and act  against  e f f e c t i v e  
i mmunisat ion.  AEI has been used success fu l l y  f o r  foot -and-mouth  
d i s e a s e  v i r u s  v a c c i n e s  ( B r o w n  e_  ^ aj^, 196  3b;  G r a v e s  and  
A r l i n g h a u s ,  1967;  W i l d  and Brown,  1968;  Doel  and B a c c a r i n i ,  
1 9 8 1 ) .  AEI  and t h e  o t h e r  i m i n e s  m a i n l y  r e a c t  w i t h  t he  v i r a l  
n u c l e i c  acid.
The second aim of  the exper iments descr ibed in t h i s  chapter
was to determine the adsorpt ion of MSV (FeLV) to AKOFDj 9®^"
I t  was d e c i d e d  t o  use t h i s  subs t a nc e  as an a d j u v a n t  because of
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i t s  c a p a c i t y  t o  d e l a y  t he  r e l e a s e  of  t l ie a n t i g e n  f rom the  s i t e  
of  i n j e c t i o n .  T h i s  a d j u v a n t  has been used p r e v i o u s l y  in FeLV 
v a c c i n e s  by J a r r e t t  aJL. ( 1 9 7 4 ,  1975)  and by Pedersen et  a l  
( 1979 ) .
M a t e r i a l s  and Methods
I .  Pr epar a t i on  of  MSV (FeLV-A/Glasgow-1)
A FeLV pseudotype of MSV was obtained by rescue of  MSV from 
CS1 c e l l s  a f t e r  s u p e r i n f e c t i o n  w i t h  FeLV.  I n  t h e  i n i t i a l  
exper iment ,  e i ght  5 cm p l a s t i c  p l a t es  were seeded wi t h  C81 c e l l s  
at  8  X 10^ c e l l s  i n  4 ml  EFC p er  p l a t e  and were  i n c u b a t e d  a t  37^
i n  5% COg i n  a i r .  Twent y  f o u r  hours L a t e r  the  c e l l s  were  
i n o c u l a t e d  w i t h  1 ml o f  FeLV i n  EFC c o n t a i n i n g  4 u g / m l  PB and 
incubated f or  90 minutes.  The inoculum was then replaced wi t h  4 
ml EFC medium and the p l a t e s  were reincubated at  37° .  Samples of  
c u l t u r e  f l u i d  were c o l l e c t e d  24 ,  4 8 ,  72 and 96 hours a f t e r  
i n o c u l a t i o n  and stored at  - 7 0 ° .  These samples were t i t r a t e d  as 
d e s c r i b e d  above and t h e  h i g h e s t  MSV (FeLV) t i t r e  o b t a i n e d  was 
f ound t o  be i n  t h e  sampl e  c o l l e c t e d  72 hours a f t e r  i n o c u l a t i o n  
( 1 . 30  X 10^ FFU/  m I )  as shown i n  T a b l e  3 .1 .  For t h e  p r e p a r a t i o n  
of  a s t o c k  of  v i r u s ,  CS1 c e l l s  were  i n f e c t e d  w i t h  FeLV as above  
and a f t e r  72 hours  when MSV (FeLV)  p r o d u c t i o n  was m a x i m a l ,  t he  
medium was r e p l a c e d  w i t h  4 ml EFC c o n t a i n i n g  1 X 10^ FEA c e l l s  
per p l a t e  and the c u l t u r e  f l u i d  was harvested 2  days l a t e r  when 
t r a n s f o r m a t i o n  i n v o l v e d  a l l  t he  c e l l s .  I n  t h i s  case t h e  t i t r e  
obtained was 4 X 10^ FFU/ml .
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TABLE 3.1
Release of  MSV (FeLV) from FeLV- i nf ect ed C81 c e l l s
Time a f t e r  
i n f e c t i o n  (hours)
MSV (FeLV) t i t r e  
(FFU/ml)
24 6 . 0 X 1 0 ^
48 1 . 0 X 104
72 1.3 X 1 0 ^ '
96 5.5 X 1 Q2 3'.#i
2.  MSV (FeLV) i n a c t i v a t i o n ,
(a)  I n a c t i v a t i o n  of  MSV (FeLV) wi th  PF
A stock s o l u t i o n  of  4 % PF was made as f o l l o w s .  Two grammes 
of  p a r a f o r m a l d e h y d e  powder  ( 8 DH) was suspended in 20 ml of  
d i s t i l l e d  water  and heated to 60°  wi t h  s t i r r i n g .  The temperature  
was m a i n t a i n e d  at  6 0 °  and 0.1 N NaOH s o l u t i o n  was added drop by 
drop wi t h  s t i r r i n g  u n t i l  the s o l u t i on  became c l ea r .  The so l u t i on  
was then  removed f rom t he  heat  and 30 ml of  0.25M phosphate  
b u f f e r  (pH 7.2)  and 425 mg of  NaCl  was added.  When t h i s  was 
dissolved the so l u t i o n  was f i l t e r e d ,  cooled and stored at  4 ° .
In the i n a c t i v a t i o n  exper iment  MSV (FeLV) was t r e a t ed  wi th  
0 . 1 ,  0.05 or  0.01% PF by add i ng  100 u I of  e i t h e r  1%, 0.5% or  
0.1% PF,  made f r om t h e  s t o c k  s o l u t i o n ,  t o  1 ml MSV (FeLV)  i n  
g l a s s  b o t t l e s .  A vo l ume of  100 u I of  L-1 5 medium was added t o  1 
ml MSV (FeLV) as a v i r u s  con t r o l .  The exper iment  was incubated  
at  room t e m p e r a t u r e  f o r  24 hours .  Samples of  150 u I  were  
c o l l e c t e d  from a l l  r eac t i ons  immedi a te l y  a f t e r  a d d i t i o n  of  PF and 
at  i n t e r v a l s  of  3 ,  6 ,  12 and 24 hours l a t e r .  These s a mp l e s ,  
i n c l u d i n g  t h e  v i r u s  c o n t r o l ,  were  t r e a t e d  w i t h  15 u I  o f  20% 
sodium t h i o s u l p h a t e  f o r  30 m i n u t e s  at  room t e m p e r a t u r e  t o  
n e u t r a l i z e  t h e  a c t i o n  o f  PF and were  s t o r e d  a t  - 7 0 ° .  The 
r e s i d u a l  i n f e c t i v i t y  of  t hese  samples was assayed as descr ibed  
above.
(b)  I n a c t i v a t i o n  of  MSV (FeLV) wi t h  PF and Glutara ldehyde
A mi x ture  of  paraformaldehyde (PF) and g l u t a r a l d e h y d e  (GA) 
prepared as 1.3% PF and 1.6% GA in 0.1 M sodium phosphate buf fer^  
pH 7 . 2 ,  was used i n  d i f f e r e n t  c o n c e n t r a t i o n s  (0.5%,  0.1%,  0.02%
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or  0.004%) to i n a c t i v a t e  the v i r us .  MSV (FeLV) i n a c t i v a t i o n  was 
c a r r i e d  out by adding 0,1 mL of a 10 X concent rated so l u t i on  to 1 
ml of  v i ru s  and i ncubat i ng the mi x t ure  at  room t emperature  f o r  24 
hours .  Samples of  150 u I  of  each r e a c t i o n  at  0 ,  3 ,  6  and 24
hours were  c o l l e c t e d  and kept  a t  - 7 0 °  u n t i l  assayed l a t e r  f o r
v i r a l  i n f e c t i v i t y .
(c)  I n a c t i v a t i o n  of  MSV (FeLV) wi th AEI
In t h i s  case the i n a c t i v a t i o n  procedure was s i m i l a r  to that  
used in the f i r s t  exper iments except  AEI concent rat ions of 0;5,  
0.1,  0.02 or  0.004% were used and a f t e r  each sample was c o l l e c t ed  
i t  was n e u t r a l i s e d  by the a d d i t i on  of  a one- tenth volume of 2 0 % 
sodium t h i o s u l p h a t e  and i n c u b a t i o n  a t  room t e m p e r a t u r e  f o r  30 
m i n u t e s .  The sampl es  were then  s t o r e d  at  - 7 0 °  and assayed as 
be f or e .
(d)  Treatment  of  MSV (FeLV) wi th DTNP in DMSO
One hundred ml o f  MSV (FeLV)  was c o n c e n t r a t e d  t e n f o l d  by 
ammonium s u l p h a t e  p r e c i p i t a t i o n  and u l t r a c e n t r i f u g a t i o n  as 
d e s c r i b e d  i n  C h a p t e r  1.  The v i r u s  was p e l  l e t t e d  i n  t he  SW50.1 
r o t o r  at  3 0 , 0 0 0  rpm f o r  60 m i n u t e s ,  resuspended in L - 15  medium 
and d i v i ded  i n t o  3 volumes of  150 u I .  To the f i r s t  a l i q u o t  15 ul  
of  DMSO was added.  To t he  second a l i q u o t  15 u l  of  0,2% DTNP i n  
DMSO was added, incubated at  room temperature  f o r  15 minutes and 
stored at - 7 0 °  f o r  assay.  The t h i r d  volume of  concent rated MSV 
( F e L V)  was a l s o  s t o r e d  a t  - 7 0 °  a f t e r  15 m i n u t e s  a t  room 
t emperature  as a v i r u s  cont r o l .
3 .  Adsorpt ion of  MSV (FeLV) t o  Al lOH)^
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Two types of  ALCOH)^ were a v a i l a b l e :  the f i r s t  was obtained
by c o u r t e s y  of  We l l come Research L a b o r a t o r i e s  (WRL) and the
second was purchased from Superfos (SF), Each contained AlCOH)^ 
at  a c o n c e n t r a t i o n  of  2%. To compare the a b s o r p t i o n  a b i l i t y  of  
each f o r  MSV (FeLV) the f o l l o w i n g  exper iment  was c a r r i e d  out.
F i r s t ,  the  pH of  t he  ALCOH)^ a l o n e  and d i l u t e d  1:10 i n  L-M 
medi um was d e t e r m i n e d  t o  e n s u r e  t h a t  i t  was w i t h i n  t h e  
p h y s i o l o g i c a l  range .  The pH of  each was found t o  w i t h i n  t he  
range 7 . 4 - 7 . 6  wh i ch  i s  s i m i l a r  t o  t h a t  o f  L-M medium.  I n  t h e  
absorpt ion exper i ment ,  0.6 ml conta in ing 2.4 X 10^ FFU MSV (FeLV) 
was d i l u t e d  w i t h  5.4 ml of  L-M medium. Then 0,2 ml of  each type
of  AlCOH)^ was added t o  2  ml of  d i l u t e d  v i r u s .  A volume o f  0.2  
ml PBS was added t o  2 ml of  the d i l u t e d  v i r us  as a v i r us  cont ro l .  
The mixtures were incubated at  4 °  f o r  16 hours and were then spun 
a t  6000 rpm f o r  20 m i n u t e s .  Samples o f  0.5 ml were  t a k e n  f rom  
t he  s u p e r n a t a n t  f l u i d  and assayed f o r  MSV (FeLV)  r e s i d u a l  
i n f e c t i v i t y .
Resul ts
K i n e t i c s  of  i n a c t i v a t i o n  of  MSV (FeLV)
a. PF: The r e s u l t s  of  i n a c t i v a t i o n  of  MSV (FeLV)  w i t h  PF are  
shown i n  T a b l e  3 . 2 .  Th e r e  was c o mp l e t e  i n a c t i v a t i o n  w i t h  PF 
c o n c e n t r a t i o n s  of  0.1% and 0.05% at  a l l  t i m e s ,  w h i l e  the  v i r u s  
cont r o l  t i t r e s  in the same per i od  dropped only s l i g h t l y  from 1,5 
X 10^ FFU/ml  t o  7,7 X 10^ F F U / m l .  The v i r u s  t i t r e  of  MSV (FeLV)  
i n a c t i v a t e d  w i t h  0.01% PF in the same i n t e r v a l  decreased from 6.4 
X 10^ FFU/ml  t o  4.3 X 10^ F F U / ml .
b, PF + GA: In t h i s  case t here  was complete i n a c t i v a t i o n  in a l l
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TABLE 3 . 2
I n a c t i v a t i o n  of  MSV (FeLV) wi th paraformaldehyde
Concent rat  ion 
(%)
Vi rus  T i t r e  (FFU/ml)  at hours
0.05
None
sampl es  at  each t i m e  p o i n t  as shown in T a b l e  3 ,3 ,  I n  c o n t r a s t  
the decrease in the t i t r e  of each sample of the v i r us  cont ro l  was 
f r om 5,1 X 10^ F l U / m l  t o  2,4 X 1 0  ^ F l U / m l  i n  24 hours .
c. AEI :  The r e s u l t s  of  AEI  i n a c t i v a t i o n  ar e  shown in T a b l e  3^4.  
There was complete i n a c t i v a t i o n  by 0.5% AEI at  a l l  i n t e r v a l s  and 
using 0,1% AEI f o r  24 hours.
d. DTNP + DMSO: As shown in Ta b l e  3 . 5 ,  t h e r e  was i nco mpl e t e
i n a c t i v a t i o n  o f  MSV (FeLV)  e i t h e r  by u s i n g  DMSO a l o n e  or  DTNP 
(0.2%) in DMSO. Ther e  was,  h o we v e r ,  an obv i ous  d i f f e r e n c e  in  
t i t r e  between the v i r u s  exposed to DMSO alone (1,0 X 10^ FFU/ml)  
and the  v i r u s  i n a c t i v a t e d  w i t h  DTNP i n  DMSO (6.4 X 10^ FFU/ ml )  
compared t o  t h e  v i r u s  c o n t r o l  t i t r e  ( 6,1 X 10^ F F U / m l ) ,  t hus  a 
s l i g h t  i n a c t i v a t i n g  ac t i on  of  DTNP was i n d i c a t ed .
e.  A d s o r p t i o n  o f  MSV (FeLV)  t o  AIOH3 : The r e s u l t s  shown i n  
Table 3.6 i n d i c a t e d  t ha t  the absorpt i ve  capaci ty  of  both Al(OH)^ 
t yp e s  were  a p p r o x i m a t e l y  s i m i l a r .  T h e r e  was an o b v i o u s  
d i f f e r e n c e  in MSV (FeLV) adsorbed to AKOH)^ compared wi th  PBS as 
c o n t r o l .  The t i t r e  o f  r e s i d u a l  MSV (FeLV)  a f t e r  exposure  t o  
AKOH)^ was 4 X 10^ FFU/ml  in c o n t r a s t  w i t h  t he  v i r u s  c o n t r o l  
t i t r e  which was 1.6 X 10^ FFU/ml ,  i n d i c a t i n g  t ha t  the absorpt ion  
capaci ty  of  the adjuvant  was approx i mate l y  75%.
Discussion
As shown i n  T a b l e  3 , 2  t h e  d e g r e e  o f  i n a c t i v a t  i 0  n o f  
unt rea t ed  MSV (FeLV) over a 24 hour per iod was r e l a t i v e l y  s ma l l ,  
d e c r e a s i n g  t o  about  50% of  the  o r i g i n a l  t i t r e .  By c o n t r a s t ,  
i n a c t i v a t i o n  o f  5 l o g s  o f  MSV ( F e L V)  was c o m p l e t e  a t  PF
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TABLE 3 . 3
I n a c t i v a t i o n  of MSV(FeLV) wi th paraformaldehyde and g lut ara I dehyde
Concent rat ion
(%)
Vi rus  t i t r e  (FFU/ml)  
0 3 6
at hours
24
0 . 5 0 0 0 0
0.1 0 0 0 0
0 . 0 2 0 0 0 0
0 . 004 0 0 0 0
None 5.1 X 10^ 3 . 5  X 10^ 3. 8  X 102 2 . 4  X 10^
. A m
TABLE 3.4
I n a c t i v a t i o n  of MSV(FeLV) wi th a c e t y l e t h y Leneimine
'Concentrat ion
(%)
Vi rus  t i t r e  (FFU/ml)  at  hours
3 . 2
0.02 9 . 6
0 . 004 6 . 4
6 , 4None
_____________
TABLE 3.5
I n a c t i v a t i o n  of  MSV(FeLV) wi th DTNP
Vi rus T i t r e  (FFU/ml )T reatment
DTNP + DMSO
DMSO alone
None
______________
TABLE 3 . 6
Adsorpt ion of  MSV(FeLV) to AlCOH)^
ALCOH)^ type Unabsorbed v i ru s  (FFU/ml)
WRL
Superfos  
None (PBS)
4 . 0  X 102
4 . 0  X 10^ 
1 . 6  X 10^
_________
concent rat ions of  0.1% and 0.05%. There was p a r t i a l  i n a c t i v a t i o n  
by PF at  0.01% t o  o n e - q u a r t e r  of  the  s t a r t i n g  t i t r e .  I n  t h i s  
case there  was an i n i t i a l  r educt ion of  i n f e c t i v i t y  over 6  hours 
but the ra t e  of  i n a c t i v a t i o n  subsequent ly decreased.
The second e x p e r i m e n t ,  t he  r e s u l t s  o f  whi ch  a r e  in T a b l e  
3-3,  showed tha t  g l u t a r a I dehyde  had an enhancing e f f e c t  on PF in 
i n a c t i v a t i n g  MSV (FeLV)  s i n c e  even a t  v e r y  low c o n c e n t r a t i o n s  
(0.004%) and at  t he  s t a r t i n g  t i m e ,  no i n f e c t i o u s  v i r u s  was 
recovered from the r e a c t i o n .
. By c o n t r a s t ,  t h e  t h i r d  i n a c t i v a t i o n  e x p e r i m e n t  where f o u r  
d i f f e r e n t  c o n c e n t r a t i o n s  of  AEI  were  used,  t he  r e s u l t  was t h a t  
o n l y  0.5% AEI  had t h e  a b i l i t y  t o  c o m p l e t e l y  i n a c t i v a t e  v i r u s  at  
a l l  i n t e r v a l s .  At 0-1% t h e r e  was o n l y  s l i g h t  i n a c t i v a t i o n  
i n i t i a l l y  and 3 logs o f  v i r u s  were i n a c t i v a t e d  by 24 hours .  I n  
t h i s  case,  the minimum AEI concent ra t i on which should be used in 
v i r us  a c t i v a t i o n  is 0,5%.
I n  t h e  l a s t  e x p e r i m e n t  of  i n a c t i v a t i o n  i n  which DTNP and 
DMSO were used f o r  a shor t  pe r i o d /  the r e s u l t  was t ha t  there  was 
i n c o m p l e t e  i n a c t i v a t i o n  of  MSV (FeLV) .  Howe v e r ,  t h e r e  was an 
obvious d i f f e r e n c e  in the v i ru s  t i t r e s  between i n a c t i v a t i o n  wi t h  
DMSO + DTNP and wi th  DMSO a lone,  which i nd i ca t ed  an i n a c t i v a t i n g  
a c t i o n  o f  DTNP on t h e  v i r u s  ( T a b l e  3 . 5 ) .  The r e a s o n  f o r  
i n a c t i v a t i o n  of  v i r us  by DTNP is not c l ea r  but may be due to the  
e f f e c t  o f  t h e  agent  i n  s t a b i l i s i n g  t h e  s t r u c t u r e  o f  t h e  v i r a l  
envelope so t ha t  the ent ry  of  the v i rus  i n t o  suscept i b l e  c e l l s  is  
i n h i b i t e d .  For use i n  t h e  v a c c i n e  e x p e r i m e n t s  d e s c r i b e d  i n  
Chapter 4 i t  was considered t h a t  a d d i t i o n a l  i n a c t i v a t i o n  wi t h  PF 
was requi red to ensure the s a f e t y  of  the vaccine,
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The Last  e x p e r i m e n t  d e s c r i b e d  i n  t h i s  c h a p t e r  was to  
d e t e r m i n e  the  a b s o r p t i v e  c a p a c i t y  of  two t ypes  of  an ALCOH)^ 
a d j u v a n t .  The r e s u l t s  o f  t h i s  e x p e r i m e n t  i n d i c a t e d  t h a t  t h e r e  
was s i m i l a r  a b s o r p t i o n  of  MSV (FeLV)  by both t ypes  of  AKOH)^  
( T a b l e  3 . 6 ) .  I t  shou l d  be n o t e d  t h a t  o n l y  unabsorbed v i r u s  
remaining in the supernatant  f l u i d  was assayed and not the v i rus
p r e s u ma b l y  a t t a c h e d  t o  t he  AI (OH)^"
I n  t he  f o r m u l a t i o n  of  c o m m e r c i a l  v a c c i n e s  i t  would be of
i n t e r e s t  to f i n d  i f  a g r e a t e r  concent ra t i on of  A l ( 0 H) 3  absorbed 
more v i r us  and whether v i r u s  could be recovered from the gel  fOr 
assay.
The general  conclusions from these exper iments were t hat  to  
i n a c t i v a t e  MSV (FeLV)  under  t he  c o n d i t i o n s  used,  PF shoul d  be 
used at  0.05%,  PF and GA at  0,04% (or  l e s s )  and AEI at  0.5%,  
DTNP t r e a t m e n t  sho u l d  be s u p p l e me n t ed  w i t h  t r e a t m e n t  of  v i r u s  
wi th an i n a c t i v a t i n g  agent .
Ther e  seemed t o  be l i t t l e  d i f f e r e n c e  in t he  a b s o r p t i v e  
c a p a c i t i es  of  the two types of  AL( 0 H) 3 ’
.î/S ï
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CHAPTER 4
VACCINATION EXPERIMENT 1: COMPARISON OF INACTIVATING AGENTS
INTRODUCTION
For reasons discussed in the I n t r o d u c t i o n  and in Chapter 2 
i t  was proposed to a t t empt  to use i na c t i v a t e d  FeLV pr epar a t i ons  
as vaccines.  Chemical  i n a c t i v a t i n g  agents were chosen because in 
general  these have been most successful  in previous i n a c t i v a t e d  
v i r a l  v a c c i n e s .  The c h e m i c a l  agent s  used i n  the  e x p e r i m e n t s  
descr ibed here were paraformaldehyde as a r ep r e s e n t a t i v e  of  the  
aldehydes which react  mainly  wi t h  both nuc l e i c  acids and pro t e i ns  
of v i ruses and produce c r o s s - l i n k i n g  w i t h i n  the nuc l e i c  acid and 
between the nuc l e i c  acid and any adjacent  p r o t e i n ,  and AEI which 
i s  a h i g h l y  r e a c t i v e  n u c l e o t r o p i c  c h e m i c a l .  I n  a d d i t i o n ,  DTNP 
t o g e t h e r  w i t h  PF was used.  The i n a c t i v a t i o n  of  MSV (FeLV) by 
these agents is descr ibed in Chapter  3 and as f a r  as possible  the  
c o n d i t i o n s  whi ch p r oved  s u f f i c i e n t  t o  i n a c t i v a t e  MSV (FeLV)  at  
t h e  minimum c o n c e n t r a t i o n  o f  t h e  c h e m i c a l  wer e  used here  t o  
i n a c t  i v a t e  FeLV.
The FeLV-A v i r u s  produced by F422 was used as a source  of  
a n t i g e n .  Two c o n c e n t r a t i o n s  o f  a n t i g e n  w e r e  used  w h i c h  
corresponded to unconcent ra t ed v i rus  from the c u l t u r e  harvest s ,  
and v i r us  concent rated t e n f o l d .
The a d j u v a n t s  which were  used were Al (OH)^ t o g e t h e r  w i t h  
saponin.  I n  r e t r o s p e c t ,  the choice of  saponin was not complete ly  
s a t i s f a c t o r y .  E x p e r i m e n t s  d e s c r i b e d  in C h a p t e r  7 showed t h a t  
s apon i n  was p r o b a b l y  not  as e f f i c i e n t  as an o i l  a d j u v a n t .  
Ho wever ,  a t  t h e  t i m e  when t h i s  s t udy  began,  saponi n  was b e i ng
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used e x p e r i m e n t a l l y  w i t h  some success in vaccines against  f o o t -  
and- mout h d i s e a s e  v i r u s  ( D a l s g a a r d  et  a l ,  1977)  and i t  was 
b e l i e v e d  t h a t  i t  m i gh t  be u s e f u l  i n  a v a c c i ne  f o r  ca t s  s i n c e  i t  
i s soluble  in w a t e r ,  would be easy to i ncorporate  i n t o  a vaccine  
and would be easy t o  a dmi n i s t e r  to cats .
Two doses of  vaccine were i noculat ed wi t h  an i n t e r v a l  of 3 
weeks b e t we e n  doses .  Ca t s  were  m o n i t o r e d  f o r  FeLV v i r a e m i a  
before each v a c c i n a t i o n ,  before chal lenge and at  i n t e r v a l s  a f t e r  
chal l enge.  Because of  the age res i s t ance  to FeLV which develops  
i n  ca t s  by about  16 weeks of  age (Hoover  e t  a I ,  1976)  i t  was 
considered necessary t o  complete vacc i na t i on  and chal lenge w i t h i n  
t h i s  per iod.  Hence cats were vaccinated when 8  and 11 weeks old  
and were chal l enged when 13 weeks of  age. Whi le i t  was be l i eved  
that  t h i s  pr o t oco l  would produce a s i t u a t i o n  in which a l l  of the  
unvaccinated cats could be made p e r s i s t e n t l y  v i r aemi c  f o l l o w i n g  
an a ppr opr i a t e  chal l enge dose,  i t  was recognised t ha t  vacc i na t i on  
of  such young k i t t e n s  might  not  give an optimum immune response.  
In p r a c t i c e ,  in n a t u r a l  con d i t i ons ,  vacc i na t i on  might be delayed  
up to 12 weeks of  age. Vacc i na t i on  at  t h i s  age would also almost  
c e r t a i n l y  a v o i d  i n t e r f e r e n c e  by m a t e r n a l  ant i bod i es  (Hoover et  
a I ,  1977; J a r r e t t  et  a l ,  1977 ) .
C h a l l e n g e  was by adm i n i  s t  r a t  i on of  FeLV i n t o  t he  nose and 
mouth.  T h i s  r o u t e  o f  a d m i n i s t r a t i o n  was used i n  o r d e r  t o  
s i mul a t e  n a t u r a l  t r ansmi ss i on .  Hoover ej  ^ aji (1977a) showed tha t  
k i t t e n s  could be s u c c e s s f u l l y  i n f e c t e d  w i t h  FeLV by i n t r a n a s a l  
i n s t i l l a t i o n  and s u b s e q u e n t l y  d ev e l op e d  l ymphosarcoma.  More  
r e c e n t l y  J a r r e t t  e t  a l  ( 1 9 8 2 a ) u s e d  o r o n a s a l  i n f e c t i o n  and
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produced p e r s i s t e n t  i n f e c t i o n s  in aLL of the 8 -week old k i t t e n s  
i n f e c t e d ,  but only in about h a l f  of the 16-week old animals.
In the va c c i n a t i o n  exper iments descr ibed in t h i s  and l a t e r  
c h a p t e r s ,  t he  k i t t e n s  were m o n i t o r e d  a f t e r  c h a l l e n g e  f o r  FeLV 
v i r aemi a  and FeLV n e u t r a l i s i n g  ant ibodies .  Samples were taken 3 
weeks a f t e r  c h a l l e n g e  s i n c e  i t  has been shown t h a t  t h i s  i s  t he  
t i m e  when a t r a n s i e n t  v i r a e m i a  would be most l i k e l y  t o  be 
detected ( J a r r e t t  et  a l ,  1982a) .  Fur ther  samples were taken 6  and 
9 weeks a f t e r  c h a l l e n g e  t o  t e s t  f o r  t he  d e v e l o pment  of  a 
p e r s i s t e n t  i n f e c t i o n .
MATERIALS AND METHODS
Seven types of  i n a c t i v a t e d  FeLV vaccine were produced using  
3 d i f f e r e n t  i n a c t i v a t i n g  agents e i t h e r  alone or in combinat ion.  
A co n t r o l  vaccine p r e p a r a t i o n  was also made.
Vaccine A1: PF (1)
One hundred ml o f  FeLV was c o l l e c t e d  f rom F422 c e l l  
c u l t u r es  48 hours a f t e r  seeding wi t h  1.2 X 10^ cel ls,  per  ml in L -  
M medium. The f l u i d  was spun at 2000 rpm f or  20 minutes and the  
s u p e r n a t a n t  was s t o r e d  a t  - 7 0 ° .  When r e q u i r e d  t h e  medium was 
t hawed and i n a c t i v a t e d  w i t h  0.5% PF at  room t e m p e r a t u r e  f o r  24 
hours.  A one- t en t h  volume of  20% sodium t h i o su l pha t e  was added 
f o r  30 minutes at  room temperat ure .  Then two 0,5 ml samples were 
t a k e n  and s t o r e d  a t  - 7 0 °  f o r  assays o f  v i r a l  i n f e c t  i v i t y .  Ten 
ml of t h i s  p r e pa r a t i on  was taken and mixed wi th  1 ml of  Al(OH)^^ 
kept  a t  4 °  o v e r n i g h t  and spun a t  3000 rpm f o r  30 m i n u t e s .  The 
s e d i me n t  was resuspended in 4 ml PBS and 4 ml of  saponi n
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c o n t a i n i n g  12 mg of  t h e  a c t i v e  i n g r e d i e n t  was added t o  g i v e  a 
f i n a l  vo lume of  8 ml .  Four ml was used i m m e d i a t e l y  w h i l e  the  
o t h e r  4 ml was kep t  a t  4 °  u n t i l  used as t he  second dose o f  
vaccine.
Vaccine A2: PF (10)
The remainder  of  the FeLV which was i n a c t i v a t e d  in the f i r s t  
step of  the p r e p a r a t i o n  of  vaccine A1 was p r e c i p i t a t e d  wi t h  SAS 
and concent rated as descr ibed above. Then 0.9 ml of  Al(OH)^ ygg 
added t o  9 ml  o f  t h e  c o n c e n t r a t e d  a n t i g e n ,  i n c u b a t e d  a t  4^ 
o v e r n i g h t ,  spun a t  3000  rpm f o r  30 mi nut es  and the s e d i me n t  
resuspended in 4 ml PBS. Four ml of  saponin cont a in ing 12 mg was 
added and 4 ml of t h i s  vaccine was used as vaccine,  whi l e  another  
4  ml was kept  a t  4 °  u n t i l  used f o r  a b o o s t i n g  dose i n  t h e  same 
cat s ,  3 weeks l a t e r .
Vaccine A3: AEI (1)
F i f t y  ml of  FeLV which had been c o l l e c t e d  f rom F422 c e l l  
c u l t u r e  48 hours a f t e r  s e e d i n g  a t  12 X 1 0 ^ / m l i n  L-M medium was 
spun at  2 0 0 0  rpm f o r  2 0  minutes and the supernatant  was stored at  
- 7 0 ° .  When r e qu i r e d ,  the f l u i d  was thawed and i n a c t i v a t e d  wi t h  
0,2% AEI f o r  24 hours at  room t e m p e r a t u r e .  The AEI was t hen  
n e u t r a l i s e d  by the a d d i t i o n  of  a one- t enth  volume of 2 0 % sodium 
t h i osu l pha t e  and i ncubat i on  for  30 minutes at  room temperature .  
The v i r u s  was then concent rated by adding an equal  volume of  SAS.
The suspension was incubated f o r  30 minutes at  4°  and was 
t hen  spun a t  3 000  rpm f o r  30 m i n u t e s .  The se d i me n t  was 
resuspended in 10 ml PBS and was layered i n t o  an SW41 c e n t r i f u g e
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tube c o n t a i n i n g  1 mi o f  50% sucr ose  and 2 ml 20% sucr ose .  The 
tube was c e n t r i f uge d  at  40,000 rpm for  1 hour and the v i r us  band 
which formed between the sucrose Layers was recovered in 0,5 ml 
by p u n c t u r i n g  t he  bo t t om of  t he  t ube .  Sucrose was removed by 
p a s s i n g  t h e  v i r u s  t h r oug h  a P h a r ma c i a  PD10 column c o n t a i n i n g  
Sephadex G25.  The f i n a l  volume was 2 ml i n  PBS,
To prepare the vacc i ne ,  0.2 ml of  t h i s  f i n a l  p r epar a t i on  was 
added to 1.8 ml PBS. A vo l ume of  0.2 ml of  AlCOH)^ ^as added and 
t he  m i x t u r e  was i n c u b a t e d  o v e r n i g h t  a t  4 ° .  Two ml o f  s apon i n  
cont a in ing 6  mg of  a c t i v e  i ngr ed i en t  was then added, so t ha t  the  
f i n a l  volume was 4 ml.
Vaccine A4: AEI (10)
The r e m a i n d e r  of  t h e  i n a c t i v a t e d  and c o n c e n t r a t e d  FeLV i n  
t he  f i r s t  e x p e r i m e n t  (1 ,8 ml )  was used t o  p r e p a r e  t h e  AEI  X 10 
v a c c i n e  by ad d i n g  0 . 2  ml of  A l l OH ) ^ ,  i n c u b a t i n g  at  4 °  o v e r n i g h t  
and t hen  add i ng  2 ml o f  s a p o n i n .  The b o o s t e r  doses f o r  bot h  
v a c c i n e s  A3 and A4 were p r e p a r e d  in  the  same way as t h e  f i r s t  
doses,  but on a separa te  occasion.
Vaccine A5: DTNP/PF (1)
A volume of  100 ml FeLV which had been p r e p a r e d  and s t o r e d  
as in the previous exper iments was thawed and p r e c i p i t a t e d  wi t h  
SAS and concent rated as descr ibed above. The v i r us  was recovered  
i n  2 ml PBS. Of t h i  s , 100 u I was added t o  0.9 ml L-M medium and 
was stored at  - 7 0 °  as two 0.5 ml volumes. I n  a d d i t i o n ,  two 0,5 
ml samples were c o l l e c t e d  before SAS p r e c i p i t a t i o n  and stored at  
- 7 0 ° .  I n a c t i v a t i o n  was done by addi ng  0.2 ml of  0.2% DTNP in  
DMSO t o  t he  c o n c e n t r a t e d  a n t i g e n  (2 ml )  and i n c u b a t i o n  a t  room
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t emperature  f o r  30 minutes.  Then 100 uL of i n a c t i v a t ed  v i r us  was 
added to 0.9 ml L-M medium and s t o r e d  at  -7Q0 as two 0.5 ml  
volumes f o r  assay of  r e s i d u a l  i n f e c t i v i t y .  The remainder of  the 
DTNP t r e a t e d  v i r u s  was d i l u t e d  to 10 ml w i t h  PBS and was 
i n a c t i v a t e d  w i t h  0.5% PF by a d d i n g  1 . 25  ml  o f  4% PF and  
i ncubat ing at room t emperat ure  f or  24 hours. Then 1.1 ml of 20% 
sodium t h i o s u l p h a t e  was added f o r  30 minutes at  room temperature ,  
A volume of  0.8 ml of the f i n a l  m a t e r i a l  (12 ml) was added t o  7.2 
ml PBS t o  make 8  ml o f  XI a n t i g e n  c o n c e n t r a t i o n ,  w h i l e  t h e  
r e ma i n i n g  volume (11.2 ml )  was used as t he  X I 0 a n t i g e n .  To 
p r e p a r e  v a c c i n e  A5,  0.3 ml o f  AI  (OH)^ was added t o  t h e  8  ml  o f  
t he  XI and i n c u b a t e d  at  4 °  o v e r n i g h t .  Then 1 ml of  saponi n  
cont a i n i ng 1 2  mg was added to form the f i n a l  f o r mu l a t i on  of  the  
vaccine as 9 ml which was used to vaccinate  and boost the cats.
Vaccine A6 : DTNP/PF (10)
T h i s  v a c c i n e  was p r e p a r e d  by adddi ng 0.8 ml of  Al (OH)^ to  8  
ml o f  X10 i n a c t i v a t e d  a n t i g e n ,  i n c u b a t i n g  a t  4 °  o v e r n i g h t  and 
t hen  addi ng  1 ml of  sapon i n  c o n t a i n i n g  1 2  mg of  t he  a c t i v e  
i n g r e d i e n t .  The f i n a l  v a c c i n e  (A6 ) was used t o  v a c c i n a t e  and 
boost the cats.  One ml of  XIO i n a c t i v a t ed  ant igen was added to 1 
ml of  L-M medium bef ore  a d d i t i o n  of  the adjuvants and was stored  
a t  - 7 0 °  as t w o  0 . 5  ml  l o t s  t o  a s s a y  t h e  v i r a l  r e s i d u a l  
i n f e c t i v i t y .
Vaccine A7: F422 c e l l s
F422 c e l l s  were grown a t  12 X 1 0 ^ / m l  i n  100 ml L-M medium 
and c o l l e c t e d  48 hours a f t e r  seed i ng  by s p i n n i n g  t h e  c u l t u r e
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îf l u i d  a t  1000 rpm f o r  10 m i n u t e s .  The c e l l s  were washed t w i c e  
w i t h  PBS by r e p e a t i n g  t he  s p i n n i n g  and r e s u s p e n s i o n  at  room 
t e m p e r a t u r e  and were  f i n a l l y  resuspended i n  50 ml of  co l d  PBS.  
An e q ua l  vo lume of  0.1% PF was added drop by drop w i t h  c o n s t a n t  
s t i r r i n g  at  4 ° .  The c e l l s  were incubated f o r  24 hours,  washed 3 
t i m e s  w i t h  PBS at  4°^ count ed and resuspended i n  2 ml of  PBS. 
Six uI  of  t h i s  c e l l  suspension was taken as a sample f o r  assaying  
of  FeLV i n f e c t i v i t y  and 0.2 ml of  Al (OH)^ ygg added t o  t he  
remaining c e l l  suspension and incubated at  4°  f o r  3 hours.  Two 
ml of saponin conta i n i ng  6 mg of  the a c t i v e  i ngr ed i en t  was added 
to prepare the f i n a l  vaccine.  Each ml contained 3.5 X 10^ c e l l s .  
The booster  dose was prepared in the same way. The i n f e c t i v i t y  
of  the i n a c t i v a t e d  c e l l s  sample was checked as f o l l ows .  The c e l l  
sampl e  was washed once w i t h  EFC, resuspended in 2 ml of  EFC 
medium and 1 ml was inocu l a t ed  i n t o  two of t w e l v e ,  5 cm p l a s t i c  
p l a t e s  which had been seeded 24 hours p r e v i o u s l y  w i t h  FEA/C81
c e l l s  a t  a r a t i o  o f  1 U:1 i n  4 ml EFC medium.  Of t h e  o t h e r  10
p l a t e s ,  2 were used f o r  a c e l l  c o n t r o l  w h i l e  8 were used to
i nocu l a t e  4,  t e n f o l d  d i l u t i o n s  of  f r e s h l y  prepared F422 c e l l s  in
L - 1 5 w i t h  10% FCS w i t h  2 p l a t e s  f o r  each d i l u t i o n .  Three  days 
l a t e r  the medium was changed and a f t e r  a f u r t h e r  4 days the c e l l s  
were checked m i c r o s c o p i c a l l y  f o r  t r a ns f or mat i on -  There was no 
c e l l  t r a n s f o r m a t i o n  in the c e l l  cont ro l  p l a t e s  or in the p l a t e s  
i n o c u l a t e d  w i t h  t h e  i n a c t i v a t e d  F422 c e l l s .  I n  c o n t r a s t ,  c e l l  
t r a n s f o r m a t i o n  o c c u r r e d  i n  a l l  p l a t e s  i n o c u l a t e d  w i t h  f r e s h l y  
p r e p a r e d  F422 c e l l s  which i n d i c a t e d  t h a t  PF t r e a t e d  F422 c e l l s  
were completely i n a c t i v a t e d .
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Control  Vaccine A8
T h i s  " v a c c i n e "  was p r e p a r e d  by t r e a t i n g  10 ml L-M medium 
wi t h  0.2% AEI f o r  24 hours at  room t emperature.  The AEI was then 
n e u t r a l i s e d  by ad d i ng  o n e - t e n t h  of  t he  volume of  20% sodjum 
t h i o s u l p h a t e .  The m i x t u r e  was i n c u b a t e d  f o r  30 m i n u t e s .  A 
v o l u m e  o f  1 ml o f  AlCOH)^ y g g added and i n c u b a t e d  a t  4 °  
overn i ght .  The mi x t ure  was then spun at  6000 rpm f o r  20 minutes  
and t he  s e d i m e n t  was resuspended in 4 ml PBS. Four ml of  
s a p o n i n ,  c o n t a i n i n g  12 mg o f  t h e  a c t i v e  i n g r e d i e n t  was added.  
P a r t  of  t h i s  p r e p a r a t i o n  was used t o  i n o c u l a t e  ca t s  and the  
r e m a i n d e r  (4 m l )  was k e p t  a t  4 °  u n t i l  used  f o r  a s e c o n d  
i n o c u l a t i o n ,  3 weeks l a t e r .
Animal Experiments
T h i r t y - t w o  SPF c a t s  were  o b t a i n e d  when 8 weeks of  age.  
These c a t s  wer e  r a n d o mi s e d  and a r r a n g e d  i n  8 groups o f  4 c a t s .  
Each group was inocu l a t ed  wi t h  one of the seven kinds of  vaccine  
or  t h e  c o n t r o l  v a c c i n e .  V a c c i n e  was g i v e n  by subcut aneous  
i n j e c t i o n  of  1 ml  of  v a c c i n e  i n  the  i n t e r s c a p u l a r  r e g i o n  of  t he  
neck.  The b o o s t e r  doses were  g i v e n  i n  t h e  same, way,  3 weeks  
l a t e r .  The FeLV chal l enge was done by a d m i n i s t r a t i o n  of  1 ml of  
FeLV cont a in ing 8.5 X 10^ i n f e c t i o u s  p a r t i c l e s  o r onasa l l y  to a l l  
cats inc l ud i ng  con t r o l  vaccine cats 2 weeks a f t e r  the second dose 
of  t h e  v a c c i n e s .  A vo l ume o f  0.25 was g i v e n  i n t o  each n o s t r i l  
and the r e m a i n d e r  g i v e n  by mouth.  Blood sampl es  (2 ml :  1 ml  
c l o t t e d  b l oo d  f o r  serum and 1 ml i n  l i t h i u m  h e p a r i n )  were  
c o l l e c t e d  f r om t he  j u g u l a r  v e i n  of  a l l  ca t s  b e f o r e  g i v i n g  the  
v a c c i n e s ,  b e f o r e  c h a l l e n g e  and a t  3 ,  6 and 9 weeks a f t e r
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chaLLenge. These blood samples were processed and used in v i r u s  
i s o l a t i o n  and serum n e u t r a l i s i n g  ant ibody t e s t s .
RESULTS
Response t o  Vacc i na t i on
The response of cats to vacc i na t i on  wi th the 7 vaccines and 
to chal l enge w i t h  FeLV are shown in Table 4.1.  The response was 
measured in two ways: f i r s t ,  whether or not a cat  was v i r aemi c  
and s e c o n d l y ,  w h e t h e r  or  not  a ca t  had v i r u s  n e u t r a l i s i n g  
ant ibodi  es.
Fol lowing va c c i n a t i o n  but before cha l l enge ,  none of the cats 
had v i r u s  i n  t he  b l o o d .  Only  one cat  i n  group A6 appear ed  t o  
have a n t i b o d i e s  b e f o r e  c h a l l e n g e .  A f t e r  c h a l l e n g e ,  over  t w o -  
t h i r d s  o f  t h e  c a t s  r esponded e i t h e r  by becoming v i r a e m i c  or  
developing an t i bod i es .  I t  was, however,  d i f f i c u l t  to  compare the 
r esponse  o f  t h e  v a c c i n a t e d  c a t s  w i t h  t h a t  o f  t h e  u n v a c c i n a t e d  
c o n t r o l s  s i n c e  not  a l l  of  t he  c o n t r o l  ca t s  became v i r a e m i c .  
Thr ee  o f  t h e s e  f o u r  c a t s  were  v i r a e m i c  a t  3 o r  6 weeks a f t e r  
chal lenge but only one was s t i l l  v i raemi c  at  9 weeks. Apart  from 
the cats in group A7 which were i noculat ed wi t h  P F - i n a c t i vatèd  
c e l l s  of  which 3 or  4 were  v i r a e m i c  at  9 weeks ,  t he  response  of  
t he  o t h e r  v a c c i n a t e d  groups were  a l i t t l e  b e t t e r  t h a n  t he  
c o n t r o l s .  For e x a m p l e ,  i n  group Al none of  the  ca t s  became  
v i r a e m i c .  I n  each of  t h e  groups A4,  AS and A6 o n l y  one cat  was 
t r a n s i e n t l y  v i r a e m i c .  At  9 weeks in group A2 one cat  was 
vi raemic  and in group A3 two cats were v i r aemi c .
V i r u s  n e u t r a l i s i n g  a n t i b o d y  was found in t h e  s e r a  of  c a t s
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TABLE 4.1 Results of Vaccination Experiment A
Group Time (weeks) r e l a t i ve to chal lenge *
No, vaccine -5 -2 0 3 6 9
VA VA VA VA VA VA
Al PF (1) -0 -0 -0 -8 -8 -0
-0 -0 -0 -0 -8 -32
-0 -0 -0 -0 -8 -128
-0 -0 -0 -0 -0 -0
A2 PF (10) -0 -0 -0 -8 -8 -0
-0 -0 -0 -8 -B -0
-0 -0 -0 -0 -8 -0
-0 -0 -0 -0 -0 +0
A3 AEI (1) -0 -0 -0 +0 +0 +0
-0 -0 -0 -0 -0 -0
-0 -0 -0 „0 -0 +0
-0 -0 -0 -0 -0 -0
A4 AEI (10) -0 -0 -0 -0 -0 -8
-0 -0 -0 +0 +0 -0
-0 -0 -0 -8 -8 -32
-0 -0 -0 -0 -8 -32
A5 DTNP/PF (1) -0 -0 -0 -0 -0 -0
„o -0 -0 -8 -0 -0
-0 -0 -0 -0 -0 -0
-0 -0 -0 +0 -0 -0
A6 DTNP/PF (10) -0 -0 -0 -0 -0 -0
-0 -0 -8 -8 -8 -0
-0 -0 -0 -0 -0 -0
-0 -0 -0 -0 4-0 -0
A7 F422 ce l l s -0 -0 -0 +0 +0 4-0
-0 -0 -0 -0 +0 4-0
-0 -0 -0 -0 -0 -0
-0 -0 -0 +0 +0 4-0
A8 Unvaccinated -0 -0 +0 4-0
-0 -0 -0 -0
-0 -0 +0 -0
-0 +0 +0 -0
V = v irus  iso la ted  from plasma 
A = t i t r e  o f v irus  n e u tra lis in g  antibody 
0 = <8
iM VM ïïl
only in the vacc i nat ed  groups.  Ant ibody was detected only a f t e r  
chal lenge except  in one cat  in group A6 which had a t i t r e  of  8 at  
the t ime of  cha l l enge ,  two weeks a f t e r  the booster  i n o c u l a t i o n .
The major  aim of t h i s  i n i t i a l  exper iment  was to have a guide 
as t o  which i n a c t i v a t i n g  agent  mi gh t  be most  e f f e c t i v e  in  
p r od u c i n g  a v i r a l  v a c c i n e .  From the i n d i v i d u a l  r esponses t o  
c h a l l e n g e  i t  was d i f f i c u l t  t o  assess which group had responded  
b e s t .  As an a i d  to t h e  e v a l u a t i o n  of  the e f f i c a c y  of  each  
vaccine a scor ing system was used which compared the response of  
each v a c c i n a t e d  group of  c a t s  and the u n v a c c i n a t e d  group.  Two 
a s p e c t s  of  t h e  response  were  i n c l u d e d .  These were  f i r s t ,  t h e  
p r o p o r t i o n  of  c a t s  whi ch became v i r a e m i c  and s e c o n d l y ,  t he  
pr opor t i on  which developed v i r u s  n e u t r a l i s i n g  an t i bod i es .  I n  the  
case of  v i r a e m i a ,  f o r  each s a m p l i n g  t i m e  a f t e r  c h a l l e n g e  t h e  
p r o p o r t i o n  o f  v i r a e m i c  c a t s  i n  a g r o u p ,  e x p r e s s e d  as a 
p e r c e n t a g e ,  was m u l t i p l i e d  by a f a c t o r  t o  g i v e  a v i r u s  s c o r e .  
T h i s  f a c t o r  was 1 f o r  3 weeks ,  2 f o r  6 weeks and 3 f o r  9 weeks.  
I t  was reasoned  t h a t  i f  a ca t  was v i r a e m i c  9 weeks a f t e r  
chal lenge i t  was l i k e l y  to be permanent ly i n f e c t e d  and t h e r e f o r e  
shoul d  have a h i g h e r  f a c t o r  t han  a cat  v i r a e m i c  a f t e r  3 weeks  
which mi g h t  o n l y  have a t r a n s i e n t  i n f e c t i o n .  By s i m i l a r  
reasoning i t  was c o n s i der ed , t ha t  cats wi th  ant ibody 3 weeks a f t e r  
chal l enge had responded b e t t e r  than the cats which had ant ibody 6 
or 9 weeks a f t e r  chal l enge.  The c o r o l l a r y  of  t h i s  was t ha t  cats  
w i t h  no a n t i b o d i e s  a t  3 weeks were  poor  r e s p o n d e r s  and s h ou l d  
have a higher  score than cats wi th  no ant i bodi es  at  6 or 9 weeks.  
Ther e f o r e ,  f o r  each sampl ing t i me  the percentage of  cats w i t h  no 
a n t i b o d y  was m u l t i p l i e d  by a f a c t o r  of  3 f o r  3 weeks ,  2 f o r  6
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weeks and 1 f o r  9 weeks.
As an example of  the scor ing system,  in group A2 at  9 weeks 
a f t e r  cha l l enge ,  1 of  the 4 cats (25%) was v i r a e mi c .  Ther e f o r e ,  
a v i r u s  score  of  75 (25 X 3) was g i v e n  to group A2 a t  t h a t  t i m e .  
At  3 and 6 w e e k s  t h e  s c o r e s  w e r e  0 (0 X 3 )  and 0 (0 X 2)  
r e s p e c t i v e l y ,  making a t o t a l  v i r u s  score  of  75.  L i k e w i s e  at  9 
weeks a l l  (100%) o f  the  same group had no a n t i b o d i e s  and so t h e  
a n t i b o d y  score  was 100 (100 X 1 ) .  At  3 and 6 weeks the scor es  
were 150 (50 X 3) and 50 (25 X 2) r e s p e c t i v e l y  so t h a t  t he  t o t a l  
a n t i b o d y  scor e  was 30 0 .  The t o t a l  score  f o r  group A2 was,  
t h e r e f o r e ,  75 + 300 (375) .  A t o t a l  score was computed f o r  a l l .  of  
t he  groups in t h i s  way.  The rank of  each group was t hen  
e s t a b l i s h e d  a c c o r d i n g  t o  t h i s  s c o r e ,  the  l o w e s t  scor e  b e i n g  
ranked 1 and t he  h i g h e s t ,  8.  A low score  i n d i c a t e d  a b e t t e r  
response to  chal l enge than a high score.  The scores and ranking  
are shown in Table 4 . 2 .
Us i ng  t h i s  system of  s c o r i n g ,  the  t wo p a r a f o r m a I d e h y d e ­
i n a c t i v a t e d  v a c c i n e s  had t h e  l o w e s t  scor es  and t h e  F422 c e l l  
vaccine had the highest  score,
S i d e - e f f e c t s  of  Vacc i na t i on
Fol l owi ng i n o c u l a t i o n  of  the f i r s t  dose of  vacc i ne ,  i t  was 
ob s e r v e d  t h a t  many o f  t he  c a t s  s u f f e r e d  some d i s c o m f o r t .  
Th er e f o r e ,  24 hours a f t e r  the second i n o c u l a t i o n  of  vaccine> thé 
c a t s  were  exami ned  more c a r e f u l l y  f o r  s w e l l i n g  a t  t h e  si  t e  of  
i n o c u l a t i o n  and f o r  p a i n  on h a n d l i n g  the  s i t e .  The r e c t a l  
t emperat ure  was a lso taken f rom most of  the cats.  The; r e s u l t s ,  
shown i n  T a b l e  4 . 3 ,  i n d i c a t e d  t h a t  the v a c c i n e s  produced a
60
(N
§H"
I
CD4Jo
0)
(-4oOtS)
IICM \0
lA LA LA LA O LA LA LACM A ' CM CM LA CM CM CM^A (A OO LA LA O 00
ÜJ j j LA O CD O A A CD CDz : o CM O CD A CM CD CDt-H h— fA A M3 A A M3 M3ccwQ_X O O CD A CD a CD CDw (U LA O CD CM CD CD CD CDA CJz Oo DL-H enh— O CD O CD CD CD CD CD< LA A CD CD CD A CD CDz X3 CD CM CM CM CM1-4 OO JDCJ •H<c JJ A CD CD A A A CD CD> • C CM A CD CM CM CM CD CD<c < CM A CM CM CM A Azh—4
tn f - iÜJ COcc +J A A A A CD A Ao o O CM CM A CM CMCJ H - CM Mf CMCD
> -LJ O A CD CD CD CD A AC * r~ A CM r~.CJ CJ CML—1 mü_ AÜ_ oÜJ oen CD CD CD CD CDCD o o A A CD A A CDco3u■H A A A CD CD> <C o o CM CM CM CD A A
T30CD CO JJr—1 CO1—1 cCl 0 ü_ ü_ 0 •H3 C CD Ou CL O OO •H CD \ \ uU U CL CL CM roC3 O L-4 1-4 z Z CM >co Li_ ü_ ÜJ ÜJ 1— l_ z0) > D_ Q_ < < Q CD ü_ 33C•HQUm o CM A A M3 h" OO> z < C <C < C C cC <
W en wj<: JC JsC0 0 00 0 0s % %
A M3 A
II II II
C CO CJ
*
~  :   ! . . _ ■
TABLE 4 .3
S i d e - e f f e c t s  o f  saponin-adjuvanted vaccines
Vaccine Cat Response- . ï * - .  Vaccine Cat Response ^
Group No. P S T fC)  Group No. P S T t Q
A1 1 _ 38 . 4 A5 1 - » 39.5
2 - — 38 .9 2 - - 40 . 3
3 — — 38 . 9 3 4- 4- 40 . 3
4 + + 40 . 6 4 4- 4- 40 . 3  .
A2 1 - - 3 8 . 9 A6 1 4* 4- 40 .3
2 + + 40 . 3 2 4- 4- 40 .6
3 + 4- 40 . 6 3 4- 4- 40 . 6
4 + + 40 . 6 4 4- 4- 40 . 6
A3 1 4* ND A7 1 + 4- 40 . 6
2 — 4- ND 2 4- 4- 40 . 6
3 - 4- ND 3 4- 4- 40 .6
4 - 4- ND 4 4- 4- 40 , 6
A4 1 - 4- ND AS 1 4" 4- ND
2 T 4- ND 2 - — ND
3 - - i ND 3 4- 4- ND
4 - 4- ND 4 — 4- ND
*  P = pain on handl ing s i t e  
S = swe l l i ng  a t  s i t e  
T = r e c t a l  temperature  
ND = Not Done.
   : : ' ^
h a r m f u l  r e a c t i o n  a t  t h e  s i t e  o f  i n o c u l a t i o n  i n  many c a t s .  I n  
a d d i t i on  most cats which developed side e f f e c t s  also had s l i g h t  
p y r e x i a .
To f i nd  whether saponin or ALCOH)^ might be responsible  f or  
t h e s e  e f f e c t s ,  members o f  a group o f  5 , 8 - w e e k  o l d  k i t t e n s  were  
i nocul a t ed  subcutaneously wi th  1 ml of PBS conta ining 1.5 mg of  
saponin.  A f u r t h e r  group of  s i m i l a r  k i t t e n s  were i nocul a ted  wi t h  
1 ml of  PBS c o n t a i n i n g  0,1 ml of  AlCOH)^ sus p e n s i o n .  These  
c o n c e n t r a t i o n s  were  t h e  same as used i n  t he  v a c c i n e s .  The 
k i t t e n s  were exami ned  24 and 48 hours a f t e r  i n j e c t i o n  f o r  p a i n  
and s w e l l i n g  at  the i n o c u l a t i o n  s i t e  and t h e i r  r e c t a l  t emperature  
was obt a i ned.  The r e s u l t s  are shown in Table 4 . 4 .
From t h e  r e s u l t s  i n  T a b l e  4.3 i t  i s  c l e a r  t h a t  a l l  o f  t h e  
vaccines produced si d e - e f f e c t s  in at least  some of the i nocul a ted  
cats.  In gener a l ,  cats which showed pain and s w e l l i n g  also had a 
mi ld  pyrex i a .  The saponin adjuvant  in the vaccine appeared to be 
p a r t l y  or whol l y  responsi b l e  f o r  these e f f e c t s  s i nce ,  as shown in 
Table 4.4. ,  k i t t e n s  i nocu l a t ed  wi t h  a s i m i l a r  amount of saponin 
as was used i n  t h e  v a c c i n e s ,  d e v e l op e d  s i d e - e f f e c t s .  K i t t e n s
i n o c u l a t e d  w i t h  AlCOH)^ r e m a i n e d  c l i n i c a l l y  normal  wi t h  only a 
minor r i s e  in temperature 24 hours a f t e r  the i n j e c t i o n .
Discussion
I t  i s  u s u a l  f o r  t h e  e f f i c a c y  of  v i r a l  v a c c i n e s  t o  be 
e v a l u a t e d  by t he  immune response  of  the  host  t o  v a c c i n a t i o n ,  
which is o f t e n  measured by the product ion of  serum ant ibodies-  to  
t he  a n t i g e n ,  and by the  r e s i s t a n c e  of  v a c c i n a t e d  a n i m a l s  t o
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TABLE 4.4
Effect of inoculation of saponin or Al(OH).
Treatment Cat
No
Respdns^ (24 hours)  
P S T ( C)
Response 
P S
(48 hours)
a ( ° c )
Saponin 1 "h 40 . 3 40 . 3
2 + ~ 4 0 . 6 - - 4 0 . 3
3 4- 4 0 . 0 - + 4 0 . 3
4 4* -  41.1 “ + 4 0 . 6
5 “h 40 . 6 - + 4 0 . 3
Al (OH)^ 1 — -  40 . 3 — 38 . 9
2 "■ -  39 . 5 — - 38.9
3 -  39 .5 - 38 . 9
4 - 39 .5 - — 38. 5
5 - -  39 . 5 - — 38.9
P = pain on handl ing s i t e  
S = swe l l i ng  a t  s i t e  
T = r e c t a l  temperature
chal l enge w i t h  a dose of v i r us  which would cause an i n f e c t i o n  or  
disease in a l l  or most of  unvaccinated cont ro l  animals.  In the 
exper iment  descr ibed in t h i s  chapter ,  i t  was d i f f i c u l t  to assess 
the e f f i c a c y  of the var ious vaccines which were used. The main 
reason f o r  t h i s  was t h a t  not  a l l  of  the unvaccinated cont r o l  cats  
became v i r a e m i c .  The dose of  v i r u s  which was a d m i n i s t e r e d  
or onasa l l y  was 8.5 X 10^ FIU and was be l i eved  at  the beginning of  
these exper iments to be s u f f i c i e n t  to cause permanent v i r aemi a  in  
most c a t s .  T h i s  p r ov e d  not  to  be t he  case and a l t h o u g h  2 of  4 
c o n t r o l  ca t s  had a t r a n s i e n t  v i r a e m i a ,  o n l y  1 had a v i r a e m i a  9 
weeks a f t e r  cha l l enge .
A more marked d i f f e r e n c e  between some of the vaccinated cats  
and t h e  u n v a c c i n a t e d  c a t s  was seen by t he  a ppear an ce  o f  v i r u s  
n e u t r a l i s i n g  a n t i b o d i e s .  None of  the  c o n t r o l  ca t s  d ev e l o p e d  
a n t i b o d i e s .  Only one ca t  i n  t he  group v a c c i n a t e d  w i t h  t he  
DTNP/PF vaccine had ant i bodi es  f o l l o w i n g  vacc i na t i on  but before  
chal l enge.  Cur i o us l y ,  these ant i bodi es  pe r s i s t e d  f o r  a per iod of  
6 weeks but  were  not  d e t e c t e d  a t  9 weeks a f t e r  c h a l l e n g e .  The 
reason of  t h i s  disappearance is  not known. A s i m i l a r  s i t u a t i o n  
was ob s e r v e d  a f t e r  c h a l l e n g e  in some o t h e r  groups and r i s i n g  
t i t r e s  of  a n t i b o d i e s  were  seen o n l y  i n  t h e  groups g i v e n  t he  
A E I ( I O )  and P F ( I )  v a c c i n e s .  I t  appear s  f rom t h e s e  r e s u l t s  t h a t  
t he  v a c c i n e  had p r i m e d  t he  immune response so t h a t  f o l l o w i n g  
i n f e c t i o n  wi th  l i v e  v i r us  a secondary response occurred.  I t  was 
c l e a r  t h a t  cats which had v i ru s  n e u t r a l i s i n g  ant i bodi es  were not  
v i r aemi c  which is  s i m i l a r  to the s i t u a t i o n  in the f i e l d  when cats  
a r e  i n f e c t e d  n a t u r a l l y  ( R u s s e l l  and J a r r e t t ,  1978b)  and i t  i s  
assumed,  but  not  p r o v e n ,  t h a t  ca t s  w i t h  a n t i b o d y  would be
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r e s i s t a n t  to f u r t h e r  r e i n f e c t i o n  wi th FeLV.
The main aim of  t h i s  i n i t i a l  e x p e r i m e n t  was t o  ga i n  
i n f o r ma t i o n  about the i n a c t i v a t i n g  agent which would produce the  
most e f f e c t i v e  FeLV v i r a l  v a c c i n e .  To t r y  t o  compare t he  
responses  of  t he  v a c c i n a t e d  g r o u p s ,  a s c o r i n g  system was used 
which took i n t o  account the propor t ion of  cats in a group which 
became v i r aemi c  and the p r o p o r t i o n  which d ev e l o p e d  a n t i b o d i e s .  
Usi ng  t h i s  s y s t e m ,  t h e  most e f f e c t i v e  v a c c i n e s  appeared  to  be 
t hos e  i n a c t i v a t e d  w i t h  PF and t he  l e a s t  e f f e c t i v e  was t h e  F422 
c e l l u l a r  v a c c i n e .  Ther e  was l i t t l e  d i f f e r e n c e  in t he  score  
b e t ween  u n c o n c e n t r a t e d  and c o n c e n t r a t e d  PF v a c c i n e s .  I t  was 
decided on the basis 'of  these r esu l t s  to concent rate future work 
on PF vaccines .
Three f u r t h e r  lessons were learned from t h i s  exper iment  and 
were  i n c o r p o r a t e d  i n t o  t h e  second v a c c i n e  e x p e r i m e n t  whi ch  i s  
descr ibed in Chapter 7. The f i r s t  chal lenge dose of  FeLV should 
be i n c r e a s e d  i n  o r d e r  t o  produced v i r a e m i a  and i f  p o s s i b l e  a 
p e r s i s t e n t  v i r a e mi a  in a l l  of  the unvaccinated cats.  Ther e f or e ,  
a s t o c k  of  F eLV“ A/ 6  l asgow- 1  was produced w i t h  a h igh t i t r e  and 
was t es ted  in cats before  being used in a vaccine exper iment ,  as 
d e s c r i b e d  i n  C h a p t e r  6,  S e c o n d l y ,  a l a r g e r  number of  c a t s  per  
group shou l d  be used to  i n c r e a s e  t he  chance of  d e m o n s t r a t i n g  
d i f f e r e n c e s  between groups.  T h i r d l y ,  the adjuvant  saponin should 
be used at  a Lower c o n c e n t r a t i o n  which had f e w e r  s i d e - e f f e c t s  
t h a n  t h o s e  obser ved  i n  t h e  p r e s e n t  e x p e r i m e n t .  C h a p t e r  5 
d e s c r i b e s  an e x p e r i m e n t  t o  f i n d  an a p p r o p r i a t e  dose l e v e l  of  
saponin.  A f ou r t h  improvement  would be to moni tor  the cats f o r  a
63
 -  ■   - __________________
Longer per iod a f t e r  chal l enge to ensure that  any  observed e f f e c t  
of  t he  v a c c i n e  was p e r m a n e n t .  I t  was not  p o s s i b l e  to ho Id t he  
c a t s  f o r  l o n g e r  t han  9 weeks i n  t h e  i n i t i a l  e x p e r i  ment but  in  
f u r t h e r  experiments the cats were maintained f o r  longer per i ods .
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CHAPTER 5
DETERMINATION OF AN INNOCUOUS DOSE OF SAPONIN 
I n t r o d u c t i o n
In v a c c i na t i on  wi t h  i n a c t i v a t e d  vaccines,  enhancement of  the  
immune response is considered des i r ab l e  and is o f t en  necessary.  
M a t e r i a l s  used f o r  t h i s  purpose  a r e  c a l l e d  a d j u v a n t s ,  many o f  
which have been used ov e r  the  y e a r s .  T h e i r  mode of  a c t i o n  i s  
s t i l l  in many cases u n c l ea r ,  however,  but one adjuvant  f unc t i on  
i s  tha t  of r e t a r d i n g  the re lease of ant igen i n t o  the body. I t  is  
p o s s i b l e  t o  s low a n t i g e n  e l i m i n a t i o n  r a t e  by f o r m i n g  a depot  
which consists  of a combinat ion of ant igen and the i nso l ub l e  s a l t  
such as those of  a luminium.  Aluminium hydroxide gels were used 
in the present  va c c i n a t i on  exper iments and no side e f f e c t s  were 
noted when inocu l a t ed  i n t o  k i t t e n s .
A second a c t i o n  of  a d j u v a n t s  i s  t o  enhance c o - o p e r a t i o n  
b e t w e e n  c e l l s  i n v o l v e d  i n  i mmun e  r e s p o n s e s ,  e s p e c i a l l y  
macrophages and lymphocytes.  I n  the f i r s t  vacc i na t i on  exper iment  
d e s c r i b e d  i n  t h e  p r e v i o u s  c h a p t e r ,  saponi n  was used f o r  t h i s  
purpose.  However,  i t  was noted t ha t  in some cats t h i s  substance 
caused p a i n  and s w e l l i n g  a t  the  s i t e  o f  i n j e c t i o n  and a r i s e  i n  
body t emperature.  I n  the exper iments descr ibed i n  t h i s  s e c t i o n ,  
the dose of  saponin which was innocuous f o r  cats wasdetermined.  
In the f i r s t  vacc i na t i on  exper i ment ,  saponin was used at a dose 
of  1,5 mg which is  s i m i l a r  to t h a t  recommended f o r  gu i nea- p i gs  in 
s t u d i e s  on f o o t - a n d - m o u t h  d i s e a s e  v i r u s  CA.J.M. G a r l a n d  -  
personal  communicat ion) .
In  the present  exper i ment ,  the same 4 cats were given graded
65
doses of  saponin,  a l l o w i n g  c l i n i c a l  recovery between each dose,  
to e s t a b l i s h  a dose which gave no side e f f e c t s .
M a t e r i a l s  and Methods
Four h e a l t h y  4 month o l d  s p e c i f i c  pa thogen f r e e  c a t s  were  
o b t a i n e d  f rom t he  c o l ony  and housed in t he  a n i m a l  house i n  t h e  
V e t e r i n a r y  School .  Three concent rat ions of saponin in PBS were 
prepared:  500,  250 and 100 ug / ml .  The pH of  the s o l u t i on  in PBS
was 7 .3 .  Four  ca t s  were  i n o c u l a t e d  s u b c u t a n e o u s l y  i n  the  
i n t e r s c a p u l a r  region w i t h  1 ml of  saponin at  a concent ra t i on of  
500 ug/ml  and the c l i n i c a l  signs and r e c t a l  t emperatures were 
m o n i t o r e d  d a i l y  f o r  4 days.  The c a t s  r e t u r n e d  t o  n or ma l  and 3 
days l a t e r  were given a dose of  250 ug of  saponin and observed as 
before.  One week l a t e r  the same cats were given 100 ug. F i n a l l y  
a f t e r  1 week t h e  ca t s  were a g a i n  g i v e n  500 ug t o  d e t e r m i n e  i f  
they had become t o l e r a n t  to saponin.
Resul ts
The r e s u l t s  of  t h e s e  e x p e r i m e n t s  are  shown in T a b l e  5*1.  
A f t e r  i n o c u l a t i o n  o f  500 ug the r e c t a l  temperature  rose in a l l  4 
cats 24 hours a f t e r  i n o c u l a t i o n  and did not re t urn  to w i t h i n  the  
normal  range u n t i l  72 hours a f t e r  inocu l a t i on -  Pain on handl ing  
was o b v i o u s  i n  t h r e e  o f  t h e  f o u r  c a t s  on t h e  day a f t e r  
i n o c u l a t i o n  and did not reduce in 2 of  the cats u n t i l  the f ou r t h  
day of  t he  e x p e r i m e n t .  S w e l l i n g  appeared in 3 o f  t he  ca t s  24 
hours a f t e r  i n j e c t i o n ,  cont inued a f t e r  48 hours and was reduced 
in 2 cats a f t e r  72 hours.
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TABLE 5.1
Reaction of cats to di f ferent  doses of saponin
Days after inoculation
1 2 3 4
Dose (ug) Cat No. T P S T P S T P S T P 5
500 1 38.7 40.0 . 38.8 . 38.2
2 39.0 + - 40.0 + + 39.0 - + 38.3 + +
3 38.7 + ~ 40.0 + 39.1 + + 38.6 + +
4 38.9 + - 40.0 - - 38.9 ” - 38.6 - -
250 1 40.3 _ - 39.8 + + 39.3 39.5
2 39.8 - “ 39.0 - — 39.2 - — 39.8 -
3 40.0 - 40.3 + + 39.8 — - 39.5 -
4 40.1 - “ 39,3 + - 38.8 — - 38.9 - «
100 1 38.4 - - 38.3 38.1 58,2
2 38.1 - - 38.2 - ~ 38.1 - - 38.1 -
3 38.5 — - 38.5 — - 38.9 - - 38.6 - -
4 39.7 - - 39.1 - » 38.4 - - 38.2 -
500 1 38.9 - _ 39.2 + 38.8 38.6 .
2 38.8 + - 40.2 + + 39.2 + + 38.4 — 4-
3 39.8 ” 40.5 - — 39.3 - ■* 39.3 -
4 39.3 " 39.4 + - 38.8 - - 38.7 -
T = Temperature ( C)
P = Pain 
S = Swelling
Dose = ug saponin/ml PBS
'r'" - _________ __________________________ ____________ _
When the cats were again c l i n i c a l l y  normal ,  they were given  
a dose of  250 ug s a p o n i n .  I n  t h i s  case t h e r e  was a s l i g h t  
i n c r e a s e  i n  r e c t a l  t e m p e r a t u r e  i n  one of  t h e  c a t s  (3)  i n  t h e  
f i r s t  and second days a f t e r  i n o c u l a t i o n  whi l e  t hat  of the others  
was n or ma l .  Pa i n  was e v i d e n t  i n  3 ca t s  on t h e  second day and 
s w e l l i n g  appeared in 2 cats on the second day of  i n ocu l a t i o n  and 
disappeared l a t e r .
The r e s u l t  of  t h e  t h i r d  i n o c u l a t i o n  w i t h  TOO ug of  sapon i n  
were t h a t  no r i s e  in r e c t a l  t emper a t ur e ,  pain or  s w e l l i n g  at  the  
s i t e  of  i n j e c t i o n  were noted.  F i n a l l y ,  when the cats were again  
g i v e n  a dose o f  500 ug a s i m i l a r  response t o  t h a t  i n  t h e  f i r s t  
i n o c u l a t i o n  was o b s e r v e d ,  w i t h  p y r e x i a  in 2 c a t s ,  p a i n  in  3 and 
sweI l i ng  in 1.
Discussion
A dose of  saponin of  500 ug,  which was t h r e e - f o l d  less than 
t h a t  g i v e n  w i t h  t h e  f i r s t  v a c c i n e  ( Ch a p t e r  4)  was found t o  
produce t o x i c  s i d e - e f f e c t s .  By decreasing the dosage in the same 
cats ,  a dose of  100 ug was found to be harmless and t h i s  dose was 
used subsequent ly in exper iments descr ibed l a t e r  in Chapter  7,
That t h i s  r e s u l t  was not due t o  thé cats becoming t o l e r a n t  
t o  s ap on i n  was su gge s t e d  by t h e  f a c t  t h a t  when t he  c a t s  wer e  
i n o c u l a t e d  a g a i n  w i t h  500 ug,  the  same e f f e c t s  as i n  t h e  f i r s t  
a d m i n i s t r a t i o n  were observed.  I t  is c l ear  f rom t h i s  exper iment  
t h a t  t h e  r esponse of  a n i m a l s  t o  sapon i n  v a r i e s  be t ween  s p e c i e s  
and must be ascer t a i ne d  f o r  each animal  p r i o r  to  the use of  t h i s  
ma t e r i a l  as an ad j uvant .
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CHAPTER 6
DETERMINATION OF AN APPROPRIATE CHALLENGE DOSE OF FeLV
I n t r o d u c t i o n
A successful  vaccine should have the e s s e n t i a l  p r op e r t i e s  of  
i nno cu i t y ,  potency and s t a b i l i t y .  Potency is the a b i l i t y  of  the 
vaccine to int roduce a minimum l eve l  of  immuni ty which is capable  
of  a f f o r d i n g  p r o t e c t i o n  a g a i n s t  t h e  maximum dose of  v i r u l e n t  
f i e l d  v i r u s .  H e n c e ,  i n  t h e  d e v e l o p m e n t  o f  v a c c i n e s ,  an 
appropr i a t e  chal lenge dose of  v i r us  should be es t ab l i shed  which 
i s  s u f f i c i e n t  t o  p r o v o k e  a r e s p o n s e  i n  e s s e n t i a l l y  a l l  
u n v a c c i n a t e d  a n i m a l s .  I n  t he  e x p e r i m e n t  d e s c r i b e d  i n  t he  
p r e v i o u s  c h a p t e r  t he  dose o f  c h a l l e n g e  FeLV whi ch was s e l e c t e d  
was c o n s i d e r e d  t o  be a p p r o p r i a t e  based on past  e x p e r i e n c e  
( J a r r e t t  e_;^  a I ,  1977) .  I t  was observed,  however,  t ha t  t h i s  dose 
was i n s u f f i c i e n t  t o  i nduce  a p e r s i s t e n t  v i r a e m i a  i n  a l l  o f  t he  
u n v a c c i n a t e d  k i t t e n s  wh i ch  made i t  d i f f i c u l t  t o  assess t he  
e f f i c i e n c y  of  the  v a c c i n e s  be i ng  t e s t e d .  I n  t h i s  c h a p t e r  an 
exper iment  i s  descr ibed in which a higher  dose of  v i r us  was used,  
prepared from concent rated v i r us .  In t h i s  way a dose which gave 
a consist ent  response was achieved.
M a t e r i a l s  and Methods
Prepara t i on  of  Chal lenge FeLV
This v i r u s  was prepared in the f o l l o w i n g  way. Each of  seven 
9 cm p l a s t i c  p l a t es  was seeded wi t h  6 X 10^ FEA c e l l s  c h r o n i c a l l y  
i n f e c t e d  w i t h  FeLV-A i n  10 ml EFC20 and i n c u b a t e d  at  3 7 °  i n  5% 
COg i n  a i r .  S e v e n t y - t w o  hours l a t e r  t h e  c u l t u r e  f l u i d s  were
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harvested and cen t r i f uged  at  2000 rpm f o r  10 minutes.  The f l u i d  
was removed and cen t r i f uged  in a SW 27 r o t or  at  10,000 rpm f o r  10 
minutes.  The supernatant  f l u i d  was then spun at  24,000 rpm f or  
90 mi n u t e s  i n  a SW 27 r o t o r  and the  resu I t  i ng v i r u s  p e l l e t  was 
r esuspended i n  5 ml  L - 15  medium w i t h  1% PCS and was s t o r e d  a t  -  
70°  in 4 one ml a l i q u o t s  and two 0.5 ml volumes as assay samples.  
This v i r u s  was t i t r a t e d  using the two-s t age  method w i t h  5 - f o l d  
d i l u t i o n s -  The t i t r e  was 6 , 5  X 10^ FlU/ml ,
I n f e c t i o n  of  cats
Four  12 week o l d  SPF ca t s  were i n f e c t e d  o r o n a s a l l y  w i t h  
concent rated FeLV-A/Glasgow-1 as a s i ng l e  dose of  1 ml cont a i n i ng
6.5 X 10^ FIU per cat as descr ibed in Chapter 4. These cats were 
m o n i t o r e d  f o r  FeLV v i r a e m i a  and v i r u s  n e u t r a l i s i n g  a n t i b o d i e s  
over  a 14 week p e r i o d .  Two ml of  b l ood was o b t a i n e d  f rom t he  
j u g u l a r  v e i n  a t  2 ,  11 and 14 weeks a f t e r  FeLV i n f e c t i o n .  The 
sera and plasma samples were assayed f o r  n e u t r a l i s i n g  an t i bodi es  
and v i r us  as descr ibed in Chapter I .
Resul ts
The r e s u l t s  are  shown i n  T a b l e , 6 .1 .  I t  i s  seen t h a t  3 of  
the 4 cats became v i ra e mi c  2 weeks a f t e r  FeLV a d m i n i s t r a t i o n  and 
t h a t  a l l  4 were v i r a e m i c  a f t e r  14 weeks.  None of  t he  ca t s  
developed n e u t r a l i s i n g  ant i bodi es .
TABLE 6.1
FeLV I s o l a t e d  from Chal lenged Cats
Vi rus i s o l a t i o n  at  weeksCat No
 ^  ^ , .c i- - L ^ " y. '' » . - ' i Ï %*.■*: I - ; -r ■ .-i-
■ ______
Discussion
The r e s u l t s  of  t h i s  e x p e r i m e n t  i n d i c a t e d  t h a t  a dose of
6 .5  X 10^ FIU o f  FeLV-A g i v e n  o r o n a s a l l y  was s u f f i c i e n t  t o
produce a l o n g - l a s t i n g ,  presumably permanent ,  v i raemi a  in most,  
i f  not  a l l  c a t s .
Hoover ejt. 2 k  (1976) showed t ha t  the response of  cats to FeLV
i s  r e l a t e d  t o  age and t h a t  c a t s  o v e r  16 weeks of  age a r e
r e l a t i v e l y  r e s i s t a n t  t o  i n f e c t i o n .  As d i s c u s s e d  above,  i t  was 
n e c e s s a r y  t o  c h a l l e n g e  t he  c a t s  i n  t h e s e  e x p e r i m e n t s  a t  an age 
when t hey  were s t i l l  f u l l y  s u s c e p t i b l e  t o  FeLV. T h i s  age Was 
around 12-13 weeks. I t  might  be expected,  however,  t h a t  at  t h i s  
age the k i t t e n s  are  in  a t r a n s i t i o n a l  p e r i o d  be t ween f u l l  
s u s c e p t i b i l i t y  and r e s i s t a n c e  and t h a t  a dose o f  FeLV whi ch  
i nduced p e r s i s t e n t  v i r a e m i a  when a d m i n i s t e r e d  t o  8 week o l d  
k i t t e n s  might  be i n s u f f i c i e n t  to permanent ly i n f e c t  12 or 13 week 
old animals.  Whi le i t  is de s i r a b l e  to chal lenge cats in vaccine  
e x p e r i m e n t s  w i t h  a dose o f  v i r u s  which w i l l  i n f e c t  a l l  of  t he  
u n v a c c i n a t e d  c o n t r o l  a n i m a l s ,  care  must be t a k e n  t h a t  an 
u n n a t u r a l l y  l a r g e  dose o f  v i r u s  i s  not  a d m i n i s t e r e d  t h a t  woul d  
overwhelm immunised animals which would nor mal l y  r e s i s t  chal lenge  
by the n a t u r a l  route of  i n f e c t i o n .  The dose of  v i r u s  used in the  
f i r s t  v a c c i n e  e x p e r i m e n t  d e s c r i b e d  in Chapter 4 was obviously  
i n s u f f i c i e n t .  The r e s u l t s  o f  t h e  p r e s e n t  e x p e r i m e n t  i n d i c a t e d  
t h a t  a dose of  6.5 X 10^ FIU g i v e n  o r a n a s a l l y  mi ght  be more 
s a t i s f a c t o r y  and t h i s  or  s l i g h t l y  h i g h e r  doses ,  were  used i n  
subsequent exper iments.
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VACCINATION EXPERIMENT 2: COMPARISON OF ADJUVANTS
I n t  reduct ion
The r e s u l t s  o f  t h e  v a c c i n a t i o n  e x p e r i m e n t s  d e s c r i b e d  i n  
C h a p t e r  4 were i n c o n c l u s i v e .  I n  the  l i g h t  o f  t hese  r e s u l t s  
f u r t h e r  e x p e r i m e n t s  w e r e  p l a n n e d  t o  o b t a i n  more  p r e c i s e  
i n f o r ma t i o n  on the e f f i c i e n c y  of  i n a c t i v a t e d  FeLV as an ant igen.  
The f o l l o w i n g  point s  were considered.
1. P a r a f o r m a l d e h y d e  was chosen as t he  s o l e  i n a c t i v a t i n g  agent  
since P F - i n a c t i v a t e d  v i r u s  appeared to be most e f f e c t i v e  in the 
f i r s t  exper iment .
2. More p r e c i s e  d e t a i l s  of  t h e  i n a c t i v a t i o n  of  both MSV (FeLV)  
and FeLV i t s e l f  w i t h  PF were  o b t a i n e d  i n  o r d e r  t o  employ t h e  
m i n i m u m  e f f e c t i v e  c o n c e n t r a t i o n  of  the agent  i n  v a c c i n e  
p re p a r a t i o n s .
3. A comparison of  adjuvants was under taken,  namely saponin and 
i n c o m p l e t e  F reund ' s  a d j u v a n t  ( I CFA) .  Saponin  was used a t  t h e  
l ower ,  non- t ox i c  dose as determined in the exper iment  repor ted in 
Chapter  5.
4.  The c h a l l e n g e  dose of  FeLV-A was i n c r e a s e d  to 1 X 10^ p i y  i ^  
order  to ob t a i n  the es t ab l i shment  of  p e r s i s t e n t  v i r aemi a  in a l l  
of  the  u n v a c c i n a t e d  c o n t r o l  ca t s  as d e s c r i b e d  in Chap t e r  6.  I n  
t h i s  way d i f f e r e n c e s  b e t we e n  t h e  response of  v a c c i n a t e d  and 
unvaccinated cats might be more obvious.
5. The number  o f  c a t s  i n  each group was i n c r e a s e d  t o  6 ,  a g a i n  
w i t h  t he  o b j e c t  of  i n c r e a s i n g  the  p r o b a b i l i t y  of  o b s e r v i n g  
d i f f e r e n c e s  between the e f f e c t s  of  the var ious vaccines .
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T h i s  c h a p t e r  d e s c r i b e s  f i r s t ,  e x p e r i m e n t s  on t h e  
i n a c t i v a t i o n  of  MSV (FeLV)  and FeLV by p a r a f o r m a l d e h y d e  and 
a t t e m p t s  t o  d e t e c t  i n f e c t i o u s  v i r u s  i n  i n a c t i v a t e d  v i r a l  
pr epara t i ons .  Secondly,  a vacc i na t i on  exper iment  i s  descr ibed in  
which P F - i n a c t i v a t e d  FeLV was used in vaccines,  and saponin and 
ICFA were compared as ad j uvant s .
M a t e r i a l s  and Methods
I n a c t i v a t i o n  of  MSV (FeLV)
The k i n e t i c s  of  i n a c t i v a t i o n  o f  MSV ( F e L V - A / 6 l a s g o w - 1 ) by 
severa l  concent ra t i ons  of  PF at  25® were s tudi ed over a per i od  
of  24 hours .  I n a c t i v a t i o n  was done w i t h  PF c o n c e n t r a t i o n s  of  
0 . 0 1 ,  0 . 0 2 ,  0 . 04 and 0.06% i n  a w a t e r  ba t h .  To f o u r  5 ml g l a s s  
b o t t l e s ,  each c o n t a i n i n g  1 ml of  MSV (FeLV)  (3.5 X 10^ F F U / ml )  
a t  25®,  100 u I  o f  PF a t  a c o n c e n t r a t i o n  o f  0 . 1 ,  0 . 2 ,  0.4 o r  0.6% 
was added.  A f u r t h e r  b o t t l e  c o n t a i n i n g  v i r u s  had no PF added.  
The b o t t l e s  were shaken and 150 ul  of  f l u i d  drawn from each was 
i m m e d i a t e l y  c o l l e c t e d .  A volume of  15 u l  of  20% sodium 
t h i os u l p h a t e  was added and the mixture was incubated at  4® f o r  
30 mi n u t es  and was then  s t o r e d  at  - 70®.  T h i s  r e p r e s e n t e d  t he  
samples at  t i m e  0. Fur ther  samples were taken at  3,  6,  12 and 24 
hours a f t e r  a d d i t i o n  of  PF. The samples were subsequent ly t es t ed  
f o r  r es i dua l  i n f e c t i v i t y .  At the same t i me ,  4 b o t t l e s  conta i n i ng  
only 1 ml EFC received PF as above. These were then incubated at  
25® f o r  24 hours and a one- t ent h  volume of  sodium t h i o s u l p h a t e  
was added.  The m i x t u r e  was i n c u b a t e d  at  4 °  as b e f o r e  and then  
stored at  -70®.
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I n a c t i v a t i o n  of  FeLV
FeLV was c oLLec t ed  f rom the f l u i d  of  F422 c e l l s  seeded at
1 . 2  X 1 0 ^ / m l a n d  h a r v e s t e d  48 hours l a t e r .  The f l u i d  was 
c l a r i f i e d  by s p i n n i n g  at  2000 rpm f o r  10 m i n u t e s  and then was 
t r e a t e d  w i t h  0 . 0 1 ,  0 . 0 2 ,  0 . 04 and 0.06% PF i n  a 25® w a t e r  ba t h  
f o r  24 hours .  The i n a c t i v a t i o n  procedur e  was c a r r i e d  out  by 
a d d i t i o n  o f  1,5 ml o f  0 . 1 , 0 . 2 ,  0.4. or  0.6% PF and 1.5 ml of  L - 1 5  
medium t o  5 u n i v e r s a l  b o t t l e s  each c o n t a i n i n g  15 ml of  f r e s h l y  
p r e p a r e d  FeLV.  The m i x t u r e  was shaken w e l l  and 3 ml o f  each 
r e a c t i o n  was c o l l e c t e d ,  n e u t r a l i s e d  w i t h  0.3 ml of  20% sodium  
t h i o su l ph a t e  at  4® f o r  30 minutes and stored at  -70® as 0 t ime  
samples.  The r e ac t i o n  was i mmedi a t e l y  immersed in a 25® water  
bath and sampled in the same manner 3,  6,, 12,  and 24 hours l a t e r .  
These samples were t r e a t e d  as above and stored at  -70®.
I n f e c t i v i t y  assay of  P F - t r e a t e d  FeLV
The r e s i d ua l  i n f e c t i v i t y  of FeLV f o l l o w i n g  PF t rea t ment  was 
assayed i n  4 ways:  by t h e  o n e - s t a g e  or  t w o - s t a g e  q u a n t i t a t i v e
assays u s i n g  FEA and C81 c e l l s ;  by the q u a l i t a t i v e  i n t e r f e r e n c e  
t e s t ;  and by a m o d i f i c a t i o n  o f  t he  t w o - s t a g e  FEA/C81 assay .  I n  
each case f i v e - f o l d  d i l u t i o n s  of  the v i rus  p r epar a t i on  were used,  
beginning w i t h  neat  v i r u s .
The q u a n t i t a t i v e  t e s t s  were c a r r i e d  out  as d e s c r i b e d  in  
Chapter 1,  The i n t e r f e r e n c e  t es t  was done as f o l l ows:
Ten 5 cm p l a s t i c  p l a t e s  were seeded w i t h  1 X 10^ FEA c e l l s  i n  4 
ml EFC and incubated at  37® in 5% COg in a i r .  Twenty four  hoUrs 
l a t e r ,  2 p l a t e s  were used t o  i n o c u l a t e  each d i l u t i o n  of  t he  PF-  
t r e a t e d  v i r u s .  P o l y b r e n e  was added t o  a c o n c e n t r a t i o n  o f  8
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ug/ml .  The neat  sample was in 1 ml and subsequent d i l u t i o n s  in 2 
ml.  The c e l l s  were i n c u b a t e d  f o r  90 m i nu t es  at  37®,  washed 
t w i c e  w i t h  E a g l e ' s  medium and 4 ml EFC was added t o  each p l a t e .  
A f t e r  72 hours of  i n f e c t i o n  and when t he  c u l t u r e  became  
c o n f l u e n t ,  i t  was s u b c u l t u r e d .  One f o u r t h  of  t h e  c e l l s  o f  each 
p l a t e  were seeded i n t o  a new p l a t e .  T h i s  s u b c u l t u r i n g  was 
repeated f o r  3 weeks when the c e l l s  were t es t ed  f o r  the presence 
of FeLV by an i n t e r f e r e n c e  t e s t .
The f our t h  assay was a mo d i f i c a t i o n  of the q u a n t i t a t i v e  t wo -  
s t a g e  assay and was c a r r i e d  out  by u s i ng  C81 c e l l s  i n  h i g h e r  
d e n s i t y  t han  p r e v i o u s l y  a t  1 X 10^ in 4 ml EFC per  5 cm p l a t e .  
A f t e r  24 hours  i n c u b a t i o n  t h e  c e l l s  were i n o c u l a t e d  w i t h  nea t  
v i rus  samples or samples d i l u t e d  1:5 and were incubated at  37°  in 
5% COg in a i r  f o r  3 hours.  The inoculum was then removed and the  
c e l l s  were subcul tured so t ha t  o n e - t h i r d  was seeded i n t o  each of  
3 p l a t e s  C 3 X 10^ c e l l s  each ) .  The assay was t hen  c o n t i n u e d  i n  
the same way as the two- s t age  FEA/C81 assay.
Removal of  i n a c t i v a t i n g  agents by u l t r a f i l t r a t i o n
As descr ibed in the Resul ts sect ion of  t h i s  Chapter ,  i t  was 
not  p o s s i b l e  t o  d e t e r m i n e  w h e t h e r  or  not  t h e r e  was i n f e c t i o u s  
v i r u s  in some o f  the  low d i l u t i o n s  of  P F - t r e a t e d  v i r a l  sampl es  
owi ng t o  t h e  t o x i c i t y  o f  t h e  PF f o r  t h e  c e l l s .  The f o l l o w i n g  
procedure was used to remove the res i dua l  PF,
Two 50 ml l o t s  of  F422 v i ru s  f r e s h l y  prepared as before  were 
i n a c t i v a t e d  s e p a r a t e l y  w i t h  0.01 and 0.02% PF in  a 25® w a t e r  
bath f o r  24 hours and were concent rated using an Ami con s t i r r e d  
c e l l  wi t h  a NucLepore membrane ( I X  10^ MW c u t - o f f )  at  4® f o r  6
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hours u n t i l  t he  o r i g i n a l  volume was reduced t o  5 ml .  Th i s  was 
thenincreased to 50 ml wi th  L-15 medium and f i l t e r e d  again t o  4 
ml.  Thus t h e  v i r u s  c o n c e n t r a t i o n  was 10 t i m e s  t h a t  o f  t h e  
o r i g i n a l  and t h e  PF c o n c e n t r a t i o n  was reduced by a f a c t o r  of  
1 : 1 2 0 .  The c o n c e n t r a t e d  v i r u s  (4 ml )  was added t o  21 m l L - 1 5  
medium so t h a t  the  c o n c e n t r a t i o n  of  the v i r u s  was t w i c e  t he  
o r i g i n a l  and 1 ml o f  i t  was s t o r e d  as t wo 0.5 ml l o t s  a t  - 7 0 °  
as samples f o r  v i r a l  r e s i dua l  i n f e c t i v i t y  assay.
The remainder  (24 ml) was stored at  -70® in 4 lots  of  6 ml 
each.  These s t o r e d  sampl es  were assayed u s i n g  t he  t w o - s t a g e  
procedure descr ibed in Chapter  I  wi th 5 - f o l d  d i l u t i o n s .
Concent rat ion of  FeLV by u l t r a f i l t r a t i o n
Ten,  9 cm p l a s t i c  p l a t e s  were  seeded w i t h  6 X 10^ FeLVrA 
i n f e c t e d  FEA c e l l s  i n  10 ml McCoy's 5a medium w i t h  10% PCS i n  
each p l a t e .  The p l a t e s  were  i n c u b a t e d  a t  37® i n  5% CO2  ^^ a i r .  
F o r t y - e i g h t  hours l a t e r  t h e  c u l t u r e  f l u i d s  were h a r v e s t e d  and 
c e n t r i f u g e d  a t  2000  rpm f o r  10 m i n u t e s .  The s u p e r n a t e n t  f l u i d  
was removed and two 0,5 ml volumes were taken and stored at -70®.  
The r e m a i n i n g  f l u i d  was f i l t e r e d  t hr oug h  a Na l gene  d i s p o s a b l e  
f i l t e r  u n i t  w i t h  a pore s i z e  of  0.45 urn and sampl es  of  the  
f i l t r a t e  were c o l l e c t e d  and stored as before.  The f i l t r a t e  was 
t hen  p l a c e d  in an Ami con s t i r r e d  c e l l  w i t h  a 43 mm Nu c l e p o r e  
f i l t e r  of  10^ molecular  weight  c u t - o f f .  Using n i t rogen gas a t . a 
p r e s s u r e  o f  10 p o un ds  p e r  s q u a r e  i n c h ,  t h e  f l u i d  was 
u l t r a f i l t r a t e d  at  4® f o r  6 hours u n t i l  the volume was reduced to
6.5 ml .  Samples o f  t h e  f i l t r a t e  (80 ml )  and c o n c e n t r a t e d  v i r u s  
were taken as befor e  and stored at  -70®.  A l l  of  the samples were
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subs e q u e n t l y  t i t r a t e d  u s i n g  t h e  t w o - s t a g e  m e t h o d .  The  
c o n c e n t r a t e d  v i r u s  was s t o r e d  at  - 7 0 °  as t h i r t e e n  0.5 mI 
a l i q u o t s ,  and was used l a t e r  to  c h a l l e n g e  t he  v a c c i n a t e d  and 
cont ro l  cats in the second vaccine exper iment ,  descr ibed in t h i s  
chapter .
FeLV vaccine p r ep ar a t i on
I n  t h e  l i g h t  of  t he  r e s u l t s  of  the  l a s t  i n f e c t i v i t y  assay  
exper iment  0.02% P F - i n a c t i v a t e d  FeLV which had been stored at  
-700 gg 6 ml and found t o  c o n t a i n  no r e s i d u a l  i n f  e c t  i v i  t y ,  was 
used t o  p r e p a r e  v a c c i n e s  61 and 82.  A vo l ume o f  0.6 ml of  
Al (OH)^ was added t o  6 ml of  the  s t o r e d  i n a c t i v a t e d  a n t i g e n ,  
mixed and i n c u b a t e d  a t  4®o v e r n i g h t .  Then 6 ml o f  a d i l u t i o n  of  
1:1250 saponin was added and mixed.  This was vaccine 82.
For v a c c i n e  01 t h e  same p r o c e d u r e  was used t o  p r e p a r e  t h e  
vaccine except  i nstead of saponin,  incomplete Freund's adjuvant  
(ICFA) (Mi l es  Lab or a t o r i es )  was used. Two volumes of  ICFA were 
added to the v i r us  pr e p a r a t i o n  and the mixture was e m u l s i f i e d  in 
a S y I v e r s o n  homogeni  s e r .  The e m u l s i o n  was d i s p e n s e d  i n  1 ml  
volumes in  s y r i n g e s  and were kept  at  4® u n t i l  used.  The 
emulsion remained s t ab l e  over a per iod of 3 weeks.
Vacc i na t i on  experiment
Three  groups of  6 8 - w e e k  o l d  k i t t e n s  were used i n  t h e  
exper iment .  One group was inocul a ted  wi th  vaccine 01,  one w i t h  
vaccine 82 and the ot her  was unt reat ed and served as a chal lenge  
c o n t r o l .
The k i t t e n s  were i nocul a ted  wi th  1 ml of  vaccine IM in the
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Lef t  hind Leg. Three, weeks l a t e r  a second booster  dose was given  
in  t he  r i g h t  h i nd  l e g .  The a n i m a l s  were c h a l l e n g e d  one week 
l a t e r  by t h e  o r o n a s a l  i n s t a l l a t i o n  o f  1 ml o f  F e L V - A / 6 - 1 ,  
c o n t a i n i n g  1 X 10^ F I U ,  0,1 ml i n t o  each n o s t r i l  and 0-8 ml i n t o  
the mouth.
S a mp l i n g  of  a l l  e x p e r i m e n t a l  ca t s  was by c o l l e c t i o n  of  
c l o t t e d  and hepar i n i sed  blood samples before each v a c c i n a t i o n ,  
at  the  c h a l l e n g e  and at  3 ,  9 ,  21 and 28 weeks a f t e r  c h a l l e n g e .  
Two ml was t a k e n  f r om t h e  j u g u l a r  v e i n ,  1 ml f o r  serum and t h e  
o t h e r  f o r  p l asma .  The serum and pl asma were  s t o r e d  at  - 70®  
u n t i l  assayed using v i r u s  i s o l a t i o n  techniques f o r  v i r aemi a  and 
n e u t r a l i s a t i o n  t e s t  f o r  ant ibody.
Resul ts
K i n e t i c s  of  i n a c t i v a t i o n  of  MSV (FeLV) by paraformaldehyde
The r e s u l t s  o f  e x p o s u r e  o f  MSV ( F e L V )  t o  v a r i o u s  
concent ra t ions  of  PF are shown in Table 7.1.
MSV (FeLV) was exposed to four  d i f f e r e n t  concent rat ions of  
PF in a 25® water  bath f o r  24 hours and samples were c o l l e c t ed  at  
0 ,  3 ,  6 ,  12 and 24 hour  i n t e r v a l s ,  s t o r e d  at  - 7 0 ®  and assayed  
l a t e r .  T her e  was an i m m e d i a t e  f a l l  i n  t h e  t i t r e  of  MSV (FeLV)  
i n a c t i v a t e d  by these 4 concent ra t ions  of PF at  0 t i me .  The t i t r e  
ranged b e t we e n  8.9 X 10^ t o  6.4 X 10^ FFU/ ml  compared t o  t h e  
t i t r e  o f  t h e  v i r u s  c o n t r o l  w h i c h  was 2 . 6  X 10^ F F U / m l .  
S u b s e q u e n t l y ,  t h e  t i t r e  o f  v i r u s  d e c r ea s e d  a c c o r d i n g  t o  t he  PF 
c o n c e n t r a t i o n .  At t he  second i n t e r v a l  (3 h o u r s ) ,  the  t i t r e  of  
t h e  v i r u s  f o r  t he  f i r s t  t h r e e  PF c o n c e n t r a t i o n s  was b e t ween
3 . 2  X 10^ and 5 X 10^ FFU/ ml  and no v i r u s  was d e t e c t e d  i n  the
77
 : -   _
o
X
es
o o o o
o
T3 X
T3 O O O O <*-
O
X=)Q . U_ü_ M3 O  O  O  O  < tXJQ
4-> O  •H  S I -P
es r-o o a < 1-ow Lu X X X X
es o o o\LO 'H  *H
<t LA O
f  < f  < t  fA  LA O O O O O
X X X X X
00
o
s: c
-o -Hr—I 4-) ^ es <}• voo o  o o
CD o Z
Q_ CJ
sample  exposed t o  0.06% PF. The v i r u s  c o n t r o l  t i t r e  was 
3 .84  X 10^ FFU/ ml .  At  t he  r e m a i n i n g  i n t e r v a l s  t he  v i r u s  was 
complete ly  i n a c t i v a t e d  at  a l l  PF concent ra t i ons ,  wh i l e  the v i r u s  
cont ro l  t i t r e  was 4-3 X 10^ at  6 hours and 3.2 X 10^ FFU/ml at  24 
hours i n t e r v a l .
FeLV i n a c t i v a t i o n
The r e s u l t s  of  the assay of  the P F - i n a c t i v a t e d  FeLV were as 
f o l l o w s ,  FeLV samples were exposed to 0,01,  0,02,  0,04 and 0.06% 
PF f or  24 hours at 25°  and were assayed f o r  r es i dua l  i n f e c t i v i t y ,  
using the one-stage method. The c e l l s  detached a f t e r  i n o c u l a t i o n  
wi th the und i l u t ed  v i r u s  samples from a l l  the PF concent rat ions  
used and a l s o  w i t h  t h e  i n o c u l a t i o n  of  t he  sampl es  d i l u t e d  1:5  
from v i rus  i n a c t i v a t e d  wi th 0.06% PF.
The c e l l s  appeared unheal thy in c u l t u r es  i nocul a t ed  w i t h  the  
1:5 and 1:25 d i l u t i o n s  of FeLV samples i n a c t i v a t e d  wi th  0,01 and 
0,04% PF. The c u l t u r es  i nocu l a t ed  wi th these same d i l u t i o n s  of  
t he  v i r u s  i n a c t i v a t e d  w i t h  0.02% PF were c o n t a m i n a t e d  w i t h  
b a c t e r i a .  At  a l l  o t h e r  d i l u t i o n s  ( 1 : 1 2 5 ,  1 : 625  and 1 : 3 1 2 5 )  t h e  
c e l l s  were h e a l t h y  and t h e r e  was no e v i de n c e  of  FeLV, I n  t he  
FeLV sampl e  i n a c t i v a t e d  w i t h  0,06% PF,  t he  r e s u l t  was t h a t  
there were unheal thy c e l l s  in the cu l t u res  i nocul a t ed  wi th  1:25 
d i l u t i o n  and h e a l t h y  c e l l s  i n  o t h e r  c u l t u r e s  and t h e r e  was no 
evidence of leukaemia v i r us .  I n  cont rast  the c u l t u r e  c e l l s  which 
were inocul a t ed  wi t h  a l l  d i l u t i o n s  of  the v i r us  cont ro l  sample  
were heal thy and t here  were 4 f oc i  in the l as t  d i l u t i o n  (1:3125)  
so t ha t  the v i r u s  t i t r e  was 1.3 X 10^ FlU/ml .
I n  u s i ng  t h e  t w o - s t a g e  assay met hod,  no r e s u l t s  were
78
 : '
o b t a i n e d  f o r  t he  sampl es  t a k e n  a t  0  t i m e ,  owi ng t o  b a c t e r i a l  
contaminat ion.  In cu l t u r es  i noculat ed wi th samples c o l l e c t e d  at  
the 3 hour i n t e r v a l ,  the c e l l s  detached a f t e r  the cu l t u r es  were 
i nocul a t ed wi th und i l u t ed  samples of  the v i r us  i n a c t i v a t e d  wi t h  
a l l  f o u r  PF c o n c e n t r a t i o n s .  The same happened i n  c u l t u r e s  
i n o c u l a t e d  w i t h  t h e  1 : 5  d i l u t i o n  o f  s a m p l e s  w h i c h  w e r e  
i n a c t i v a t e d  w i t h  0 . 0 2 ,  0 . 04 o r  0-06% PF and a l s o  w i t h  t h e  1 :25  
d i l u t i o n  of  the samples i n a c t i v a t e d  wi th  0.06% PF. At the other  
d i l u t i o n s  of  the sample i n a c t i v a t e d  wi t h  0.01% PF, the c e l l s  were 
h e a l t h y  and t h e r e  were  4 f o c i  i n  the  1 :625 d i l u t i o n  so t h a t  t h e  
t i t r e  was 2.5 X 10^ F l U / m l .  A l l  o t h e r  c u l t u r e s  whi ch  were  
i n o c u l a t e d  w i t h  the  r e m a i n i n g  d i l u t i o n s  of  the  FeLV sampl es  
i n a c t i v a t e d  w i t h  0 . 0 2 ,  0 . 04 or  0.0.6% PF were h e a l t h y  and t h e r e  
was no evidence of  i n f e c t i o u s  FeLV. In the same exper iment  the  
r e s u l t s  of  the assay of  samples c o l l ec t e d  at  6  hours were s i m i l a r  
t o  t he  r e s u l t s  of  t he  assays of  samples c o l l e c t e d  at  3 hours  
e x c e p t  t h a t  no i n f e c t i o u s  v i r u s  was d e t e c t e d  i n  t h e  0.01% PF 
i n a c t i v a t e d  sample at  any d i l u t i o n  i n d i c a t i n g  t h a t  t h e r e  was 
c o m p l e t e  i n a c t i v a t i o n  o f  t h e  v i r u s  e x c e p t ,  p e r h a p s ,  i n  t h e  
u n d i l u t e d  sample  or  t he  sample  d i l u t e d  1:5 which cou l d  not  be 
t es t ed due to  t o x i c i t y  of the inoculum.
The i n t e r f e r e n c e  t e s t  r e s u l t s  were t h a t  i n f e c t i o u s  v i r u s  
appear ed  i n  t h e  nea t  d i l u t i o n  o f  t he  sample  i n a c t i v a t e d  w i t h  
0.01% PF f o r  24 hours.  In t h i s  t e s t  only neat and a 1:5 d i l u t i o n  
of  t h e  FeLV i n a c t i v a t e d  w i t h  t h e  f o u r  PF concent  r a t  i ons f o r  24 
hours was used. The s i d e - e f f e c t  of  the PF on the c e l l s  was that  
t he  c e l l s  were  u n h e a l t h y  i n  t h e  c u l t u r e s  i n o c u l a t e d  w i t h  nea t
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samples i n a c t i v a t e d  w i t h  0.01 or 0.02% PF and the c e l l s  detached 
in neat  sampl es  i n a c t i v a t e d  w i t h  0.04 or 0.06% PF. A l s o ,  t he  
c e l l s  were unheal thy in 1:5 d i l u t i o n s  of the same samples.
The l as t  way of assaying the PF i n a c t i v a t e d  samples of FeLV 
was by u s i n g  a h i g h e r  i n i t i a l  d e n s i t y  o f  C81 c e l l s  w i t h  
subsequent  r e - p l a t i n g  and a d d i t i o n  of  f u r t h e r  FEA c e l l s .  The 
r e s u l t s  were t ha t  a l l  c e l l s  detached a f t e r  i n o c u l a t i o n  wi t h  neat  
and 1:5 d i l u t i o n s  of the samples so t hat  no r e s u l t s  were obtained  
wi th t h i s  t e s t .
Removal of  i n a c t i v a t i n g  agent by u l t r a f i l t r a t i o n
From t h e  r e s u l t s  d e s c r i b e d  above i t  was c l e a r  t h a t  t he  
r e s i d u a l  i n a c t i v a t i n g  agent  i n  the  v i r u s  sampl es  was t o x i c  f o r  
the c e l l s  in the i n f e c t i v i t y  assays when und i l u t ed  samples were 
t es ted.  Consequent ly,  i t  was considered necessary to remove the  
PF from the samples in order  to ensure t ha t  t he r e  was no v i r us  in  
t he  v a c c i n e s .  T h i s  was a c h i e v e d  by " wa s h i ng"  t he  P F - t r e a t e d  
v i r u s  by u l t r a f i l t r a t i o n .
I n  t he  l i g h t  of  t he  r e s u l t s  of  i n a c t i v a t i n g  MSV (FeLV)  
descr ibed in t h i s  Chapter ,  two concent rat ions of  PF were used to  
t r e a t  FeLV at  25°  f o r  24 hours.  These were 0.01% and 0.02%.
A f t e r  u l t r a f i l t r a t i o n  the samples were t e s t e d  f o r  i n f e c t i o u s  
v i r u s  by u s i ng  t he  t w o - s t a g e  assay.  A sampl e  of  i n a c t i v a t e d  
v i r u s  was a l s o  t i t r a t e d .  The r e s u l t s  were  t h a t  t h e r e  was no 
t o x i c  e f f e c t  o f  P F - t r e a t e d  v i r u s  on the  c e l l s .  A few f o c i  were  
found i n  t h e  n e a t ,  1 : 5  and 1 :25  d i l u t i o n s  o f  t h e  v i r u s  t r e a t e d  
w i t h  0,0.1% PF,  but  none were  found in the  v i r u s  t r e a t e d  w i t h  
0.02%,  The t i t r e  o f  t he  u n i n a c t i v a t e d  v i r u s  c o n t r o l  was
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6.3  X 10^ w h i c h  was r a t h e r  Low.  The r e s u l t s  i n d i c a t e d ,  
t h e r e f o r e ,  t h a t  a t  l e a s t  3 logs of  v i r u s  were i n a c t i v a t e d  by
0.02% PF since the PF - t r e a t ed  prepara t i ons  were concent rated two­
f o l d .
Concent rat ion of  FeLV by u l t r a f i l t r a t i o n
The r es u l t s  of  t i t r a t i n g  the samples obtained dur ing Amicon 
u l t r a f i l t r a t i o n  of  FeLV-A/Glasgow-1 are shown in Table 7,2.  I n  
t h i s  p r ocess  t h e  v i r u s  was c o n c e n t r a t e d  by a f a c t o r  o f  13.3 and 
62% of  t he  o r i g i n a l  i n f e c t i v i t y  was r e c o v e r e d .  No v i r u s  was 
d e t e c t e d  i n  t h e  u l t r a f i l t r a t e  i n d i c a t i n g  t h a t  a l l  o f  t h e  v i r u s  
was r e t a i ned  w i t h i n  the Amicon c e l l .  The f i n a l  concent rate  had a 
t i t r e  of  4.4 X 10*  ^ F l U/ ml  and was used d i l u t e d  in L-15 medium to  
1 X 10^ F l U / m l  as t he  c h a l l e n g e  v i r u s  i n  the  v a c c i n a t i o n  
exper i ment .
Vaccine p r epar a t i on
From the r e s u l t s  descr ibed above,  the vaccine which was used 
consisted of  the FeLV p r e p a r a t i o n  i n a c t i v a t e d  wi t h  0.02% PF and 
d e t o x i f i e d  by u l t r a f i l t r a t i o n ,  in which no i n f e c t i o u s  v i r us  was 
detected.  This vaccine was used to vacc i nate  two groups of  s i x  
8 -week old k i t t e n s .  Two adjuvants were compared: saponin and
i n c o m p l e t e  F r e u n d ' s  a d j u v a n t .  A t h i r d  g r o u p  was l e f t  
unvaccinated as a v i r us  c o n t r o l .  The second dose of  vaccine was 
given 3  weeks l a t e r  and the chal l enge was made one week a f t e r  the  
second vacc i na t i on .
The r e s u l t s  of  the vacc i na t i on  exper iment  are shown in Table  
7.3. A l l  the unvaccinated cont r o l  cats were v i r a e mi c  3,  9 and 21 
weeks a f t e r  c h a l l e n g e  and d i d  not  d e v e l op  v i r u s  n e u t r a l i s i n g
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TABLE 7.2
Concentration of FeLV by Amicon UltrafiItration
Flu/ml Volnme (ml) Total FIU
5.2 X 1086.5Culture supernatant fluid 6.0 x 10
86 .0 5.6 X 100.45 urn filtrate 6.5 X 10
10 80.0Amicon Ultrafiltrate
4.9 X 10Amicon concentrate X  10
TABLE 7.3 Results of Vaccination Experiment B
Group Time (weeks) relative to challenge * 
- 4 - 1 0  3 9 21 , 28
N o. Vaccine V A V A V A V A V A V A V A
B1 PF (ICFA) - 0 - - — 0 - 0 - o - 16 - 32
- 0 - - - 0 + o + o + 0 + 0
- 0 - - - 0 - 0 + 0 + 0 + 0
- 0 - - - 0 + o -, 0 - 0 - 0
- 0 - - - 0 + 0 + 0 - 8 - 0
- 0 - - - 0 + 0 - 0 - 16 - 128
B2 PF (Saponin) - O - - - 0 - 0 - o + 0 + 0
- 0 - - - 0 - 0 - o + 0 + 0
- 0 - - 0 + 0 + 0 + 0 + 0
- o - _ - 0 + 0 + 0 + 0 + o
- 0 - - - 0 - 0 - G - 32 - 64
- 0 - - - 0 - 0 - 0 - 8 - o
B3 Unvaccinated - 0 + 0 + 0 + 0
- 0 + 0 + 0 + 0
- 0 + 0 + 0 + 0
- 0 + 0 + 0 + 0
- 0 + 0 + 0 + 0
— 0 + 0 + 0 + 0
V =* Virus isolated from plasma 
A = Titre of virus neutralising antibody 
0 = <  8
v"r:: ! i ï  :
a n t i b o d i e s .  These ca t s  were assumed to have p e r s i s t a n t  FeLV 
i n f e c t i o n s .  I n  t h e  group o f  ca t s  v a c c i n a t e d  u s i n g  sapon i n  CB2) 
t he  r e s u l t s  were  t h a t  none of  t he  c a t s  was v i r a e m i c  b e f o r e  
c h a l l e n g e ,  but  2 o f  them were v i r a e m i c  3 and 9 weeks a f t e r  
c h a l l e n g e  and t h o s e  c a t s  t o g e t h e r  w i t h  a n o t h e r  2  ca t s  wer e  
v i raemi c  21 and 28 weeks a f t e r  chal lenge.  None of  the 6  cats had 
v i r u s  n e u t r a l i s i n g  a n t i b o d i e s  b e f o r e  c h a l l e n g e .  None o f  t h e  4 
v i raemi c  cats developed ant i bodi es  a f t e r  chal lenge and only one 
of the non- v i raemic  cats had ant i bodi es  at  2 1  and 28 weeks.
The r e s u l t s  of  v a c c i n a t i o n  us i ng  ICFA as a d j u v a n t  i n  t he  
second group of  vaccinated cats were t ha t  again none of  the cats  
were v i r aemi c  before cha l l enge ,  but 4 of  them became v i ra e mi c  3 
weeks a f t e r  chal l enge.  One of  these was p e r s i s t e n t l y  v i r aemi c  at  
9,  21 and 28 weeks and one other  was v i r aemi c  at  21 and 28 weeks.  
The o t h e r  3 c a t s  whi ch were  v i r a e m i c  a t  3 weeks ap p e a r e d  t o  
recover  from the i n f e c t i o n .  The s i x t h  cat was not v i r a e mi c  at  
any t i me .  As in the two other  groups,  none of  the v i r a e mi c  cats 
had n e u t r a l i s i n g  ant i bodi es .  Only 2 of  the 4 non- v i r aemi c  cats 
had ant i bod i es  at  28 weeks a f t e r  cha l l enge .
Since n e i t h e r  of  the vaccines prot ected 100% of  the k i t t e n s  
f rom c h a l l e n g e ,  t he  s c o r i n g  syst em d e s c r i b e d  i n  C h a p t e r  4 t o  
compare the vaccines was used and the r e s u l t s  are shown in Table  
f . 4 .  These show t h a t  t h e r e  was l i t t l e  d i f f e r e n c e  i n  e f f i c a c y  
be t ween  t he  v a c c i n e s  u s i ng  saponi n  or i n c o m p l e t e  Freund' s  
a d j u v a n t  a l t h o u g h  t he  l a t t e r  appear ed  t o  be s l i g h t l y  more 
e f f e c t i v e .
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Discussion
I n  t h i s  c h a p t e r ,  t he  i n a c t i v a t i o n  of  MSV (FeLV)  by PF was 
s t u d i e d  more t h o r o u g h l y  t han  i n  the  e x p e r i m e n t  d e s c r i b e d  i n  
Cha pt e r  4.  These r e s u l t s  gave an i n d i c a t i o n  of  the minimum 
c o n c e n t r a t i o n  (0.02%) o f  PF whi ch mi ght  be used to i n a c t i v a t e  
FeLV. FeLV was then  t r e a t e d  w i t h  PF at  c o n c e n t r a t i o n s  whi ch  
c o m p l e t e l y  i n a c t i v a t e d  4 logs o f  MSV (FeLV) .  However ,  g r e a t  
d i f f i c u l t y  was encountered in t e s t i n g  whether or not t here  was 
r e s i d u a l  i n f e c t i o u s  v i r u s  i n  t he  P F - t r e a t e d  FeLV p r e p a r a t i o n s  
because these were t ox i c  f o r  the c e l l s  in the usual  assay systems 
when i n o c u l a t e d  n e a t  or  d i l u t e d  1 : 5 .  Four d i f f e r e n t  t y p e s  o f  
assay were t r i e d  but none were successful .  The f i r s t  two methods 
were the standard one-stage and two- s tage  assays which used C81 
and FEA c e l l s .  Each of  t h e s e  assays uses c e l l s  which a r e  
i n i t i a l l y  seeded at  low d ens i t y  and i t  was considered t ha t  these  
c e l l s  mi ght  be p a r t i c u l a r l y  s e n s i t i v e  t o  PF. T h e r e f o r e ,  t wo  
other  methods were t r i e d  in which the i n i t i a l  c e l l s  were almost  
conf luent :  an i n t e r f e r e n c e  t e s t  using FEA c e l l s ,  and a modi f i ed  
t w o - s t a g e  C81/FEA assay i n  whi ch t he  C81 i n i t i a t o r  c e l l s  were  
c o n f l u e n t  when i n f e c t e d .  However ,  n e i t h e r  of  t h e s e  t e s t s  
produced a r e s u l t  when und i l u t ed  v i r us  was used as the inoculum.  
By c o n t r as t ,  assays of MSV (FeLV) which was i n a c t i v a t e d  wi t h  the  
same concent ra t ions  of  PF were successful .  The reason f o r  t h i s  
d i f f e r e n c e  may be t h a t  t h e  i n i t i a t o r  FEA c e l l s  i n f e c t e d  w i t h  
FeLV-B wh i ch  wer e  used i n  t h e  sarcoma v i r u s  assay wer e  l ess  
s e n s i t i v e  t o  the  e f f e c t s  of  t he  r e s i d u a l  i n a c t i v a t i n g  agent  i n  
t he  P F - t r e a t e d  MSV (FeLV)  p r e p a r a t i o n s  t ha n  t h e  u n i n f e c t e d  FEA
8 3
and CSI c e l l s  used i n  the  FeLV assays .  The reason f o r  t h i s  
d i f f e r en c e  is not known.
Comparing these r e s u l t s  wi t h  the r e s u l t s  of  Pedersen et  a l  
( 1 9 7 9 ) ,  t h e s e  a u t h o r s  d i d  not  m e n t i o n  p r o b l e m s  i n  t he  assay  of  
f o r m a l d e h y d e - i n a c t i v a t e d  FeLV,  presumably because they s t a r t e d  
t h e i r  assays w i t h  a 1 : 10  d i l u t i o n  o f  t h e  i n a c t i v a t e d  v i r u s .  I t  
i s  not  c l e a r ,  t h e r e f o r e ,  i f  P e d e r s e n ’ s v a c c i n e  was c o m p l e t e l y  
i n a c t i v a t e d .  To ensure as f a r  as poss ib le  t h a t  the v i r us  used in  
the present  exper iment  was comple t e ly  i n a c t i v a t e d  i t  was f i n a l l y  
necessary to wash the P F - t r e a t e d  FeLV by uLt  r a f  i 11 r a t  i oh  w hi  ch 
shoul d  have removed m o l e c u l e s  of  l ess  t han  1 X 10^ m o l e c u l a r  
weight .  There was no d e t ec t ab l e  i n f e c t i o u s  v i r u s  in t h i s  sample.
I n  t he  l i g h t  of  t h e s e  r e s u l t s ,  i t  was d e c i d e d  t hen  t o  use 
t h e  washed v i r u s  as v a c c i n e .  The reasons were  t h a t  as w e l l  as 
being n o n - t o x i c ,  such a p r epar a t i on  might a lso have the advantage 
t h a t  p15E might  have been removed. This molecule is supposed to 
be immunosuppressive (Olsen ^  a_ly 1980b) and i t s  absence from a 
v a c c i n e  mi g h t  produce  a b e t t e r  immune r e sp onse .  On t h e  o t h e r  
hand,  f r e e  gp70 and FOG MA mi ght  a l s o  be removed (Ol sen et  a l ,  
198Cb;)so t h a t  some use f u l  ant igens might be l o s t .  The r e s u l t s  of  
c o n c e n t r a t i n g  l i v e  FeLV-A/G l asgow- 1  by Amicon u l t r a f i l t r a t i o n  
w h i c h  a r e  shown i n  T a b l e  7 . 2 ,  i n d i c a t e d  t h a t  62% o f  t h e  
i n f e c t i o u s  v i r u s  was r e t a i n e d  in t he  p r o c e s s .  S i nce  t h i s  
procedure was c a r r i e d  out over a per iod of  6  hours,  i t  i s l i k e l y  
t h a t  a t  l e a s t  some of  t he  loss of  i n f e c t i v i t y  was due t o  t h e  
r e g u l a r  i n a c t i v a t i o n  p r o c e s s .  T h e r e f o r e ,  i t  woul d  be e x p e c t ed  
tha t  g r e a t e r  than 62% of  P F - i n a c t i v a t e d  v i r u s  would be included  
i n  t h e  v a c c i n e .  A l t h o u g h  i n  t h e  p r o d u c t i o n  o f  t h e  P F - t r e a t e d
84
_________________ !___________________ '  :______________L.
iFeLV o n l y  3 logs of  v i r u s  were shown to be i n a c t i v a t e d ,  f u r t h e r
e v i d e n c e  t h a t  t h e r e  was no i n f e c t i o u s  v i r u s  i n  t he  v a c c i n e  was 
t h a t  v a c c i n a t e d  c a t s  d i d  not  d e v e l o p  v i r a e m i a  or  produce  v i r u s
n e u t r a l i s i n g  ant i bodi es .
The r es u l t s  of  vacc i na t i on  were b e t t e r  than in the previous  
exper iment  descr ibed in Chapter  4. A l l  of the unvaccinated cats  
became p e r s i s t e n t l y  v i r a e m i c  as e x p e c t e d  f rom t he  r e s u l t s  o f  
Chapter  6 ,  so t h a t  the p r o t e c t i v e  ac t i on  of vacc i n a t i o n  was more
i
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obvious.  I n  a d d i t i o n ,  none of  the unvaccinated cats made v i r us  
n e u t r a l i s i n g  a n t i b o d i es .
I n  t he  v a c c i n a t e d  gr oup ,  on l y  two of  t h e  s i x  c a t s  g i v e n  
v a t c i n e  w i t h  saponin as adjuvant  r e s i s t ed  the chal l enge a f t e r  28 
w e e k s .  One o f  t h e s e  c a t s  d e v e l o p e d  v i r u s  n e u t r a l i s i n g  
a n t i b o d i e s .  Ther e  was a s l i g h t l y  b e t t e r  r esponse  i n  t h e  group  
whi ch was g i v e n  vac cc i ne w i t h  t he  o i l  a d j u v a n t .  Four o f  s i x  of  
these cats r e s i s t ed  the chal l enge and were not v i r aemi c  a f t e r  28 
weeks. However,  three  of  these cats were t r a n s i e n t l y  v i r a e m i c ,  3 
weeks a f t e r  c h a l l e n g e .  These r e s u l t s  a r e  s i m i l a r  t o  t h o s e  o f  
Pedersen (1979 )  who showed t ha t  f o r ma l d e h y d e - i n a c t i v a t ed
v a c c i n e  d i d  not  p r e v e n t  t r a n s i e n t  v i r a e m i a  but  d i d  p r e v e n t  
p e r s i s t e n t  v i r a e m i a  in a p r o p o r t i o n  of  cats ,  f o l l o w i n g  n a t ur a l  
exposure to FeLV-excret ing cats.
The reason why h a l f  of  t h e  s i x  v a c c i n a t e d  c a t s  whi ch  
r e s i s t e d  cha l l enge ,  inc l ud i ng  two which had a t r a n s i e n t  v i r a e m i a ,  
did not develop v i r us  n e u t r a l i s i n g  ant i bodi es  i s  not c l e a r .  . I t  
i s  known, however,  from ep i demi o l og i ca l  studies  t ha t  there  is a 
s m a l l  but  s i g n i f i c a n t  p r o p o r t i o n  of  ca t s  n a t u r a l l y  exposed t o
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FeLV which are non- v i raemi c  and which do not have n e u t r a l i s i n g  
ant i bodi es  (Hardy et  a l ,  1976) .
The s c o r i n g  system i n d i c a t e d  t h a t  t h e  v a c c i n e  us i ng  the  
incomplete  Freund's adjuvant  was s l i g h t l y  super i or  to the vaccine  
wi t h  saponin.  Thus in the f i n a l  vacc i na t i on  exper iment  which is 
descr ibed in the next chapt er ,  the o i l  adjuvant  was used.
’lié):
CHAPTER 8
VACCINATION EXPERIMENT 3: COMPARISON OF ANTIGENS
INTRODUCTION
The r e s u l t s  of  the two vacc i na t i on  exper iments repor ted in 
Cha pt e r s  4 and 7 i n d i c a t e d  t h a t  a c o n s i d e r a b l e  degr ee  of  
p r o t e c t i o n  against  exper i ment a l  FeLV chal lenge was obtained using  
p a r a f o r m a l d e h y d e - i n a c t i v a t e d  FeLV d e r i v e d  f rom t he  F422 c e l l  
l i n e .  However,  p r o t e c t i o n  was not complete and i t  was considered  
t h a t  t h e r e  mi ght  be at  l e a s t  two reasons f o r  t h i s .  F i r s t ,  i t  
might be t h a t  the q u a n t i t y  of  v i r a l  ant igen used in the vaccines  
was i n s u f f i c i e n t  a l t h o u g h  in t he  f i r s t  exper iment  descr ibed in  
C h a p t e r  4 no d i f f e r e n c e  was ob ser ved  i n  t he  response of  c a t s  
i mmuni sed  w i t h  a n t i g e n  e q u i v a l e n t  to u n c o n c e n t r a t e d  or  X 1 0  
c o n c e n t r a t e d  F422 c e l l  c u l t u r e  f l u i d .  N e v e r t h e l e s s ,  s i n c e  t h e  
r e s u l t s  of  the second exper iment  were more encouraging,  i t  was 
decided to compare again an unconcentrated and a X I 0 concent rated  
FeLV-A/F422 vaccine.
A second p o s s i b i l i t y  mi ght  be t h a t  t he  q u a l i t y  of  t he  F422 
v i r u s  was poor  and,  i n  p a r t i c u l a r ,  t h a t  t he  v i r a l  e n v e l o p e  gp70  
was not present  in such high concent rat ions as in FeLV grown in  
f i b r o b l a s t  c u l t u r e s .  E l ec t ron  microscopy of F422 c e l l s  has shown 
t ha t  budding v i r us  has prominent  spikes on the envelope but t ha t  
t h e  v i r u s  which i s  p r e s e n t  a round the  c e l l s  f o l l o w i n g  r e l e a s e  
f rom t h e  c e l l s  does not  have o bv i ous  s p i k e s  ( T o t h ,  1 9 8 0 ) .  T h i s  
i s  i n  c o n t r a s t  t o  FeLV produced i n  f e l i n e  embryo f i b r o b l a à t  
cu l t u r es  which has prominent  spikes when budding and mainta ins  
i t s  spikes f o r  24-48  hours a f t e r war ds  ( L a i r d ,  H.M. and J a r r e t t >
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0 , ,  personal  communicat ion) .  I n  the Light  of  these observat ions  
i t  was decided to compare FeLV obtained from F422 c e l l s  and from 
f i b r o b l a s t  cu l t u r e s  as a source of vaccine.  I t  was assumed t ha t  
a v i r us  wi t h  w e l l - p r e s e r v e d  spikes might be more a n t i g e n i c  than  
one w i t h o u t  s p i k e s .  I t  shou l d  be emphas i sed  a g a i n  t h a t  t h e  
amount of  FeLV produced by F422 c e l l s  is approx i mat e l y  ten t imes  
t ha t  produced by FEA c e l l s .  There f ore  FeLV grown in f i b r o b l a s t s  
was concent rated t e n f o l d ,  to make i t  equ i va l ent  to unconcent ra ted  
F422 v i r u s .
Whi le these exper iments were in progress i t  was found t ha t  
some c a t s  wh i ch  appear  t o  r e c o v e r  f o l l o w i n g  expo s ur e  t o  FeLV,  
mai nt a i n  a l a t e n t  FeLV i n f e c t i o n  in bone marrow c e l l s  (Post and 
Warren,  1980; Rojko et a I ,  1982; Madewel l  and J a r r e t t ,  1983) .  I t  
was c o n s i d e r e d  i m p o r t a n t  to d e t e r m i n e  w h e t h e r  v a c c i n a t e d  c a t s  
which r e s i s t e d  chal l enge wi t h  FeLV had e l i m i n a t e d  the v i r u s  or  
had a l a t e n t  i n f e c t i o n .  T h e r e f o r e ,  bone marrow c u l t u r e s  were  
made from pr o t ec t ed  cats and examined f o r  the presence of  l a t e n t  
v i r u s .
M a t e r i a l s  and Methods
Exper imental  groups
F i v e  groups of  ca t s  were used in t h i s  e x p e r i m e n t .  Thèse  
were designated as f o l l ows :
Cl :  Vaccinated wi th FeLV-A/F422,  XI
C2: Vaccinated wi th FeLV-A/F422>, X10
C3: Vaccinated wi th FeLV-A/Glasgow-1,  X10
C4: I nocu l a t ed  wi th cont r o l  "vacc i ne" ,  FEA c u l t u r e  f l u i d  XIO
C5: Cont rol  group,  unvaccinated
8 8
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Vaccines Cl and C2
Two hundred ml of  F422 c u l t u r e  f l u i d  h a r v e s t e d  f rom a 
c u l t u r e  seeded 24 hours before at  1.2 X I Q^/ml  c e l l s  per ml in L -  
M medium was c l a r i f i e d  by s p i n n i n g  a t  2 0 0 0  rpm f o r  2 0  m i n u t e s .  
The v i r us  was i n a c t i v a t e d  w i t h  0.02% PF in a 25°  water  bath f o r  
24 hours and a o n e - t e n t h  volume o f  20% sodium t h i o s u I p h a t e  was 
a d d e d  f o r  30 m i n u t e s  a t  4 ° .  The i n a c t i v a t e d  v i r u s  was  
concent rated at 4 °  by u l t r a f i l t r a t i o n  in an Amicon s t i r r e d  c e l l  
using a 43 mm Nuclepore membrane wi t h  a 1 X 10^ molecular  weight  
c u t - o f f  at  a n i t r ogen  pressure of  20 lb per in . A volume of  175 
ml was reduced to 75 ml.  An a d d i t i o n a l  100 ml of  L-15 medium was 
added and t h i s  was f u r t h e r  c o n c e n t r a t e d  t o  a volume of  55 ml .  
Samples o f  5 ml were  s t o r e d  a t  - 7 0 ° .  The v i r u s  was assayed  
using the two-s tage  assay which i nd i ca t ed  complete i n a c t i v a t i o n ,  
whi l e  the i n f e c t i v i t y  of  u n i n a c t i v a t ed  FeLV was 3.5 X 10^ F lU/ ml .  
A f t e r  the t es t  f o r  r e s i du a l  i n f e c t i v i t y  the i n a c t i v a t e d  ant igen  
was thawed and spun in a Beckman SW41 r o t or  at  40,000 rpm f o r  60 
mi n u t e s  and t he  p e l l e t  was resuspended i n  6 . 6  ml L - 1 5  medium 
which represents a concent ra t i on  of  3 0 - f o l d .  Then 0-6 ml of  the  
30X a n t i g e n  was d i l u t e d  to  6  ml in  L - 1 5  medium to make a 3X 
concent rate .  Each of  these ant igens was mixed wi t h  a one- t ent h  
volume of Al(OH)^^ incubated at  4 °  overnight  and then two volumes 
of  ICFA was added. The mixtures  were e m u l s i f i e d  in a SyIverson  
homogen i se r  and used t o  v a c c i n a t e  8  week o l d  c a t s  as 1 ml IM i n  
t h e  h i nd  l e g .  The r e m a i n d e r  of  t he  v a c c i n e s  were  kept  a t  4 °  
u n t i l  used in the boost ing dose.
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Vaccine C3
Th i s  v a c c i n e  was p r e p a r e d  i n  a s i m i l a r  manner  t o  t hose  
above.  About  200 ml o f  FeLV- A/ GLasgow-1  c u l t u r e  f l u i d  was 
harvested from two c h r o n i c a l l y  FeLV- infected FEA monolayer c e l l  
cu l t u r es  in 2,5 l i t r e  r o l l e r  b o t t l e s  48 hours a f t e r  seeding wi t h  
1 X 10^ c e l l s  in 100 ml McCoy's medium w i t h  10% FCS. The f l u i d  
was c l a r i f i e d  by spinning at  2 0 0 0  rpm f o r  2 0  minutes,  i n a c t i v a t e d  
wi t h  0.02% PF in a 25°  water  bath f o r  24 hours,  n e u t r a l i s e d  wi th  
a o n e - t e n t h  vo l ume o f  20% sodium t h i o s u l p h a t e  a t  4 °  f o r  30  
minutes and concent rated by Amicon u l t r a f i l t r a t i o n  as above to a 
f i n a l  volume of  40 ml.
Samples were taken f o r  v i r u s  assay before i n a c t i v a t i o n  and 
a f t e r  i n a c t i v a t i o n  and concent ra t i on .  No v i r u s  was observed in 
the i n a c t i v a t e d  sample wh i l e  the v i rus  t i t r e  of  the u n i n a c t i v a t ed  
sampl e  was 1-2 X 10^ F l U / m l .  To p r e p a r e  t h e  v a c c i n e  t h e  
i n a c t i v a t e d  and concent rated FeLV was thawed,  spun at  40,000 rpm 
f o r  60 minutes in the SW41 r o t or  and the p e l l e t  was resuspended 
i n  6 . 6  ml L - 1 5  medium,  so t h a t  t he  f i n a l  c o n c e n t r a t i o n  o f  the
i n a c t i v a t e d  ant i gen was X30. A volume of  0,66 ml of AKOH)^ was 
added and kept  at  4 °  o v e r n i g h t ,  when two vo l umes  of  ICFA were  
added and the mi x t ure  was e mu l s i f i e d .
Cont rol  vaccine C4
This vaccine was prepared in the same way as the C3 vaccine  
e x c e p t  t h a t  i n s t e a d  o f  u s i n g  F e L V - i n f e c t e d  FEA c e l l  c u l t u r e  
f l u i d ,  t he  f l u i d  o f  u n i n f e c t e d  FEA c e l l s  was used.  T h i s  was 
t r e a t e d  w i t h  PF,  c o n c e n t r a t e d ,  sampl ed  and assayed as b e f o r e .  
The AlCOH)^ and ICFA were added as f o r  the other  prepar a t i ons .
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V acc in a tio n  experiment
A l l  30 k i t t e n s  were vaccinated wi t h  the d i f f e r e n t  types of  
vaccine as descr ibed in Chapter  7. These k i t t e n s ,  t oget her  w i t h  
the  s i x  k i t t e n s  which c o mp r i s e d  the u n v a c c i n a t e d  group were  
t hen  c h a l l e n g e d  a t  1 2  weeks of  age (one week a f t e r  t he  second  
vacc i na t i on )  by g i v i ng  0.8 ml of Amicon concent rated FeLV-A (6.25 
X 10^ FIU)  by d r o p p i n g  0.1 ml i n  each n o s t r i l  and 0.6 ml i n  t h e  
mouth of  each k i t t e n .  A l l  t he  e x p e r i m e n t a l  k i t t e n s  were b l e d  
b e f o r e  each v a c c i n a t i o n  and c h a l l e n g e ,  and a t  3 ,  6 ,  12 and 18 
weeks a f t e r  chal lenge.  Samples of  1 ml c l o t t e d  blood f o r  serum 
and 1 ml w i t h  l i t h i u m  h e p a r i n  f o r  p l asma were  t a k e n ,  p r o c e s s e d  
and s t o r e d  at  - 7 0 °  u n t i l  assayed f o r  FeLV v i r a e m i a  by v i r u s  
i s o l a t i o n ,  or f o r  n e u t r a l i s i n g  ant i bod i es .
Establ ishment  of  bone marrow cu l t u r es
Bone marrow cu l t u r es  were es t ab l i shed  by a m o d i f i c a t i o n  of  
the method of  Madewel l  and J a r r e t t  (1983).  Ce l l s  were obtained  
by a s p i r a t i o n  of  femora l  marrow using a Rosenthal  p a t t e r n  needle  
(18 gauge,  1 i n c h ) .  T h i s  p r o c e d u r e  was c a r r i e d  out  by P r o f .  0.  
J a r r e t t .  The c e l l s  were  i m m e d i a t e l y  d i s p e r s e d  i n  co l d  medium 
cons i s t i ng  of  Alpha medium (Gibco) supplemented wi t h  10% FCS, 
1 0 "^ M hydrocor t i sone sodium succinate  (Sigma) and 10 u n i t s / m l  of  
p r e s e r v a t i v e - f r e e  hepar in sodium BP (Pabyrn).
Bone marrow c e l l  c u l t u r es  were prepared in d u p l i c a t e  in  25
ocm f l a s k s  w i t h  1 0  ml of  g r o wt h  medium (as above but  w i t h o u t  
h e p a r i n )  as f o l l o w s .  F i v e  ml of  t h e  a s p i r a t e d  c e l l  su s p e n s i o n  
was c e n t r i f u g e d  at  1000 rpm f o r  5 mi nu t es  and the  p e l l e t  was 
resuspended in 5 ml of  cold NH^Cl and incubated at  4 °  on ice f o r
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5 minutes to lyse contaminat ing red blood c e l l s .  The c e l l s  were 
t hen  p e l l e t e d  by c e n t r i f u g a t i o n  and r esuspended i n  g r owt h  
medium. The nucleated c e l l s  were counted in a haemocytometer  and 
t he  c e l l  s u sp ens i on  was a d j u s t e d  t o  2 X 10^ c e l l s  pe r  ml  in  
g r o w t h  medium.  Two f l a s k s  were  seeded each w i t h  10 ml o f  c e l l  
s u s p e n s i o n ,  gassed w i t h  5% CO^ i n  a i r  and i n c u b a t e d  at  3 7 * .  
These cu l t u r e s  were designated MA or MB.
The r e m a i n i n g  5 ml o f  t he  o r i g i n a l  marrow c e l l  s u s pe ns i o n  
was c e n t r i f u g e d  and the  p e l l e t e d  c e l l s  were  r esuspended t o  
2 X 10^ per  ml in g r owt h  medium based on t h e  c e l l  count  of  the  
c e l l s  t r e a t e d  w i t h  NH^Cl .  Two c u l t u r e s  were  p r e p a r e d  as above  
and designated A or B.
H a l f  of  t h e  medium f rom each c u l t u r e  was rep l a  ced e v e r y  7 
days w i t h  f r e s h  medium.  The medium whi ch was removed was 
c en t r i f ug ed  at  2 0 0 0  rpm f or  1 0  minutes and the supernatant  f l u i d  
was stored at  - 7 0 °  before being t es t ed  f o r  FeLV.
Resul ts
As d e s c r i b e d  i n  t h e  o t h e r  t w o  p r e v i o u s  v a c c i n a t i o n  
e x p e r i m e n t s  i n  C h a p t e r  4 and 7 ,  i n  t h i s  f i n a l  e x p e r i m e n t  a 
comparison of  ant igens was made in which F422 and FeLV-A/Glasgow-  
1 v i r u s e s  were  used.  At t he  same t i m e  c u l t u r e  f l u i d s . o f  
un i n f ec t ed  FEA c e l l s  were used as a cont ro l  vaccine t o  e s t a b l i s h  
i f  t her e  might  be any response in the cats t o  the serum pr o t e i ns  
i n  t he  medium or t o  c e l l u l a r  a n t i g e n s  shed i n t o  t he  c u l t u r e  
f l u i d .
Resul ts of  vacc i na t i on  in t h i s  exper iment  are shown in Table
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8.1. These r e s u l t s  were assessed by comparing the pr opor t i on  of  
v i raemi c  cats in each vaccinated group wi th  the pr opor t i on  in the 
u n v a c c i n a t e d  group a t  c h a l l e n g e  and 3 ,  6  and 18 weeks a f t e r  
c h a l l e n g e .  Ther e  were no a n t i b o d i e s  in any group of  t he  c a t s ,  
vaccinated or unvaccinated at  chal lenge.  None were v i r aemi c  at  
t h i s  t ime.
The cats in the unvaccinated group were v i raemi c  3 ,  6  and 18 
weeks a f t e r  c h a l l e n g e .  None of  t hese  c a t s  produced v i r u s  
n e u t r a l i s i n g  a n t i b o d i e s .  Also t h e  ca t s  in t h e  c o n t r o l  v a c c i n e  
g r o u p  a l l  b e c a me  v i r a e m i c  w i t h i n  t h r e e  w e e k s  and w e r e  
p e r s i s t e n t l y  v i r a e m i c .  None produced v i r u s  n e u t r a l i s i n g  
ant i bodi es  at  any t i me.  Two of the cats in t h i s  group d i ed ,  s i x  
weeks a f t e r  chal lenge.
Of t he  v a c c i n a t e d  c a t s ,  t h e  m a j o r i t y  of  t h e s e  g i v e n  
i n a c t i v a t e d  F422 v i r u s  r e s i s t e d  c h a l l e n g e  w i t h  FeLV.  By 
c o n t r a s t ,  o n l y  one of  s i x  c a t s  v a c c i n a t e d  w i t h  t he  i n a c t i v a t e d  
Fe L V - A / G l a s g o w - 1  v i r u s  r e s i s t e d  c h a l l e n g e .  Th e r e  was l i t t l e  
d i f f e r e n c e  i n  t he  r e s u l t s  o f  the  groups g i v e n  F422 ( X I )  or  F422 
(XIO)  v a c c i n e .  I n  t h e  f i r s t  group ( C l )  one o f  t h e  s i x  c a t s  
became p e r s i s t e n t l y  v i r a e m i c  f o l l o w i n g  chal lenge.  None of  the  
o t h e r  c a t s  i n  t h i s  g r o u p  b e c a me  e i t h e r  t r a n s i e n t l y  o r  
p e r s i s t e n t l y  v i r aemi c .  Whi le none of the cats had n e u t r a l i s i n g  
a n t i b o d i e s  f o l l o w i n g  v a c c i n a t i o n  but  b e f o r e  c h a l l e n g e ,  a l l  
developed ant i bodi es  a f t e r  chal lenge.
In the second va c c i n a t i o n  group (C2) two of  the cats became 
permanent ly v i r aemi c  a f t e r  chal l enge.  One of these v i r aemi c  cats  
( cat  6 ) died 16 weeks a f t e r  chal l enge.  One ot her  cat  (cat  4) had
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TABLE 8.1 Réduits of Vaccination Experiment C
Group Time (weeks) relative to challenge *
-4 -1 G 3 6 12 18
No. Vaccine V A V A V A V A V A V A V A
Cl F422 (1) . 0 0 . 0 G _ 8 - 52 128
- 0 - 0 - 0 - 0 - 8 16 - 32
- 0 - 0 — 0 - 0 - 16 - 32 - 32
- 0 - 0 - 0 + G - G + G + 0
- 0 - 0 - 0 - 8 - 8 8 - 16
0 _ 0 G - a - G 8 - 16
C2 F422 (10) G - G G - G - G - 8 - a nG 0 0 + G G • 0 + 0
0 - G - G 8 - 8 - 8 - 8
0 - G - G -  8 + G - 16 - 64
G 0 0 -  8 - 16 - 16 - 64
0 0 0 - 0 - 16 0 0 0
C3 FeLV-A (1G) - 0 _ 0 G + G G + G + 0
“ 0 - 0 — G + G + G + G + G
- 0 0 ~ G - 0 - 128 - 64 - 64
- 0 - G — G - 0 - G + 0 + 0
- 0 - G - G + G - G + G + 0
- 0 - G - G + G G 4 - 0 + 0
C4 Control _ 0 _ G _ G + G + G 4- 0 + 0
Fluid - G - G - 0 + G 0 0 0 D D D
- G - 0 - 0 + Ü + 0 + 0 4- G
- G - 0 - G + G - 0 4* 0 4- G
- G ~ 0 “ 0 + 0 D D 0 D D 0
- G - G - G + 0 + G + 0 4- 0
C5 Unvaccinated G — G - G + 0 + G + 0 + G
- G - G - G + 0 + G •f 0 + 0
- G - G - G + 0 + G + 0 + G
- 0 - G - 0 + G + G + G + 0
“ 0 - 0 - 0 + G + 0 + 0 + 0
- 0 - G - 0 + G + G 4- G + 0
V = virus isolated from plasma 
A = Titre of virus neutralising antibody 
0 = <8
___    : : : : :________
3  t r a n s i e n t  v i r aemi a  which was detected s ix  weeks a f t e r  chal lenge  
but  not  at  12 or  18 weeks.  As in the f i r s t  g r o u p ,  a l l  of  the  
non- v i raemi c  cats developed v i r us  n e u t r a l i s i n g  ant i bod i es .
The response of the t h i r d  vaccinated group (C3) to chal l enge  
was much p o o r e r .  F i v e  of  t h e  s i x  c a t s  became p e r s i s t e n t l y  
v i r a e m i c .  Only  one ( c a t  3) r e s i s t e d  t he  c h a l l e n g e  and produced  
v i r us  n e u t r a l i s i n g  ant i bodi es .
Three cats developed disease dur ing t h i s  exper iment  and had 
t o  be d e s t r o y e d .  These were  ca t  6  i n  group C2 and ca t s  2 and 5 
i n  group C4. A l l  of  t hese  c a t s  were v i r a e m i c  at  t he  t i m e  of  
d ea t h .  A l l  were  s u f f e r i n g  f rom a h a e m o r r h a g i c  c o l i t i s  w i t h  
h a e m o r r h a g i c  m e s e n t e r i c  lymph nodes.  Lar ge  numbers o f  B-  
haemolyt ic E. co l i  were i s o l a t e d  from the colonic  contents.
The r e s u l t s  of  using the scor ing system as in Chapters 4 and
7 a r e  shown i n  T a b l e  8 . 2 ,  f rom whi ch  i t  i s  c l e a r  t h a t  t h e  F422
( X I )  v a c c i n e  ranked f i r s t  i n  e f f i c a c y  of  a l l  t h e  v a c c i n e s  t r i e d  
i n  t h i s  e x p e r i m e n t .  The c a t s  g i v e n  t h e  c o n t r o l  FEA c u l t u r e  
f l u i d s  v a c c i n e  gave e s s e n t i a l l y  t he  same response as t h e  
u n v a c c i n a t e d  c a t s ,  and t h e  response  of  t h e  F e L V- A / Gl as g o w - 1  
vaccinated cats was.only mar g i na l l y  b e t t e r .
Establ ishment  of  bone marrow cu l t u r e s
The l a t e n c y  c o n d i t i o n  of  FeLV i n  t he  f i r s t  group ( C D  of
t h i s  vacc i na t i on  exper iment  was d e t e r m i n e d .  The f l u i d s  o f  t h e
cul t ures  es t ab l i shed  from bone marrow a s p i ra t e s  were t es t ed  f o r  
i n f e c t i o u s  FeLV using t he  t w o - s t a g e  v i r u s  i s o l a t i o n  p r o c e d u r e .  
The r esu l t s  are shown in Table 8.3. Only cat  4 was p o s i t i v e  for  
v i ru s  in the f l u i d  of  the as p i r a t e d  bone marrow samples wh i l e  the
94
(N
œ
ÜJ
CD
CC ' CH rA LA
rH  (U
to M
4-J O r ~ CH o CD
u O U <0- rA LA CDI— en < r CTV CH4-JCeuE rH•a co
(W 4J r \ o ov a CDm o co < t a CDQ. 1— CH CH LA VÛ VÛX
0)
c * VÛ o rA o Oo (U CH 00 o CD•H A  CJ4-) oCD üC co•H vû o VÛ o OO CO o VÛ o Oü ■a CD CH CHco a> -Q•Hc 4*) o o o CD•H c o LA o o CD<  < CH rA lA rA(0
CDAO rHO cdCO 4 J <d' CH CH o CDo H3 co LA C3>% t—' rA LA VÛUcoü•H CO O ov o (3U - <± VÛ o CDt»- CJ CH rA (AUJ * 0)AO O VO Û o OU HD VÛ LA CDCO CD o CH
CO3A HD VÛ A - o CD•H VÛ o CD>  <
XJ•H TD3 @3o rH 4->C - CDO C
CX Q) rH •H3  C <c o OO  -H 1 H OA  O CH CH > 4J COCJ O CH CH c >CO < f 0) o CCD > ü_ Cl. u . CJ CDC■HClU  •CO O CH lA LA
>  z CJ CJ CJ CJ CJ
CO to
CO
Jd j»: CD
(U CD (U
CD (U 33 3
rA VÛ
00
II II II
< CQ CJ
*
.:'.Æm
TABLE 8.3
Latent FeLV in bone marrow cultures of vaccinated cats
Cat Viraemia FeLV in Marrow FeLV isolated (weeks) 
No. BMSF * culture' 1 2 3
NA
NB
MB
BMSF = Bone marrow supernatant fluid. The medium into which
the bone marrow aspirate was taken was tested for
infectious FeLV
...
' > j . : V    .
other  f i v e  cats of the group were negat ive.  These r es u l t s  were 
e x p e c t e d  f rom t he  r e s u l t s  of  v i r u s  i s o l a t i o n  f rom t he p l asma  
samples c o l l e c t e d  18 weeks a f t e r  chal lenge.  The other  r e s u l t s  of  
FeLV i s o l a t i o n  f rom the c e l l  c u l t u r e  f l u i d s  c o l l e c t e d  one week  
a f t e r  seeding of  the, bone marrow were t hat  cat  3 was negat i ve  f o r  
the v i rus  whi l e  the others were p o s i t i v e .  Samples of  f l u i d s  were 
t es t ed  2 and 3 weeks a f t e r  es tabl i shment  of the c u l t u r es  and the  
same r e s u l t s  were obtained.
Ther e  was no d i f f e r e n c e  i n  t he  r e s u l t s  w h e t he r  or  not  t h e
bone marrow c e l l s  had been t r e a t e d  wi t h  NH4 CL to remove red blood  
c e l l s .  A t y p i c a l  bone marrow c u l t u r e ,  3 weeks a f t e r  seeding,  is  
shown in F i g .  8 . 1 .
Discussion
The plan of  t h i s  exper iment  on FeLV vacc i na t i on  was decided  
upon in the l i g h t  of  the r e s u l t s  of  the two previous exper iments.  
There were two main aims.  The f i r s t  aim was t o  f i n d  whether  or  
not  a g r e a t e r  de gr e e  of  p r o t e c t i o n  was a c h i e v e d  by u s i n g  a 
g r e a t e r  a n t i g e n i c  mass o f  F422 v i r u s .  A v a c c i n e  c o n t a i n i ng 10 
t imes concent rated v i r us  was compared wi th one prepared from the  
equi va l ent  of  unconcent ra t ed  v i r u s .  The r e s u l t s  o b t a i n e d  were  
t h a t  t h e r e  was a good response  t o  v a c c i n a t i o n  w i t h  e i t h e r  
v a c c i n e .  F i v e  o f  s i x  c a t s  v a c c i n a t e d  w i t h  t h e  unconcent  r a t e d  
v i rus  vaccine were non- v i raemi c  1 2  and 18 weeks a f t e r  chal l enge.  
Approximately  s i m i l a r  r e s u l t s  were obtained f o l l o w i n g  v a c c i n a t i o n  
w i t h  the c o n c e n t r a t e d  v i r u s  v a c c i n e .  I n  a d d i t i o n ,  good v i r u s  
n e u t r a l i s i n g  a n t i b o d y  t i t r e s  dev e l o p e d  i n  t h e s e  c a t s ,  r a n g i n g  
f rom 8  t o  32 and f r om 16 t o  128 at  12 and 18 weeks r e s p e c t i v e l y
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Fig. 8.1. Feline bone marrow culture
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This culture was established 3 weeks previously sind contains 
fibroblasts, large macrophages and small round myeloid cells 
( X 125)
a f t e r  c h a l l e n g e .  I t  appear ed  t h a t  t h e r e  was l i t t l e  d i f f e r e n c e  
b e t ween  t h e  r e s u l t s  of  v a c c i n a t i o n ,  w i t h  F422 CXÎ) or  (XIO)  
vaccines.  A s i m i l a r  r e s u l t  was found in the exper iment  descr ibed  
i n  Cha p t e r  4,  The reason why i n c r e a s i n g  the a n t i g e n i c  mass of  
t he  v a c c i n e  had no e f f e c t  on t he  i m m u n i s i n g  c a p a c i t y  o f  t h e  
i n a c t i v a t e d  v i r u s  i s  not  c l e a r .  I n  o t h e r  s y s t em s ,  t h e  immune  
response t o  vaccines is dependent on the q u a n t i t y . o f  ant igen in 
the vaccine.  Thus, in potency t es t s  of rabies vaccine,  Romanova 
(1981) showed t ha t  by reducing the ant igen content  of vaccine by 
f i v e - f o l d ,  t h e r e  was a c o r r e s p o n d i n g  d e c r ea s e  i n  t he  a n t i b o d y  
response o f  i n o c u l a t e d  mi ce  and i n  t he  p r o t e c t i o n  t o  c h a l l e n g e  
w i t h  v i r u l e n t  v i r u s .  An exampl e  of  the e f f e c t  of  v a c c i n e  
c o n c e n t r a t i o n  on the  e x t e n t  of  t he  immune r esponse  t o  a 
r e t r o v i r u s  vaccine was the exper iment  of  Charney ^  (1976) in
whi ch  mi ce  were  v a c c i n a t e d  w i t h  s e r i a l  doses o f  f o r m a l i n -  
i n a c t i v a t e d  murine mammary tumour v i rus  (MMTV) in e i t h e r  complete  
or incomplete  Freund's adjuvant .  The r e s u l t  was t h a t  t her e  was 
s i g n i f i c a n t  p r o t ec t i o n  against  chal lenge wi th  l i v e  MMTV in mice 
whi ch r e c e i v e d  1 ug o f  v i r a l  a n t i g e n ,  l ess  i n  mice g i v e n  0 , 1  ug. 
and no p r o t e c t i o n  in mice vaccinated wi th 0 , 0 1  ug or l ess.
I t  woul d  be i n t e r e s t i n g  t o  know i f  by d e c r e a s i n g  t h e  
a n t i g e n i c  mass of  the p r e s e n t  FeLV v a c c i n e ,  t he  p o t en c y  o f  t he  
v a c c i n e  woul d  be d e c r e a s e d  or  i n c r e a s e d .  I f  a p l a t e a u  had been  
r eached i n  t h e  r e l a t i o n s h i p  be t ween  a n t i g e n i c  mass of  FeLV and 
the immune response,  one would expect  t h a t  a reduct ion in ant igen  
q u a n t i t y  would  l ead  t o  a r e d u c t i o n  in  p r o t e c t i o n .  However ,  i f  
t here  was an i n h i b i t o r y  f a c t o r  in the concent rated Vaccine (e.g.
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p15E) ,  i t  mi g h t  be e x p e c t e d  t h a t  d i l u t i o n  o f  t he  v a c c i n e  mi gh t  
give increased p r o t e c t i o n .
The l e v e l  o f  p r o t e c t i o n  i n  t h e  p r e s e n t  v a c c i n a t i o n  
e x p e r i m e n t  was 83%,  w h i l e  i n  t h e  e x p e r i m e n t  o f  Pedersen e t  a I
( 1979 )  i t  was 100% ( 0 / 6 )  w i t h  ICFA and 92% ( 1 / 1 3 )  w i t h  Al (OH)?3-
I t  shou l d  be n o t e d ,  h o w e v e r ,  t h a t  i n  Pe d e r s e n ' s  v a c c i n a t i o n  
e x p e r i m e n t s  t he  ca t s  were  v a c c i n a t e d  when 16 weeks o l d  and 
chal lenged when 2 0  weeks old by exposure to p e r s i s t e n t l y  v i r a e mi c  
c a r r i e r  cats.  Only 10/25 (40%) of the unvaccinated cont ro l  cats  
became v i r aemi c  f o l l o w i n g  chal l enge so i t  i s  d i f f i c u l t  to compare 
those  r e s u l t s  w i t h  t he  r e s u l t s  in the  p r e s e n t  s t ud y .  The l e v e l  
of p r o t e c t i o n  in the present  study was s i m i l a r  to tha t  achieved  
by Olsen et  a l ( ' i 9 8 0 a )  wh i ch  was more t han  80%. A second aim in  
t h i s  study was to compare the p r o t e c t i o n  achieved by F422 v i r u s  
and FeLV-A/Glasgow-1 v i ru s  from FEA c e l l s .
The F e L V- A / G l a s g o w - 1  v a c c i n e  was not  s u c c e s s f u l .  I t  had 
been e x p e c t ed  t h a t  the  gp70 a n t i g e n  i n  FeLV-A mi ght  be more 
immunogenic than the F422 v i r u s .  In t h i s  exper iment  an at tempt  
was made to equa l i se  the amount of  v i rus  in each pr e pa r a t i on  but  
since n e i t h e r  v i ru s  was p u r i f i e d ,  i t  was not poss i b l e  to measure 
the p r o t e i n  content  of  each v i r us  to ensure t h a t  each contained  
the same q u a n t i t y .  I t  was assumed, based on previous exper i ence ,  
t ha t  the F422 v i r u s  would contain about ten t imes the amount of  
v i r a l  p r o t e i n  o f  F e L V - A / G l a s g o w - 1 .  The r easons f o r  f a i l u r e  o f  
Fe L V - A / G l a s g o w - 1  as an immunogen mi ght  be due t o  a l oss  of  
ant igen dur ing concent r a t i on  or to a more d e l e t e r i o u s  e f f e c t  of  
p a r a f o r m a l d e h y d e  on t h e  v i r a l  a n t i g e n ,  compared to  F422 v i r u s .  
The v a c c i n e  made f rom FEA c u l t u r e  f l u i d  d i d  not  p r o t e c t  c a t s .
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T h i s  r e s u l t  i n d i c a t e d  t h a t  i t  i s  not  a n o n - s p e c i f i c  e f f e c t  of  
serum p r o t e i n s  or c e l l u l a r  a n t i g e n s  which p r o t e c t s  v a c c i n a t e d  
cats against  FeLV cha l l enge .
An a d d i t i o n a l  s t udy  i n  t h i s  e x p e r i m e n t  was t o  d e t e r m i n e  
w h e t h e r  or  not  ca t s  whi ch  had been v a c c i n a t e d  and r e s i s t e d  
chal lenge e l i m i n a t ed  the chal lenge v i rus  or whether the v i r us  was 
l a t e n t  i n  t h e i r  bone marrow c e l l s .  I t  was shown r e c e n t l y  t h a t  
cats recovered from na t u r a l  or exper i ment a l  FeLV exposure may be 
l a t e n t l y  i n f e c t e d  ( Post  and W a r r e n ,  1980 ;  Roj ko  e t  a I ,  198.2;  
Madewel l  and J a r r e t t ,  1983).  The cats vaccinated wi t h  the F422 
( X I )  v a c c i n e  were  t e s t e d  f o r  l a t e n t  v i r u s  and i t  was found t h a t  
of the f i v e  cats which r es i s t ed  cha l l enge ,  four  had bone marrow 
c e l l s  which r e l e a s e d  FeLV a f t e r  7 days i n  c u l t u r e .  T h i s  r e s u l t  
i nd i ca t es  t ha t  in most cats the chal lenge v i r us  was not prevented  
by vacc i na t i on  from reaching the bone marrow and s e t t i n g  up an 
i n f e c t i o n .  However,  since no v i r u s  was found in the blood of  the  
f i v e  cats which r e s i s t ed  cha l l enge ,  there was a rapid development  
of an immune response which prevented f u r t h e r  spread of  the Vi rus  
and r e s t r i c t e d  the v i r us  to  the l a t e n t  s t a t e  in the bone marrow.
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CHAPTER 9
ANTIGENICITY OF FeLV EXPOSED TO CHEMICAL INACTIVATING AGENTS
I n t r e d u c t i o n
I t  was c o n s i d e r e d  t h a t  i t  would  be u s e f u l  i n  f o r m u l a t i n g  
FeLV vaccines to have an in  v i t r o  method to t e s t  the a n t i g e n i c i t y  
o f  FeLV a n t i g e n s  wh i ch  had been t r e a t e d  w i t h  t he  c h e m i c a l  
i n a c t i v a t i n g  agents used to prepare vaccines in t h i s  study.  I t  
was b e l i e v e d  t h a t  t r e a t m e n t  o f  v i r u s  w i t h  a g e n t s  l i k e  
paraformaldehyde might  r e s u l t  in some loss of  a n t i g e n i c i t y  and 
t h a t  i t  would  not  be p o s s i b l e  f o r  reasons o f  t i m e  and cost  t o  
t e s t  t h i s  in c a t s  in o r d e r  t o  f i n d  an opt imum c o n c e n t r a t i o n  of  
the agent to use in vaccine pr epar a t i o n .  When t h i s  study 'began,  
the method which seemed most appropr i a t e  in t e s t i n g  a n t i g e n i c i t y  
was one which used v i r u s  n e u t r a l i s a t i o n  since the n e u t r a l i s a t i o n  
r eac t i on  i nvolves the ant igens which are, thought to be i mpor t ant  
i n  i m m u n i t y  t o  FeLV.  A t t e m p t s  w e r e  made t o  d e v e l o p  a 
n e u t r a l i s a t i o n  i n h i b i t i o n  t es t  in which chemi ca l l y  t r e a t e d  FeLV 
ant igen might  be used to i n h i b i t  t he  a n t i  g e n - a n t i  body r e a c t i o n  
measured by n e u t r a l i s a t i o n .  S i m i l a r  t e s t s  t o  q u a n t i t a t e  FeLV 
c e l l u l a r  ant igens were descr ibed p r ev i ous l y  (Russel l  and J a r r e t t ,  
1 9 7 8 a ) .  For reasons d i s c u s s e d  b e l o w ,  t h e  p r e s e n t  e x p e r i m e n t s  
were not successful .  However,  dur ing the course of  t h i s  study,  
s e v e r a l  mouse mon o c l o n a l  a n t i b o d i e s  became a v a i l a b l e  which  
n e u t r a l i s e d  FeLV. There f ore  they recognised FeLV epi topes which 
were i n v o l v e d  i n  n e u t r a l i s a t i o n .  These a n t i bod i es  were t es t ed  
and found to bind to FeLV in an enzyme- l inked immunosorbent assay 
(ELISA) and could,  t h e r e f o r e ,  be used to assess the a n t i g e n i c i t y
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of FeLV determinant s  r e l e v a n t  to v a c c i n a t i o n  a f t e r  exposur e  t o  
chemical  i n a c t i v a t i n g  agents.  This Chapter o u t l i n e s  a t t empt s  to  
s e t u p  a n e u t r a l i s a t i o n  i n h i b i t i o n  t e s t  and t he n  d e s c r i b e s  
e x p e r i m e n t s  us i ng  mouse a n t i b o d i e s  and an ELISA t o  t e s t  t he  
a n t i g e n i c i t y  of  FeLVs from F422 and FL74 c e l l s  which wer e  t rea ted  
w i t h  v a r y i n g  c o n c e n t r a t i o n s  of  paraf ormaldehyde,  f ormaldehyde,  
AEI and b e t a - p r o p r i o l a c t o n e  CBPL).
M a t e r i a l s  and Methods
N e u t r a l i s a t i o n  I n h i b i t i o n
Thr ee  FeLV a n t i g e n s  were used in an a t t e m p t  t o  i n h i b i t  
n e u t r a l i s a t i o n  of  MSV (FeLV-A): F422 c e l l s ,  F422 c u l t u r e  • f l u i d ,
and combined c e l l s  and f l u i d .  These were p r e p a r e d  by s e e d i n g  
F422 c e l l s  a t  a d e n s i t y  of  1.2 X 1 0 *^/ml i n  30 ml L-M medium 
conta i n i ng 15% FCS in 75 cm^ p l a s t i c  f l asks  (Nunc) and har ves t i ng  
t h e s e  c e l l s  48 hours  l a t e r .  The c u l t u r e  f l u i d  was spun a t  1000  
rpm f or  15 minutes and the c e l l s  were resuspended in L-15 medium,  
spun again and resuspended in L - 1 5 medium wi t h  10% FCS at  a c e l l s  
concent ra t i on  of  5 X 10^/ml .
The ant igens were d i l u t e d  wi th  L-15 medium cont a i n i ng  10% 
FCS t o  g i v e  d i l u t i o n s  o f  4 ,  3 ,  1 6 ,  32 ,  64 and 128 i n  9 6 - w e l l  U-  
bo t t omed p l a s t i c  p l a t e s .  To a l l  d i l u t i o n s  an e q u a l  vo l ume (25 
ul )  of  cat  FeLV immune serum d i l u t e d  1:4 in L-15 medium w i t h  10% 
FCS was added.  The c o n t r o l s  c o n s i s t e d  o f  25 u l  of  d i l u e n t  w i t h  
25 u l  of  serum as the serum cont r o l  and 50 u l  of  d i l uent / ,  as the  
v i r u s  c o n t r o l .  The p l a t e  was i n c u b a t e d  at  3 7 °  f o r  2 hours  t o  
a l l ow any a n t i gen- ant i body  r e ac t i on  to take place and then 50 ul  
of MSV (FeLV-A) d i l u t e d  in L-15 medium wi th  10% FCS to give  20-730
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foc i  in the t e s t  was added to each we l l .  The p l a t e s  were shaken,  
i n c u b a t e d  at  3 7 °  f o r  1 hour  and t hen 25 u l  of  each r e a c t i o n  was 
i n o c u l a t e d  i n t o  one w e l l  o f  a 2 4 - w e l l  p l a s t i c  p l a t e  whi ch  had 
been seeded 24 hours in advance wi th  FeLV- B- i n f ect ed  FEA c e l l s .  
The r e m a i n d e r  of  t h e  t e s t  was c a r r i e d  out  as d e s c r i b e d  f o r  t h e  
n e u t r a l i s a t i o n  t e s t  in C h a p t e r  1. The same e x p e r i m e n t  was 
r e p e a t e d  u s i n g  t h e  same p r o c e d u r e  e xcep t  t h a t  i n s t e a d  o f  
i ncubat ion of the an t i g e n - a n t i b o d y  r eac t i on  at 37°  f o r  2 hours,  
t h i s  reac t i on  was incubated at  4°  f o r  16 hours.
ELISA i n h i b i t i o n
1.  Pr epar a t i on  of  v i r us
The c o n c e n t r a t e d  and p u r i f i e d  FeLV used in t h i s  t e s t  were  
Fe LV - A / F 4 2 2  and FeLV-ABC/ FL74 which were p r e p a r e d  as f o l l o w s .  
One l i t r e  of  FL74 c e l l  c u l t u r e  f l u i d  was prepared by seeding FL74 
c e l l s  a t  1.2 X 1 0 ^ / m l  i n  L-M medium and h a r v e s t i n g  48 hours  
l a t e r .  The f l u i d  was c e n t r i f u g e d  at 7,000 rpm f o r  30 minutes and 
t h e  s u p e r n a t a n t  was f r o z e n  a t  - 7 0 ^ .  I t  was t h a w e d  and  
concent rated in an Amicon CH4 hol low f i b r e  concent ra t or  at  4 °  t o  
100 ml which was then spun at  20,000 rpm f o r  2 hours in the SW27 
R o t o r .  The s u p e r n a t e n t  f l u i d  was d i s c a r d e d  w h i l e  the  v i r u s  
p e l l e t  was resuspended i n  30 ml o f  PBS. T h i s  sus p e n s i on  was 
c e n t r i f u g e d  i n  3 p o t a s s i u m  t a r t r a t e  grad i ent s  (1.08-1.23 g.cm"’^) 
in the SW41 Rotor at  40,000 rpm f o r  1 hour.  The v i ru s  bands were 
recovered,  combined and d i l u t e d  to 10 ml in PBS and spun again in  
t h e  SW5Ü.1 r o t o r  a t  3 0 , 0 0 0  rpm f o r  2 hours .  The p e l l e t e d  v i r u s  
was r esuspended in 2 ml of  0 . 15 M NaCl  and s t o r e d  a t  4 °  b e f o r e  
use.  The f i n a l  c o n c e n t r a t i o n  o f  t h i s  v i r u s  was a p p r o x i m a t e l y
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5 0 0 - f o l d .
The FeLV/ F422  v i r u s  was c o n c e n t r a t e d  and p u r i f i e d  in t he  
same way»
2.  ELISA t e s t
The coat ing b u f f e r  was 0 .05  M Na^CO^: NaHCO^, pH 9 . 6  
The c o m p o s i t i o n  of  s o l u t i o n s  A, 3 ,  C and 0 was as shown i n  
Table 9 . 1 ,
A Hybr i doma S c r e e n i n g  K i t  was p ur chased  f rom Bethesda  
Research Labor a t or i es  Ltd.  which contained sheep ant i -mouse IgG
CFab' )^ c o n j u g a t e d  w i t h  B - g a l a c t o s i d a s e  (Hybr i doma S c r e e n i n g  
Reagent ) ,  and p - n i t r o p h e n o l - B - D - ga l a c t o s i d e  as a s u b s t r a t e .
3.  Ant ibodies
Two ant i bodi es  were used.
a.  Mouse monoclonal  ant ibody to FeLV-A
A monoclonal  ant ibody which n e u t r a l i se d  MSV (FeLV-A/Glasgow-  
1) (0.  J a r r e t t ,  p e r s o n a l  c o m m u ni ca t i o n )  was o b t a i n e d  f r om C.K. 
G r a n t ,  H a r v a r d  School  of  P u b l i c  H e a l t h ,  Bo s t o n ,  U.S.A. T h i s  
ant ibody is designated I9B4
b.  Mouse monoclonal  ant ibody to FeLV-B and FeLV-C
A monoclonal  ant ibody which n e u t r a l i s e d  MSV (FeLV-B/Sarma)  
and MSV (FeLV-C/Sarma) (0. J a r r e t t ,  personal  communicat ion)  was 
o b t a i n e d  f r o m H, L u t z ,  V e t e r i n a r y  S c h o o l ,  Z u r i c h ,  S w i t z e r l a n d .  
This ant ibody is designated B9B12. The ant ibody recognises the 
major an t i g e n i c  de t e r mi nant  of  the v i r us  produced by FL74 c e l l s  
d e s c r i b e d  by R u s s e l l  a nd  J a r r e t t  ( 1 9 7 8 a ) .  F u r t h e r  
c h a r a c t e r i s t i c s  of  t h i s  ant ibody have been descr ibed by Vedbrat
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TABLE 9.1
Solu t ions  used in ELISA t e s t
So l u t i on  A 0.01 M PBS, pH 7 , 2
1 . 5  mM MgCL
2 . 0  mM 2-mercaptoethanol  
0.05% Tween 20
S o l u t i on  B 0.01 M PBS, pH 7 . 2
1 . 5  mM MgC^
2 . 0  mM 2-mercaptoethanol
So l ut i on  C 50 mM NagPO^ b u f f e r ,  pH 7 . 2
1 . 5  mM MgCl 2
Sol u t i on  D 0 . 5  M NaCO^
2 1  i l  <1933) .
4 .  Optimum condi t i ons  f o r  the ELISA t es t
The f i r s t  procedure was to e s t a b l i s h  the optimum d i l u t i o n s  
of  both ant igen and ant ibody.  Doubl ing d i l u t i o n s  of  ant igen from 
1: 10  t o  1 : 6 4 0  were  made i n  c o a t i n g  b u f f e r .  A vo l ume of  50 u l  o f  
each d i l u t i o n  was placed in each of  the seven h o r i z o n t a l  Wel ls  of  
a 9 6 - w e l l  Linbro enzyme immunoassay (ETA) p l a t e .  A volume of  50 
u l  of  c o a t i n g  b u f f e r  was put  i n t o  each Of t he  Last  s i x  w e l l s  of  
t he  top h o r i z o n t a l  row as an a n t i g e n  c o n t r o l .  The p l a t e  was 
incubated overn ight  at  4° .
Twent y  f o u r  hours l a t e r  t he  p l a t e  was washed 4 t i m e s  w i t h  
s o l u t i o n  A and 50 u l  o f  f o u r - f o l d  d i l u t i o n s  of  a n t i b o d y  was 
dispensed i n t o  the v e r t i c a l  we l l s  s t a r t i n g  from the second row at  
the l e f t  s ide.  These d i l u t i o n s  were from 1:20 t o  1:1280 made by 
using s o l u t i o n  A as d i l u e n t -  A volume of  50 ul  of  so l u t i o n  A was 
dispensed in each w e l l  of  t he  f i r s t  v e r t i c a l  row as an ant ibody  
c o n t r o l .  The p l a t e  was then  i n c u b a t e d  at  room t e m p e r a t u r e  f o r  
one hour to  a l low b inding of  ant ibody to an t i gen .
The p l a t e  was washed 4 t imes wi th s o l u t i on  A and 50 u l  Of a 
1:200 d i l u t i o n  of  Hybridoma Screening Reagent was dispensed i n t o  
a l l  the we l l s .  The p l a t e  was incubated at room temperature  wi th  
constant  shaking f o r  2 hours.  The p l a t e  was then washed 4 t imes  
wi t h  s o l u t i o n  A and 50 u l  p - n i t r op h e n y I ,  prepared in s o l u t i o n  C 
a t  a f i n a l  c o n c e n t r a t i o n  o f  1 m g / m l  and 100  u l  o f  2 -  
mercaptoethanol ,  was added to a l l  the we l l s .  The p l a t e  was again  
incubated at  room t empera t ur e  f o r  one hour w i t h  constant  shaking.  
F i n a l l y  50 u l  of  s o l u t i o n  D was added t o  a l l  t he  w e l l s  t o  s t op
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t he  r e a c t i o n  and the o p t i c a l  d e n s i t y  COD) o f  each w e l l  was read  
in a n icro-ELISA Autoreader  MR580 (Dynatech) at a wavelength of  
410 nm. The optimum d i l u t i o n s  of  ant igen and ant ibody were taken  
as those which produced an o p t i c a l  densi ty  of approx i mat e l y  0 . 4 -  
1.0.
5.  I n a c t i v a t i n g  agents
The c h e m i c a l s  used were PF,  f o r m a l d e h y d e  (BDH) ,  AEI and 
be t a - p r o p i o l a c t o n e  (BPL) ( S i g ma ) .
6 .  The exposure of  ant i gen  to chemical  i n a c t i v a t i n g  agents
The second p r o c e d u r e  was to e s t a b l i s h  t he  e f f e c t s  o f  
c h e m i c a l  i n a c t i v a t i n g  agent s  on t he  c a p a c i t y  o f  i m m o b i l i s e d  
a n t i g e n  t o  b i n d  a n t i b o d y .  The s t eps  of  t h i s  p r o c e d u r e  wer e  as 
f o l  lows.
A volume of 50 ul  of  coat ing b u f f e r  cont a i n i ng  the optimum 
a n t i g e n  d i l u t i o n  e s t a b l i s h e d  as above was d i s p e n s e d  i n  a l l  9 6 -  
welLs of  an EIA p l a t e ,  except  in the top l e f t  hand w e l l  in which 
50 ul  of  coat ing b u f f e r  was dispensed as a blank.  The p l a t e  was 
i n c u b a t e d  o v e r n i g h t  a t  4 ° .  The w e l l s  were t h en  washed 4 t i m e s  
w i t h  s o l u t i o n  A and t he  c h e m i c a l  i n a c t i v a t i n g  a g e n t s  were  
d i s p e n s e d .  E l ev e n  d o u b l i n g  d i l u t i o n s  in PBS s t a r t i n g  w i t h  2% 
were made and dispensed in the h o r i z o n t a l  w e l l s .  The l e f t  hand 
w e l l s  of  each row were kept  as a n t i b o d y  c o n t r o l s .  I n  one p l a t e  
h o r i z o n t a l  rows 1-4 contained d i l u t i o n s  of  one chemical  and rows 
5-8 contained d i l u t i o n s  of  a second. The p l a t e s  were incubated  
at  room temperat ure .
A f t e r  24 hours the p l a t es  were washed ID t imes wi t h  s o l u t i o n  
A t o remove any t r a c e s  of  t he  c h e m i c a l s  and t h e n  50 u l  o f  t h e
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opt imum d i l u t i o n  of  the a p p r o p r i a t e  mo n oc l o na l  a n t i b o d y  in  
so l u t i o n  A was added to a l l  the we l l s  in h o r i z o n t a l  rows 1,  2,  5 
and 6 wh i l e  50 ul  of  s o l u t i o n  A was added to the w e l l s  in rows 3,  
4,  7 and 8 as an a n t i g e n  c o n t r o l .  The p l a t e s  were i n c u b a t e d  at  
room t e m p e r a t u r e  f o r  1 hour  and were then washed 4 t i m e s  w i t h  
s o l u t i o n  A-
The remainder  of the t e s t  was then c a r r i e d  out as descr ibed  
above.
Resul ts
N e u t r a l i s a t i o n  i n h i b i t i o n  t es t
R e s u l t s  of  a c h a r a c t e r i s t i c  n e u t r a l i s a t i o n  i n h i b i t i o n  t e s t  
a r e  shown i n  T a b l e  9 .2 .  I n  t h i s  i n i t i a l  e x p e r i m e n t  l i v e  F422 
c e l l s  a n d / o r  v i r u s  were used as i t  was e x p e c t ed  t h a t  u n t r e a t e d  
a n t i g e n  w o u l d  be most  l i k e l y  t o  p r o d u c e  i n h i b i t i o n  o f  
n e u t r a l i s a t i o n  by b i n d i n g  t o  a n t i b o d y .  I t  i s  c l e a r ,  h o w e v e r ,  
f r om t h e  r e s u l t s  i n  T a b l e  9.2 t h a t  v e r y  l i t t l e  i n h i b i t i o n  
occurred and then only in the r eac t i on  using F422 c e l l s .  Because 
t here  appeared to be no e f f e c t  wi t h  unconcent rated F422 cu l t u r e  
f l u i d ,  which was the source of  vaccine in these s t ud i e s ,  the t e s t  
was not considered to be use f u l .
ELISA i n h i b i t i o n
E f f ec t  of  i n a c t i v a t i n g  agents on FeLV-A/F422
The r e s u l t s  a r e  shown in  T a b l e s  9.3 -  9 , 6 .  Each r e a c t i o n  
was done in d u p l i c a t e  and the mean of the o p t i c a l  dens i t y  at 410 
nm was c a l c u l a t e d .  The mean of  each of  t h e  c o n t r o l  r e a c t i o n s
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TABLE 9 .2
N e u t r a l i s a t i o n  i n h i b i t i o n  t e s t
Condi t ions of  Ant igen  
incubat ion
3 7 0  f o r  
H hours
F422 c e l l s  
F422 f l u i d  
F422 c e l l s  
and f l u i d
Foci  at  these d i l u t i o n s :
4 8 16 32 64 128
20 15 11 7 6 5
11 13 13 13 11 9
14 15 14 8 10
4°  f o r  
16 hours
F422 c e l l s  
F422 f l u i d  
F422 c e l l s  
and f l u i d
12 12 14 14 8 11
12 14 16 16 8 13
14 15 11 15 13 13
a.  I n  E x p e r i m e n t  1 t h e  no.  o f  f o c i  i n  t h e  v i r u s  c o n t r o l  w e l l s
were 36,  37 and 38 (mean 37) and in the serum cont r o l  w e l l s ,
9 ,  10 and 11 (mean 1 0 ) .
I n  E x p e r i m e n t  2 t h e  no.  o f  f o c i  i n  t h e  v i r u s  c o n t r o l  w e l l s
were 33,  35 and 37 (mean 35) and in the serum co n t r o l  weLl s ,
1 2 ,  12 and 12 (mean 1 2 ) .
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( w i t h o u t  a n t i b o d y )  was s u b t r a c t e d  f r o m  t h e  mean o f  t h e  
c o r r e s p o n d i n g  t e s t  r e a c t i o n s  and the d i f f e r e n c e  was then  
expressed as a percentage of the value f o r  the u n t r ea t ed  cont ro l  
(no i n a c t i v a t i n g  a g e n t ) .  As shown in t he  T a b l e s ,  t h e  v a r i a t i o n  
be t we e n  d u p l i c a t e s  was r e l a t i v e l y  s m a l l  and t h e r e  was l i t t l e  
d i f f e r e n c e  be t ween t he  v a l u e s  among a l l  of  t he  a n t i g e n - f r e e  
cont ro ls  i n d i c a t i n g  t ha t  the i n a c t i v a t i n g  agent  d id not produce 
no n - s p e c i f i c  b inding of ant ibody to the w e l l s .
As shown i n  T a b l e  9 . 3 ,  h i gh  c o n c e n t r a t i o n s  o f  PF i n h i b i t e d  
t he  b i n d i n g  of  a n t i b o d y  t o  the  a n t i g e n - c o a t e d  w e l l s .  At a 
c o n c e n t r a t i o n  o f  2% t h e  b i n d i n g  was o n l y  23% o f  t he  u n t r e a t e d  
c o n t r o l -  As t he  c o n c e n t r a t i o n  o f  PF d e c r e a s e d ,  t h e  e x t e n t  of  
binding increased s t e a d i l y  u n t i l  a t  concent ra t i ons  of  0.003% and
0.001% t he  b i n d i n g  was s l i g h t l y  g r e a t e r  t han  i n  t he  c o n t r o l s  
(113% and 110% r e s p e c t i v e l y ) ,
A s i m i l a r  r es u l t  was obtained wi th  formaldehyde as shown in 
T a b l e  9 .4 .  I n  t h i s  ca s e ,  t h e  i n h i b i t i o n  o f  b i n d i n g  a t  2% 
formaldehyde was less than wi th  PF (57% as aga i nst  23%). A l eve l  
o f  b i n d i n g  e q u a l  t o  t h a t  i n  t he  u n t r e a t e d  c o n t r o l  was found at  
formaldehyde concent rat ions between 0.03 and 0.015% and the peak 
binding of  145% of  the cont ro l  was again at  0.003%.
The r e s u l t s  u s i ng  AEI  and BPL are shown i n  T a b l e s  9.5 and 
9.6,  The p a t t e r n  observed wi t h  these agents was q u i t e  d i f f e r e n t  
f rom that  using PF or formaldehyde.  The range of  d i f f e r e n c e s  in 
binding of  ant ibody between c o n c e n t r a t i o n s  o f  t h e s e  a g e n t s  was 
n ot  so m a r k e d  as w i t h  PF o r  f o r m a l d e h y d e ,  r a n g i n g  f r o m  
approx i mate l y  60% t o  106% of  the l eve l  of  the un t r ea t ed  c ont r o l .
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High c o n c e n t r a t i o n s  d i d  not  i n h i b i t  b i n d i n g  as w i t h  PF or  
forma Ldehyde.
E f f e c t  of  i n a c t i v a t i n g  agents on FeLV-ABC/FL74
S i m i l a r  exper iments to those descr ibed above f o r  F422 v i r us  
were done u s i n g  p u r i f i e d  FL74 v i r u s  and a mono c l ona l  a n t i b o d y  
whi ch  n e u t r a l i s e d  t h a t  v i r u s .  The r e s u l t s  are  shown i n  T a b l e s  
9 . 7  -  9 . 1 0 .
Using PF i t  i s  seen f rom T a b l e  9.7 t h a t ,  as i n  t he  p r e v i o u s  
e x p e r i m e n t  u s i n g  F422 v i r u s ,  t he  b i n d i n g  o f  a n t i b o d y  to  t h e  
a n t i g e n  was s e v e r e l y  i n h i b i t e d  at  high c o n c e n t r a t i o n s .  At 2% 
c o n c e n t r a t i o n ,  b i n d i n g  was o n l y  10% of  t h e  c o n t r o l .  As t h e  PF 
was d i l u t e d ,  the  b i n d i n g  i n c r e a s e d  u n t i l  t he  c o n t r o l  l e v e l  was 
reached a t  0.06%. The peak o f  b i n d i n g  was a t  0.03% at  whi ch  
concent rat ion binding was 133% of the c o n t r o l ,  and wi t h  f u r t h e r  
d i l u t i o n  the l e v e l  of  b inding f e l l  o f f .
The e f f e c t  of formaldehyde is shown in Table 9.8.  As in the
previous exper iment  wi t h  F422 v i r u s ,  the r e s u l t  was very s i m i l a r  
to t hat  obta ined wi t h  PF. Also the damaging e f f e c t  on the v i rus  
appeared  t o  be l e s s  t han w i t h  PF. A peak of  b i n d i n g  at  165% of  
t he  c o n t r o l  was found at  0.015% and,  as w i t h  PF,  the l e v e l  of  
b i n d i n g  f e l l  o f f  t o  106% at  a f o r m a l d e h y d e  c o n c e n t r a t i o n  of  
0 .001%.
The r e s u l t s  wi th AEI and BPL were again qu i t e  d i f f e r e n t  from 
t hose  o b t a i n e d  w i t h  PF or  f o r m a l d e h y d e .  T he r e  was l i t t l e  
v a r i a t i o n  in the extent  of  b inding at a l l  concent ra t ions .  With 
A E I ,  the l e v e l  was b e t w e e n  98% and 135% o f  t h e  c o n t r o l  and w i t h
BPL was b e t ween  72% and 92% of  the  c o n t r o l .  Ther e  was no
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d i s t i n c t  peak as wi t h  PF and formaldehyde,
DISCUSSION
This chapter  descr ibes exper iments to assess the e f f e c t s  of  
four  chemical  i n a c t i v a t i n g  agents on the FeLV ant i gen  i nvolved in 
n e u t r a l i s a t i o n .  I t  was hoped t h a t  an assay c ou l d  be d e v e l o p e d  
which might determine the concent rat ions of  an i n a c t i v a t i n g  agent  
which would be l eas t  damaging t o  the ant igen.  These exper iments  
were i n i t i a t e d  w i t h  a n e u t r a l i s a t i o n  i n h i b i t i o n  t e s t  i n  which  
F422 c e l l s  and i t s  re leased FeLV-A were used but  the exper iment  
was not successful ,  because i t  became obvious t ha t  l arge amounts 
o f  a n t i g ' e n  w o u l d  be r e q u i r e d  i n  o r d e r  t o  i n h i b i t  t h e  
n e u t r a l i s a t i o n  r e a c t i o n .  T h i s  t e s t  was n o t  c o n s i d e r e d  
t e c h n i c a l l y  f e a s i b l e  wi t hout  concent ra t ion of  v i r u s  and was not  
t h e r e f o r e  not cont inued.
Another oppor t un i ty  to car ry  out t h i s  study occurred l a t e r  
when mo n oc l o na l  a n t i b o d i e s  whi ch n e u t r a l i s e d  FeLV became  
a v a i l a b l e  d u r i n g  t h e  course of  t h i s  work .  I n  t h e  second and 
t h i r d  e x p e r i m e n t s ,  t h e s e  were  used w i t h  F e L V - A / F 4 2 2  and FeLV-  
ABC/FL74. These ant i bodi es  were obviously  d i r e c t e d  against  the  
ant igens which were i nvolved in n e u t r a l i s a t i o n  r eac t i ons  to the  
v i r u s  and which were p r e s u ma b l y  a l s o  i n v o l v e d  in i m m u n i t y .  
Assays were developed using t h e  ELISA t e c h n i q u e  whi ch asses sed  
a n t i g e n i c i t y  by me a s u r i ng  t he  b i n d i n g  of  t h e  a n t i b o d i e s  t o  t h e  
i m m o b i l i s e d ,  c h e m i c a l l y - t r e a t e d  a n t i g e n s .  T h i s  t e s t  was 
successful  and i n t e r e s t i n g  r e s u l t s  were obtained which i nd i ca t ed  
t h a t  the e f f e c t  of PF and formaldehyde were q u i t e  d i f f e r e n t  from
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t he  e f f e c t s  of  AEI  and BPL and t h a t  a t  some c o n c e n t r a t i o n s ,  PF 
and formaldehyde enhanced the binding of ant ibody to ant igen.
In exper iments wi t h  F422 or FL74 v i r u s ,  ant igen t reated:  wi t h  
PF o r  f o r m a l d e h y d e ,  t h e r e  was r e d u c e d  b i n d i n g  a t  h i g h  
c o n c e n t r a t i o n  o f  t h e  i n a c t i v a t i n g  a ge n t .  T h i s  r e d u c t i o n  was 
a t t r i b u t e d  to the damaging e f f e c t s  of  the i n a c t i v a n t s .  A s i m i l a r  
e f f e c t  was observed p r e v i o u s l y  when o n e - h a l f  of  the a n t i g e n i c i t y  
of the g l ycopr o t e i n  of  bovine leukaemia v i r us  was lost  f o l l o w i n g  
t r ea t ment  w i t h  0.05% formaldehyde wh i l e  t rea t ment  w i t h  AEI had no 
e f f e c t  ( M i l l e r  and van d e r M a a t en,  1 9 7 8 ) ,  The e f f e c t  of  PF and 
f o r m a l d e h y d e  i s  p r o b a b l y  due t o  c r o s s - l i n k i n g  o f  a d j a c e n t  
gl ycoprot e i ns  and de s t r u c t i o n  of  the ant ibody b i nding s i t e s .  In  
t h i s  s t udy  i t  i s  assumed t h a t  i n h i b i t i o n  i s  caused by a d i r e c t  
e f f e c t  of  the agent  on t he  a n t i g e n  bound to  t h e  p l a s t i c ;  An 
a l t e r n a t i v e  exp l ana t i o n  is  t h a t  the PF or  formaldehyde removed 
the ant igen from the p l a s t i c ,  so tha t  t here  was a reduced amount 
o f  a n t i g e n  l e f t  f o r  b i n d i n g  t o  t he  a n t i b o d y .  W h i l e  i t  i s  riot  
p o s s i b l e  t o  e l i m i n a t e  or  c o n t r o l  f o r  t h i s  p o s s i b i l i t y ,  i t  i s  
c o n s i d e r e d  u n l i k e l y .  I n d e e d ,  i t  i s  more l i k e l y  t h a t  t h e s e  
f i x a t i v e s  would bind the ant igen more c l o s e l y  to the p l a s t i c -
Wi th d i l u t i o n  of  PF or formaldehyde,  t here  was a reduct ion  
i n  i n h i b i t i o n  u n t i l  a l e v e l  of  b i n d i n g  was obs e r v e d  which was 
gr ea t e r  than t ha t  of  the un t r ea t ed  ant igen.  The concent ra t i on  of  
PF which gave b i n d i n g  eq u a l  t o  t h e  c o n t r o l  was 0 . 007 - 0 . 0 03% f o r  
F422 v i r u s  and 0,06-0.03% f o r  FL74 v i r u s .  For formaldehyde these  
c o n c e n t r a t i o n s  were 0 . 0 3 - 0 . 0 1 5 % f o r  F422 v i r u s  and 0 .125-0^06%  
f o r  FL74 v i r u s .  Hence,  f o r m a l d e h y d e  was l e s s  i n h i b i t i n g  t han  
paraformaldehyde at  the same concent ra t i ons .
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With f u r t h e r  d i l u t i o n ,  enhancement of ant ibody binding was 
seen w i t h  both PF and f o r m a l d e h y d e .  The c o n c e n t r a t i o n s  which  
produced g r e a t e s t  b i n d i n g  were s l i g h t l y  d i f f e r e n t  f o r  PF and 
formaldehyde,  and f o r  F422 v i r u s  and FL74 v i r u s .  I n  the case of  
FL74 v i r u s  t h e r e  was a v e r y  marked peak o f  b i n d i n g  a t  0.03% PF 
and 0.015% of  f o r m a l d e h y d e .  The reasons f o r  enhancement  are  
u n c l e a r -  Th er e  may be c r o s s - l i n k i n g  w i t h i n  t h e  g l y c o p r o t e i n  
which preserves the a n t i g en i c  determinant  from degradat ion as is  
seen wi t h  some s t r a i n s  of  foot -and-mouth disease v i r u s  (Rowlands 
et  a l ,  1972) .
Ther e  was v e r y  l i t t l e  damaging e f f e c t  o f  AEI  or  BPL on t he  
a n t i g e n i c i t y o f  e i t h e r  F422 or FL74 v i r u s .  However ,  n e i t h e r  was 
t here  a c l ea r  enhancing e f f e c t  of these agents.  This d i f f e r e n c e  
may be due t o  t he  d i f f e r e n t  mode o f  a c t i o n  o f  AEI  and BPL 
compared t o  the  a l d e h y d e s .  These are  more r e a c t i v e  w i t h  v i r u s  
nuc l e i c  acid than w i t h  v i r a l  p r o t e i n s  (Wi ld  and Brown,  T968) and 
might not be expected to damage ant ibody b i nding s i t e s .
The relevance of these r e s u l t s  to vaccine product ion is t hat  
t hey  may g i v e  an i n d i c a t i o n  of  t he  a n t i g e n i c i t y  o f  v i r u s  
f o l l o w i n g  chemical  i n a c t i v a t i o n .  The r e s u l t s  may t h e r e f o r e  act  
as a gu i de  in t he  cho i ce  of  t he  c o n c e n t r a t i o n  of  i n a c t i v a t i n g  
agent  t h a t  shou l d  be used ,  assuming t h a t  t h i s  c o n c e n t r a t i o n  
i n a c t i v a t e s  t he  v i r u s .  I t  shou l d  be remember e d ,  h o w e v e r ,  t h a t  
the ant i bodi es  which were used were mouse monoclonal  an t i bod i es  
and the r eac t i on  of these an t i bod i es  wi th  FeLV might  be d i f f e r e n t  
f r om t h a t  o f  ca t  a n t i b o d i e s ,  a l t h o u g h  bot h o f  t he  mouse 
ant i bodi es  n e u t r a l i s e d  FeLV. A second point  is t h a t  a n t i g e n i c i t y
:3„
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is not ne c e s s a r i l y  the same as immunogenici ty  and wi thout  t e s t i n g  
t h e  r e s p o n s e  o f  a n i m a l s  t o  v i r u s  t r e a t e d  w i t h  d i f f e r e n t  
concent rat ions of  each i n a c t i v a t i n g  agent i t  i s not poss i b l e  to  
answer t h i s  quest ion.  I t  would be usefu l  to study t h i s  quest ion  
in f u t u r e .  I t  i s  i n t e r e s t i n g ,  however,  t ha t  the concent ra t i on  of  
PF which was used in the successful  vaccine exper iments (0;02%) 
was s i m i l a r  to t h a t  which caused l east  damage to the FeLV ant igen  
in the ELISA i n h i b i t i o n  t e s t ,  and in some cases gave an increase  
in a n t i g e n i c i t y .
I l l
CHAPTER 10
PERSISTENCE OF FeLV NEUTRALISING ANTIBODIES IN CATS
I n t r o d u c t i o n
Once a v a c c i n e  i s  produced  which p r o t e c t s  a g a i n s t  v i r u s  
c h a l l e n g e  f o l l o w i n g  a p r i m a r y  course of  v a c c i n a t i o n  i t  i s  
d e s i r a b l e  to determine how long immuni ty l as t s  a f t e r  va c c i n a t i o n  
in o r d e r  t o  know i f  and when a b o o s t e r  dose of  v a c c i n e  mi gh t  be 
r e q u i r e d .  I t  was t h e  i n t e n t i o n  i n  t h i s  s t udy  t o  c a r r y  out  Such 
an i n v e s t i g a t i o n .  As a compa r i s on  t o  a r t i f i c i a l l y  produced  
immuni ty i t  was a lso considered va l uab l e  to a t t empt  to f i n d  How 
Long immuni ty l ast ed f o l l o w i n g  recovery from n a t u r a l  exposure to 
FeLV.  I n  t h e  even t  i t  was not  p o s s i b l e  f o r  r easons  of  t i m e  t o  
complete the f i r s t  par t  of  the proposed study but the second par t  
was begun.
I t  was c o n s i d e r e d  t h a t  t he  p r esen ce  o f  v i r u s  n e u t r a l i s i n g  
ant i bodi es  in the serum was a good i n d i c a t o r  of  the immune s t a t us  
of cats to FeLV since i t  has been shown t ha t  maternal  an t i bod i es  
p r o t e c t  a g a i n s t  FeLV c h a l l e n g e  ( Hoover  e t  a l , 1977^^ J a r r e t t  e t  
a I ,  1977)  and t h a t  c a t s  which have n e u t r a l i s i n g  a n t i b o d i e s  
f o l l o w i n g  recovery from n a t u r a l  or exper i ment a l  i n f e c t i o n  and are  
then housed t oge t her  wi th  v i r a e mi c  cats do not become v i r aemi c  
( J a r r e t t  e t  a l ,  1982 a.  H o we v e r ,  t h e r e  i s  v e r y  l i t t l e ,  e x i s t i n g  
i n f o r m a t i o n  about  t he  p e r s i s t e n c e  of  a n t i b o d i e s  t o  FeLV. Both 
Hoover  e_l 21. d 9 7 7 a ) a n d  J a r r e t t  ± 1  ( 1977 )  s t u d i e d  m a t e r n a l  
ant i bodi es  in k i t t e n s  of  FeLV-immune queens and showed tha t  the  
h a l f - l i f e  of  v i r us  n e u t r a l i s i n g  an t i bodi es  was approx i mate l y  14 
days.  There  i s ,  h o w e v e r ,  no p u b l i s h e d  d a t a  on p e r s i s t e n c e  of
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ant i bodi es  a f t e r  n a t u r a l  i n f e c t i o n  in the absence of  cont inuing  
exposure to v i r u s - e x c r e t i n g  cats.
The plan of  the present  exper iment  was to expose a group o f  
1 6 - we e k  o l d  c a t s  t o  n a t u r a l  c h a l l e n g e  w i t h  FeLV and t o  o b ser ve  
t h e i r  r espo nse .  I t  was e x p e c t e d  t h a t  most of  t he  c a t s  would  
recover  f rom the i n f e c t i o n  and d ev e l o p  n e u t r a l i s i n g  a n t i b o d i e s  
(Hoover  e t  a I ,  1976;  Peder sen  e t  a l ,  1 9 7 9 ) ,  When t he  p a t t e r n  
became e s t a b l i s h e d ,  h a l f  o f  t h e  r e c o v e r e d  c a t s  woul d  be housed  
wi t h  any cats which developed p e r s i s t e n t  v i r aemi a  and h a l f  would 
be housed s e p a r a t e l y .  The c a t s  woul d  t hen  be sampl ed  a t  
i n t e r v a l s  t o  m e a s u r e  t h e i r  l e v e l s  o f  v i r u s  n e u t r a l i s i n g  
a n t i b o d i e s  and t h e  i n f l u e n c e  of  t he  p r e s e n c e  or  absence of  
constant  exposure to FeLV on the pers i s t ence  of  an t i bod i es  would 
be d e t e r m i n e d .  D u r i n g  t h e  course o f  t he  e x p e r i m e n t  t he  
phenomenon of FeLV l a tency  was discovered (Post and Warren,  1980;  
Rojko et a I ,  1982) and L a t e n t l y  i n f e c t e d  cats were subsequent ly  
found i n  the c a t s  in t he  p r e s e n t  e x p e r i m e n t  by M a d e w e l I  and 
J a r r e t t  ( 1 9 8 3 ) .
M a t e r i a l s  and Methods
Four ,  3 - we e k  o l d  c a t s  were  i n f e c t e d  by i n t r a p e r i t  one a I 
i n o c u l a t i o n  of  1 ml FeLV c o n t a i n i n g  1.8 X 10^ p i g .  These ca t s  
became p e r s i s t e n t l y  v i ra e mi c  and when 6 months old were used as 
donors.  The cats were mixed wi t h  19,  16 week-dld k i t t e n s  Which 
were f r e e  of  FeLV and v i r us  n e u t r a l i s i n g  ant i bod i es .  A l l  of  t he  
23 cats were housed in a room wi t h  a f l o o r  area o f  ID m^. The 19 
r e c i p i e n t  c a t s  were  sampl ed  a t  4 ,  16 ,  2 0 ,  2 2 ,  2 7 ,  3 5 ,  6 0 ,  70 and
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88 weeks a f t e r  exposure to the v i r a e mi c  cats and were tested,  f o r  
v i raemi a  and v i r us  n e u t r a l i s i n g  ant i bod i es-  Femoral  bone marrow 
biopsies  were taken at  20,  35,  60 and 88 weeks by 8.R. Madewel l  
or 0. J a r r e t t  and cu l t u r e s  were set  up as descr ibed in Chapter 8. 
The c u l t u r e  f l u i d s  were t e s t e d  f o r  i n f e c t i o u s  FeLV. At 20 and 35 
weeks a f t e r  mix ing,  these cats were t es t ed  f o r  v i r a e mi a  and f o r  
the presence of  l a t e n t  FeLV in the bone marrow- In the l i g h t  of  
t hese  r e s u l t s  the  c a t s  were  d i s t r i b u t e d  i n  t h r e e  houses as 
f o l l o w s .  The cat  numbers are shown in Table 10.1,
House 1 c o n t a i n e d  a l l  3 ca t s  whi ch were v i r a e m i c  ( c a t s  1 7 ,  
18 and 19)  t o g e t h e r  w i t h  c a t s  3 and 4 which were  c l a s s e d  as 
having recovered from the i n f e c t i o n ,  and cats 6,  13 and 16 which 
had a l a t e n t  i n f e c t i o n .  These c a t s  were  kep t  i n  t h e  o r i g i n a l  
room.
There were no v i ra e mi c  cats in Houses 2 or 3.
House 2 contained cats 1 and 2 which were recovered and cats 
10 and 11 which were l a t e n t l y  i n f e c t e d .
House 3 c o n t a i n e d  c a t s  5 ,  9 ,  14 and 15 wh i ch  had l a t e n t  
i n f e c t i o n s .  The area of  Houses 2 and 3 was 4 m^ _
Resul ts
The v i r u s  n e u t r a l i s i n g  a n t i b o d y  t i t r e s  o f  t h e  ca t s  over  a 
p e r i o d  o f  88 weeks f r om t he  t i m e  o f  f i r s t  expo s ur e  t o  FeLV'-  
i n f ec t ed  donor cats are shown in Table 10.1.  The cats have been 
p l a c e d  i n  f i v e  c l a s s e s  dep en d i ng  on w h e t h e r  or  not  FeLV was 
i s o l a t ed  from t h e i r  bone marrow and on the number of  occasions on 
which v i r u s  was i s o l a t e d  f r o m t h e  bone mar r ow.  Bone marrow
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examinat ion was done at  weeks 20,  35 ,  60 and 88,
CLass 1 consists  of  cats from which no v i rus  was i s o l a t e d  in
the cu l t u r es  of  bone marrow.  These cats were considered to have
r e c o v e r e d  f rom t he  i n f e c t i o n  and t h e i r  s t a t u s  in  T a b l e  10-1 i s
g i v e n  as "R". C l a s s e s  2 ,  3 and 4 i n c l u d e  c a t s  f r om whi ch  v i r u s  
was i s o l a t e d  in bone marrow c u l t u r e s  on 1 ,  2 o r  4 o c c a s i o n s ,  
r e s p e c t i v e l y .  A l l  of  these cats were considered to have a l a t e n t  
i n f e c t i o n  and were designated "L" in Table 10,1,  The reason why 
v i r u s  was found on o n l y  one or  t wo o c c a s i o n s  i n  some c a t s  may 
mean t h a t  at  l e a s t  some of  t h e s e  a n i m a l s  mi ght  have r e c o v e r e d  
f rom t he  l a t e n t  i n f e c t i o n  and shou l d  be i n c l u d e d  i n  t h e  "R" 
g r o u p .  H o w e v e r ,  a n o t h e r  r e a s o n  m i g h t  be t h a t  t h e r e  i s  
considerable  sampl ing e r r o r  in ob t a i n i ng  l a t e n t l y  i n f e c t e d  c e l l s  
i n  t he  bone marrow b i o p s i e s ,  and t h a t  in  f a c t  a l l  o f  t h e s e  ca t s  
have a l a t e n t  i n f e c t i o n .  C l as s  5 c o n t a i n s  t he  t h r e e  ca t s  wh i ch  
d e ve l op ed  a p e r s i s t e n t  v i r a e m i a .  A l t hou gh  not  shown i n  t he  
Table,  FeLV was i s o l a t e d  f rom bone marrow cu l t u r es  of  these cats  
on each occasion.
The housing of  the cats is  i nd i ca t ed  in Table 10.1 by e i t h e r  
" i s o l a t e d "  or  " v i r a e m i c " ,  " I s o l a t e d "  means t h a t  the  c a t s  were  
housed w i t h  o t h e r  r e c o v e r e d  or  l a t e n t l y - i n f e c t e d  cats and were 
not  i n  c o n t a c t  w i t h  v i r a e m i c  ca t s  so were not  c o n t i n u o u s l y  
exposed to exogenous FeLV, "Vi raemic"  means tha t  the cats were 
kept in the same house as the 3 p e r s i s t e n t l y  v i r a e mi c  cats.
The c o n c l u s i o n s  f rom the  r e s u l t s  in  T a b l e  10.1 were t h a t  
n o n - v i r a e m i c  c a t s  a p p e a r e d  t o  f a l l  i n t o  two c a t e g o r i e s  o f  
a n t i b o d y  p r o d u c e r s .  Some c a t s ,  l i k e  ca t s  1 ,  3 ,  10 and 14 ,
a
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responded w i t h  Low t i t r e s  o f  v i r u s  n e u t r a l i s i n g  a n t i b o d i e s  
( t i t r e s  of 2-16)  wh i l e  the remainder  produced higher  t i t r e s  (up 
t o  1 28 ) .  These two c a t e g o r i e s  d i d  not  c o r r e s p o n d  t o  any o t h e r  
c l a s s i f i c a t i o n  used in t h i s  e x p e r i ment .  For e x a m p l e ,  t he  h i gh  
responders were not e x c l u s i v e l y  l a t e n t l y  i n f e c t e d  ca t s  or  c a t s  
which were cont inuously  exposed to v i raemi c  cats.  I n  f a c t ,  these  
cats were d i s t r i b u t e d  between a l l  of  the c lasses .
Anot her  i m p o r t a n t  f i n d i n g  was t h a t ,  once e s t a b l i s h e d ,  t h e  
l e v e l  o f  t h e  v i r u s  n e u t r a l i s i n g  a n t i b o d y  t i t r e  d i d  not  v a ry  
s i g n i f i c a n t l y  t h r o u g h o u t  t he  p e r i o d  of  t he  e x p e r i m e n t .  T h i s  
r e s u l t  means t ha t  exposure to v i r a e mi c  cats is not necessary to  
maintain the l eve l  of  v i r us  n e u t r a l i s i n g  an t i bod i es  in the serum 
of  cats which have been exposed to na t u r a l  FeLV i n f e c t i o n .
Discussion
The r e s u l t s  of t h i s  exper iment  appear to show t h a t  the t i t r e  
of  FeLV n e u t r a l i s i n g  a n t i b o d i e s  i s  m a i n t a i n e d  i n  c a t s  f o r  a 
per iod of  over one year  whether  or not the cats are cont inuously  
exposed t o  c a t s  e x c r e t i n g  FeLV. The r e s u l t s  i n d i c a t e  t h a t  
f o l l o w i n g  c o n t a c t  i n f e c t i o n  a ca t  becomes a low or  a h i gh  
responder.  I n  t h i s  exper iment  the reason f o r  t h i s  i s  not c l e a r .  
I t  does not  appear  t o  depend bn t h e  t i m e  t a k e n  f o r  a ca t  t o  be 
i n f e c t e d  and pr oduce a n t i b o d i e s  s i n c e  cat  2 d i d  not  have  
a n t i b o d i e s  u n t i l  27 weeks and was t h en  a r e l a t i v e l y
■ -r e s p o n d e r ,  w h i l e  cat  3 had a n t i b o d i e s  at  16 weeks arid became a 
low r e s p o n d e r .  I f  t h e  p e r i o d  t a k e n  f o r  t h e  a n i m a l  t o  produce  
a n t i b o d i e s  i s  dependent  on t h e  dose of  v i r u s  t o  whi ch i t  was
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exposed, t h i s  r e s u l t  suggests t h a t  the l e v e l  of  ant i bod i es  might  
not n e c e s s a r i l y  be c o r r e l a t e d  wi th the i n f e c t i n g  dose of  v i r u s .
The r e s u l t s  a l s o  show t h a t  ca t s  whi ch appear  t o  have  
r e c o v e r e d  f rom t he  i n f e c t i o n  ( i n  t h a t  no v i r u s  was i s o l a t e d  
f rom t h e i r  bone marrow cu l t u r e s )  or  l a t e n t l y  i n f ec t ed  cats may 
have e i t h e r  low or  h i gh a n t i b o d y  l e v e l s .  T h i s  r e s u l t  sugg es t s  
t ha t  v.i'rus cont inuously  being re leased i n  l a t e n t l y - i n f e c t e d  c a t s  
may not be requi red t o  ma i n t a i n  ant ibody l eve l s .  A major problem 
i n  i n t e r p r e t i n g  t h e s e  r e s u l t s  i s  t h a t  i t  i s  not  p o s s i b l e  t o  
complete ly  e l i m i n a t e  the p o s s i b i l i t y  t ha t  a l l  cats which become 
non- v i r aemi c  f o l l o w i n g  exposure to FeLV are l a t e n t  c a r r i e r s  even 
though the v i r u s  cannot be i s o l a t e d  from t h e i r  bone marrow. I t  
i s  poss i b l e  t h a t  v i r u s  may be l a t e n t  in ot her  c e l l s  in the body.  
This would mean t ha t  cats ,  l i k e  cats 1 - 4 ,  which are considered to  
have recovered from the i n f e c t i o n  and e l i m i n a t e d  the i n f e c t i o n ,  
might have a l a t e n t  i n f e c t i o n .  This might exp l a i n  why in these  
c a t s  t h e  a n t i b o d y  l e v e l s  were  m a i n t a i n e d .  I f ,  h o w e v e r ,  i t  i s  
assumed t ha t  the " recovered” cats were not l a t e n t l y  i n f e c t e d ,  the  
r e l e v a n c e  o f  t h e s e  f i n d i n g s  f o r  v a c c i n a t i o n  i s  t h a t  once an 
ant ibody t i t r e  is e s t a b l i s h e d ,  i t  might be mainta ined f o r  a long 
per iod.  U n f o r t u n a t e l y ,  in none of  the exper iments descr ibed in 
C ha pt e r s  4 ,  7 and S,  were ca t s  found w i t h  v i r u s  n e u t r a l i s i n g  
ant i bodi es  a f t e r  v a c c i n a t i o n  but  b e f o r e  c h a l l e n g e .  T h e r e f o r e ,  
a l t h o u g h  the  v a c c i n a t e d  ca t s  appear ed  t o  be i m m u n o l o g i c a I  l y  
p r i m e d  by t h e  v a c c i n e  and many made a n t i b o d i e s  f o l l o w i n g  
c h a l l e n g e ,  i t  i s  not  p o s s i b l e  t o  p r e d i c t  f rom t he  r e s u l t s  
presented here whether  or  not ,  wi t hout  cha l l enge ,  t h e i r  immune 
status would p e r s i s t  f o r  as long as the an t i bod i es  found in t h i s
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exper iment .  To obt a i n  t h i s  i n f o r m a t i o n ,  v a c c i n a t e d  ca t s  woul d  
have to be mainta ined in i s o l a t i o n  for  an appropr i a t e  per i od  and 
t hen  c h a l l e n g e d  w i t h  l i v e  v i r u s .  The ma j or  p r o b l e m i n  such an 
exper iment  is t ha t  i f  the cats were kept u n t i l  they were adu l t s  
and then cha l l enged,  only a smal l  propor t i on  of  the unvaccinated  
cats would become v i r a e m i c ,  so i t  would be very d i f f i c u l t  to  show 
any d i f f e r e n c e  between vacc i na t es  and cont ro l s  unless very l arge  
numbers of  animals  were employed.
The r e s u l t s  i n  C h a p t e r  8 showed t h a t  f o l l o w i n g  c h a l l e n g e ,  
most o f  t h e  v a c c i n a t e d  c a t s  became l a t e n t l y  i n f e c t e d .  The  
exper iment  was not c a r r i e d  on long enough to know i f  t h i s  was a 
pe r ma ne n t  s t a t e .  Ho we v e r ,  t h e s e  c a t s  developed t i t r e s  o f  v i r u s  
n e u t r a l i s i n g  a n t i b o d i e s .  From the  r e s u l t s  of  t h i s  c h a p t e r ,  i t  
seems l i k e l y  t h a t  the ant ibody t i t r e s  f o l l o w i n g  chal l enge would 
p e r s i s t  over  a long per iod of  t i me.
11
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CHAPTER 11 
GENERAL DISCUSSION
In the exper iments descr ibed in t h i s  t h e s i s ,  a v i r a l  vaccine  
was prepared against  FeLV i n f e c t i o n  which pr o t ec t ed  over 80% of  
v a c c i n a t e d  k i t t e n s  a g a i n s t  o r o n a s a l  c h a l l e n g e  w i t h  a dose of  
v i r u s  which caused p e r s i s t e n t  v i r a e m i a  i n  a l l  o r  most o f  t h e  
unvaccinated cont r o l s .  This vaccine was more e f f e c t i v e  than any 
previous i n a c t i v a t e d  FeLV vaccine prepared from v i r u s  and was as 
e f f e c t i v e  as p r e v i o u s  n o n - i n f e c t i o u s  c e l l u l a r  v a c c i n e s .  I n  
a d d i t i o n ,  t h e  q u a n t i t y  o f  t h e  v i r a l  a n t i g e n  i n  t he  p r e s e n t  
v a c c i n e  was much l ess  t ha n  i n  p r e v i o u s  v i r a l  v a c c i n e s  and 
t h e r e f o r e '  t h e  v a c c i n c e  woul d  be r e l a t i v e l y  i n e x p e n s i v e  t o  
m a n u f a c t u r e .  The v a c c i n e  i s  now at  a s t ag e  where i t  cou l d  be 
t e s t e d  f o r  i t s  c a p a c i t y  t o  p r o t e c t  c a t s  f r om FeLV under  f i e l d  
c ondi t i ons .
There were t hree stages in the development of  the vaccine.  
F i r s t ,  s e v e r a l  c h e m i c a l  i n a c t i v a t i n g  a g e n t s  were  t e s t e d  and 
p a r a f o r m a l d e h y d e  was chosen f o r  f u r t h e r  s t ud y  ( Ch a p t e r  4 ) .  
S e c o n d l y ,  t wo  a d j u v a n t s ,  s a p o n i n  and i n c o m p l e t e  Freund' s  were  
compared and the  l a t t e r  was s e l e c t e d  ( C h a p t e r  7 ) .  T h i r d l y ,  t h e  
e f f e c t  of  ant igen dose and ant i gen  type was studied (Chapter  8) .  
The f i n a l  v a c c i n e  was produced f rom the c u l t u r e  f l u i d  of  F422 
c e l l s ,  was i n a c t i v a t e d  w i t h  0.02% p a r a f o r m a l d e h y d e ,  f o r m u l a t e d
with AKOH)^ and incomplete Freund's adjuvant and was given by 
two intramuscular injections, three weeks apart.
During the development of  the vaccine,  cons i dera t i on  had to  
be given t o  the f o l l o w i n g  mat ters :  f i r s t ,  the source of  ant igen
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and choice of i n a c t i v a t i n g  agent;  secondly,  the va c c i n a t i o n  and 
chal lenge schedule;  and t h i r d l y ,  the measurement of  the response 
of  v a c c i n a t e d  c a t s  t o  t h e  c h a l l e n g e .  I n  t h i s  c h a p t e r ,  t h e s e  
points  are discussed in r e l a t i o n  to the present  r esu l t s  and the  
previous r e s u l t s  of  o t he r s .
1.  Vaccine p r e p a r a t i o n
a.  Source of  v i r u s  f o r  FeLV vaccine
F422 c e l l s  g r o w i n g  i n  s u sp ens i on  and p r od u c i ng  l a r g e  
q u a n t i t i e s  of  FeLV-A ( R i c k a r d  e t  a I ,  1969 )  were  used.  Most  
p r e v i o u s  v a c c i n e s  have used FL74 c e l l s  which produced FeLV-ABG 
( J a r r e t t  et  a l ,  1 9 7 4 ,  1975;  P eder sen  et  a l ,  19 7 9 ) ‘. The reasons  
why many e a r l i e r  e x p e r i m e n t s  were done w i t h  FL74 c e l l s  was 
because these produced FeLV of  a l l  t hree  subgroups of  FeLV, so i t  
was considered t ha t  immuni ty might develop against  a l l  t h r ee .  I t  
is now known t ha t  most of  the gp70 ant igen in FL74 v i r us  is FeLV-  
C ( R u s s e l l ,  1977) and very  l i t t l e  is :EeLV-=-A. S i nce  
i t  i s  l i k e l y  t h a t  p r o t e c t i o n  a g a i n s t  FeLV-A i s  most i m p o r t a n t  
( J a r r e t t  and R u s s e l l ,  1 9 7 8 ) ,  i n  t h i s  work a ce 11 I i ne p r o d u c i n g  
FeLV-A was used as a s o u r c e  o f  v a c c i n e  v i r u s -  The ch o i c e  o f  
v i r u s - p r o d u c i n g  c e l l s  was be t we e n  F422 and FeLV-A- infected FÈA 
c e l l s .  F422 c e l l s  were favoured because they produced about 10 
t i m e s  more v i r u s ,  in t e r m s  of  v i r a l  p r o t e i n ,  t han  FEA c e l l s .  
Since FeLV-A i s o l a t e s  appear t o  belong to one serotype (Russel l  
and J a r r e t t ,  1978a) ,  immuni ty t o  one FeLV-A might be expected to  
pr o t ec t  against  i n f e c t i o n  by any o t her .
The condi t ions f o r  the product ion of  F422 c e l l s  were s tudied
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( C h a p t e r  2) and i t  was found t h a t  by m a i n t a i n i n g  t h e  c e l l s  a t  
high concent rat ion ( g r ea t e r  than 1 0 6  per ml) and harvest i ng  the  
v i ru s  24 or 48 hours a f t e r  s e t t i n g  up the c u l t u r e ,  good y i e l d s  of  
i n f ec t i o u s  v i r us  were obtained.  In  t h i s  way l a rge  q u a n t i t i e s  of  
v i r u s  c ou l d  be produced v e r y  r a p i d l y  f o r  v a c c i n e  p r o d u c t i o n .  
However,  a t tempts  to use a less expensive medium (RPMI-1640)  in  
p l a c e  o f  L-M wer e  not  e n t i r e l y  s u c c e s s f u I .  I t  i s  p o s s i b l e ,  
h o we v e r ,  t h a t  i n  f u t u r e  F422 c e l l s  cou l d  be s e l e c t e d  t o  grow i n  
RPMI or another  medium and in lower  concent ra t i ons  of  PCS. The 
content  of  PCS in the vaccine might be a problem f o r  two reasons.  
F i r s t ,  t h e s e  serum p r o t e i n s  m i g h t  cause h y p e r s e n s i t i v i t y  
react ions in cats given severa l  doses of  vaccine.  Secondly,  the  
p r o t e i n s  mi ght  i n h i b i t  t h e  a d s o r p t i o n  o f  i n a c t i v a t e d  v i r u s  t o
Al(OH)^ -jn the vaccine.  Fur t her  studies to  reduce the content  of  
PCS in the F422 c u l t u r e  medium would be use f u l .
I n  t h i s  work i t  was d e c i d e d  t o  use u n c o n c e n t r a t e d  c u l t u r e  
f l u i d  ( C h a p t e r  8) as f a r  as p o s s i b l e  s i n c e  t h i s  woul d  be more 
e c on o m i c a l  i n  v a c c i n e  p r o d u c t i o n  t han  c o n c e n t r a t e d  v i r u s .  I n  
p r e v i o u s  s t u d i e s  o f  v i r a l  v a c c i n e s ,  o t h e r s  have used v e r y  
c o n c e n t r a t e d  v i r u s .  For e x a m p l e ,  Yohn et _Ak ( 19 7 6 )  used a ddSe 
of  3 X 10^^ v i r u s  p a r t i c l e s  o f  FeSV and a s i m i l a r  q u a n t i t y  o f  
Rickard FeLV i n a c t i v a t e d  wi th  f o r m a l i n  or U V - l i g h t .  Olsen et a l
(1977) used 10^^ p a r t i c l e s  of  U V - i r r a d i a t e d  FeLV from FL74 c e l l s ,  
whi l e  Salerno ^  (1979) used 100 - t i mes  concent rat ed f o r m a l i n -  
i n a c t i v a t e d  FeLV-ABC/ FL74  and Peder sen  ej^ atj  ^ ( 1979 )  used 2 0 0 -  
t imes concent rated f o r m a l i n - i n a c t i v a t e d  FeLV-ABC/FL74.
The e x p e r i m e n t  i n  C h a p t e r  S showed t h a t  t h e r e  was l i t t l e  
d i f f e r e n c e  be t ween  a v a c c i n e  whi ch contained the equi va l ent  of
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unconcentrated v i r us  and one which was t e n - t i m e s  c o n c e n t r a t e d .  
A l t h o u g h  i n  t h e s e  e x p e r i m e n t s  t h e  v a c c i n e  v i r u s  was hot  
concent rated,  in f a c t  the v i r u s  was concent rated and then d i l u t e d  
in the course of  washing to remove the t ox i c  i n a c t i v a t i n g  agents 
i n  o r d e r  t o  assay f o r  r e s i d u a l  i n f  a c t i v i t y .  I n  f u t u r e  i t  wou l d  
be of  i n t e r e s t  to f i n d  i f  wash i ng  is  n e c e s s a r y  t o  o b t a i n  an 
e f f i c i e n t  vaccine.  This would a lso determine whether  t her e  were 
any substances in the vaccine which were immunosuppressive (e.g.  
p15E).  Avoidance of  washing the v i r us  would,  of  course,  be more 
economical  in the product ion of  a commercial  vaccine.  Ant igens  
used in the present  s t udies  were  F e L V - A / F 4 2 2 ,  F e L V - A / G l as g o w - 1  
and F422 c e l l s .  The v i r u s e s  were used c o n c e n t r a t e d  t e n f o l d  or  
unconcent rated,  wh i l e  F422 c e l l s  were used at  3.5 X 10^ c e l l s  per  
dose. The general  i n d i c a t i o n  was that  the best  ant igen was t ha t  
obtained by using u n c o n c e n t r a t e d  Fe L V - A / F422.
b.  I n a c t i v a t i n g  agent
In  these exper iments paraformaldehyde was chosen f o r  severa l  
reasons.  F i r s t ,  t here  was exper ience of  PF in previous c e l l u l a r  
v a c c i n e s  produced in t h i s  l a b o r a t o r y  which induced anti -FOCMA 
ant i bodi es  ( J a r r e t t  JJL' 1975) and p r o t ec t ed  cats against  FeLV 
c h a l l e n g e  (W.F.H.  J a r r e t t  -  personal  communicat ion) .  T h er e f o r e ,  
PF app ear ed  t o  p r e s e r v e  t h e  a n t i g e n i c i t y  of  v i r a l  a n t i g e n s .  
S e c o n d l y ,  t he  k i n e t i c s  of  i n a c t i v a t i o n  of  both  MSV(FeLV-A)  and 
F422 v i r us  were less compl icated than w i t h  the o t her  i n a c t i v a t i n g  
ag en t s  t e s t e d  ( C h a p t e r s  3 and 7 ) .  O t her  a dv a n t ag e s  a r e  t h a t  PF 
i s  r e l a t i v e l y  l es s  t o x i c  f o r  man than  AEI  and BPL and i s  
inexpensive.  Disadvantages of  PF and formaldehyde are t ha t  wi t h
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some v i r u s e s  t h e r e  i s  a p e r s i s t e n t  f r a c t i o n  o f  v i r u s  which i s  
r e s i s t a n t  t o  t h e i r  a c t i o n ,  Gard ( 1 9 6 0 ) ,  i n  a c l a s s i c a l  s t u d y ,  
showed t ha t  t h i s  occurred dur ing i n a c t i v a t i o n  of  p o l i o v i r u s  w i t h  
formaldehyde and suggested t ha t  the reason was t ha t  the i n i t i a l  
r e a c t i o n  o f  t h e  a gent  w i t h  v i r a l  c a p s i d  p r o t e i n  made t h e  v i r u s  
p a r t i c l e  l ess  p e r m e a b l e  t o  t he  agent  so t h a t  t he  r a t e  of  
i n a c t i v a t i o n  d e c r e a s e d ,  A r e c e n t  e x a m p l e  o f  t h e  t r a g i c  
consequences of  the f a i l u r e  of  formaldehyde to i n a c t i v a t e  v i rus  
complete ly  was the recent  outbreaks of  f oot -and-mouth disease in 
F r a n c e ,  t he  Channel  I s l a n d s  and the  I s l e  of  Wi ght  (DonaIdson et  
a l ,  1982).  I t  was obv ious ly  very i mpor tant  to ensure t hat  a l l  of  
the v i r us  used in the present  vaccine was i n a c t i v a t e d .  Under the  
c o n d i t i o n s  used (0.02% PF f o r  24 hours a t  2 5 ° )  no i n f e c t i o u s  
v i r u s  r e ma i n e d  in t h e  vo l ume of  v a c c i n e  t e s t e d  which was about  
10% of  the t o t a l  volume.  Another p o t e n t i a l  disadvantage of  PF is  
t hat  i t  may decrease the a n t i g e n i c i t y  of v i r us  by c r o s s - l i n k i n g  
adjacent  molecules and des t roy i ng  an t i g e n i c  s i t e s  ( M i l l e r  and Van 
der  M a a t en ,  1 9 7 8 ) .  T h i s  ap p e a r e d  t o  occur  w i t h  FeLV i n  t h i s  
s t u d y  when t r e a t e d  w i t h  PF o r  f o r m a l d e h y d e  a t  h i g h  
c o n c e n t r a t i o n s .  H o we v e r ,  as d i s c u s s e d  in Ch a p t e r  9 ,  t h e r e  was 
enhancement  o f  a n t i g e n i c i t y  o f  both FL74 and F422 v i r u s  a t  low 
c o n c e n t r a t i o n s  of  t h e s e  a g e n t s .  At the  c o n c e n t r a t i o n s  used i n  
t he  v a c c i n e  ( 0 . 02%) ,  t h e  a n t i g e n i c i t y  was e q u a l  t o ,  or  g r e a t e r  
than,  unt r ea t ed  ant igen.
I n  previous s tudies  Pedersen e^ t1979) and Salerno et  a l  
(1979) used formaldehyde to i n a c t i v a t e  FL74 v i r us .  Pedersen and 
his co-workers i n a c t i v a t e d  FeLV-ABC/FL74 wi t h  0.1% formaldehyde
123
—   :   .    , ;
■ t i
overnight  at  4°  p r i o r  to use. This vaccine was t es t ed  f o r  V i r a l  
r e s i d u a l  i n f e c t  i v i  t y  and was used e m u l s i f i e d  wi th ,  Freund' s  
i ncomplete  adjuvant  or  AlCOHjj  to vacc i nat e  16-week old k i t t e n ,  
Salerno and his co-workers p u r i f i e d  the v i r us  and ; t r ea t ed  i t  w i t h '
0.025% f o r m a l i n  f o r  21 days a t  4 °  and used t h é  p r o d u c t  w i t h  and 
w i t h o u t  Freund' s  c o mp l e t e  a d j u v a n t  t o  v a c c i n a t e  gu i n ea  p i g s .  
Ot h e r  i n a c t i v a t i n g  a g e n t s  wh i ch  have been used to:  p r e p a r e  ;FeLV 
v i r a l  vaccines are u l t r a v i o l e t  CUV) i r r a d i a t i o n  and heat  (Yohn et  
a I ,  1976 and Ol sen  e t  a l ,  1 9 7 6 ) .  Yohn and h i s  c o - w o r k e r s  used  
U V - i n a c t 1 vated FeLV-ABC/FL74 wi t h  adj uvant - 65  t o  vacc i nate  cats.  
This i n a c t i v a t i o n  was done by an exposure of  the v i r us  sur face to 
an UV dose rat e  of  150 ergs/sq-  mm/sec f o r  an aeQUbmuiated t o t a l  
dose o f  3 5 , 0 0 0  e r g s / s q .  mm. Ol sen  et.  fJL ^1976)  p r e p a r e d  t h e i r  
FeLV v a c c i n e  by t h e r m a l  i n a c t i v a t i o n  o f  FeLV a t  5 6 °  f o r  t h r e e  
mi n u t e s  or  4 5 °  f o r  v a r y i n g  t i m e s  r a n g i n g  f r o m 0 t o  50 m i n u t e s ,  
but in the l a t t e r  case the i n a c t i v a t i o n  was i n s u f f i c i e n t  to k i l l  
a l l  v i r u s .  V i r u s  was c o m p l e t e l y  i n a c t i v a t e d  o n l y  a f t e r  100  
m i n u t e s .  I n  the p r e s e n t  v a c c i n a t i o n  e x p e r i m e n t s ,  v a r y i n g  
concent rat ions of  sever a l  chemicals were used and the chemical  
and concent ra t i on chosen was 0.02% paraformaldéhyde at  25°  f o r  24 
hours.  The r e s u l t s  of  t e s t i n g  of  the i n a c t i v a t e d  v i r u s  f o r  v i r a l  
r e s i d u a l  i n f e c t  i v i  t y  were t h a t  c o m p l e t e  i n a c t i v a t i o n  was  
achieved.
c.  Adjuvants
Two adjuvants were used in the present  vaccine:  Al(OH)^ and
i n c o m p l e t e  Freund ' s  a d j u v a n t  (TC FA).  AlCOH)^ had been used  
b e f o r e  i n  FeLV v a c c i n e s  by J a r r e t t  e t  a l  ( 1 9 7 5 ) ,  Peder sen  e t  a I
1 2 4
( 1979)  and S a l e r n o  o_t_ _aj  ^ (1 9 7 8 ) .  I n  the s tudy  of  Pedersen  et  a l  
( 1979 )  t h e r e  was a compar i son  of  A l ( OH) ,  and IGFA used w i t h  an 
i n a c t i v a t e d  FL74 v i r u s  vaccine.  The number of cats in each group 
in the  e x p e r i m e n t  was s m a l l ,  but  t h e r e  d i d  not  appear  t o  be any 
d i f f e r e n c e  in the e f f i c a c y  of  e i t h e r  vaccine.
I n  a l l  of  t hese  s t u d i e s  and in the p r e s e n t  e x p e r i m e n t s ,
t h e r e  was no i n d i c a t i o n  t h a t  AI  (OH) : U F A  gave r i s e  t o  s i d e
e f f e c t s .  I n  Ch ap t e r  3 e v i de n c e  i s  p r e s e n t e d  t h a t  75% of  v i r u s  
adsorbed to Al(OH)^ in the concent ra t ion used ( one- tenth volume
of 2% AKOH)^).  In some other  vaccines Al(OH);^ is used at  higher  
c o n c e n t r a t i o n s  (up t o  o n e - h a l f )  and i t  would  be i n t e r e s t i n g  i n  
f u t u r e  t o  exami ne  t he  a d s o r p t i o n  of  i n a c t i v a t e d  FeLV to h i g h e r  
c o n c e n t r a t i o n s .  I t  mi gh t  be p o s s i b l e  by u s i ng  a d s o r p t i o n  of
v i r u s  t o  A l ( O H ) ^  t o  e l i m i n a t e  t h e  w a s h i n g  o f  v i r u s  by 
u l t r a f i l t r a t i o n  i n  o r d e r  t o  r e m o v e  t o x i c  p r o d u c t s  o f  
i n a c t i v a t i o n .
Saponin was tes t ed  as an adjuvant  in the e a r l y  par t  of  t h i s  
work ( Ch a p t e r  5)  but  was not  c o n s i d e r e d  v e r y  s a t i s f a c t o r y .  I n  
t he  f i r s t  e x p e r i m e n t  ( Ch a p t e r  4)  the sapon i n  produced s i d e  
e f f e c t s  of  pain and s w e l l i n g  at  the s i t e  of i n j e c t i o n , a n d  f e v e r .  
When saponin was subsequent ly used at a concent ra t i on  which was 
not ha r mf u l ,  as determined by the exper iment  descr ibed in Chapter  
5 ,  i t  d id not give as good a response as ICFA.
ICFA d i d  not  appear  t o  have a h a r m f u l  e f f e c t  on c a t s .  O i l  
a d j u v a n t s  are  c u r r e n t l y  used in a k i l l e d  combined f e l i n e  
c a l i c i v i r u s ,  f e l i n e  h e r p e s v i r u s ,  f e l i n e  pan I e u k o p a e n i a  v i r u s  
v a c c i n e  ( Vax i c a t - p  I us;  TVL L t d )  and no s i de  e f f e c t s  have been 
r e p o r t e d  i n  t h e  f i e l d .  I n  o t h e r  s t u d i e s  on FeLV v a c c i n a t i o n ,
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ICFA has bo GO, used ( Peder sen  et: a L, 1 979 ) .  Comp l e t e  F reund ' s  
a d j u v a n t  (CFA) has a l s o  been used and a l t h o u g h  i t  produces  
granuLomata in many species ,  there was no ment ion in the work of  
Yohn ^  2 I  ( 1 9 7 6 ) ,  S a l e r n o  (1978)  or  Grant  e_t. ±1. ( 1930 )
t ha t  any harmful  e f f e c t s  were noted in cats .
2.  Vacc i nat i on schedule and chal l enge
A ma j o r  p r ob l e m whi ch  was e n c o u n t e r e d  by many p r e v i o u s  
workers on FeLV v a c c i na t i on  is the a ge - re l a t ed  r es i s t ance  to FeLV 
i n f e c t i o n  in cats (Hoover et  a l ,  1976).  K i t t en s  o l der  than about
14 weeks of  age are r e l a t i v e l y  r e s i s t a n t  to the type and dose of
c h a l l e n g e  whi ch  i s  u s u a l l y  g i v e n .  Because of  t h i s  p r o b l e m ,  in  
some s t u d i e s  i t  has been d i f f i c u l t ,  i f  not  i m p o s s i b l e ,  t o  
determine whether  a vaccine has been successful  or not since the  
response of the vaccinates  and cont ro ls  to chal lenge was s i m i l a r
(Salerno et a l ,  1979 ) .
To av o i d  t h i s  p r o b l e m ,  i n  the p r e s e n t  s t u d y ,  ca t s  were  
v a c c i n a t e d  and c h a l l e n g e d  b e f o r e  t h e y  were  1 2 - 1 3  weeks o f  age.  
The cat s  were  v a c c i n a t e d  when 3 weeks o l d  and a g a i n  2 - 3  weeks  
l a t e r .  They were  t hen  c h a l l e n g e d  1 - 2  weeks f o l l o w i n g  t h e  l a s t  
v a c c i n a t i o n .  I n  t h i s  way a l l  or  most of  t he  c o n t r o l  c a t s  
developed a p e r s i s t e n t  v i r a e mi a  and i f  a vaccine was e f f e c t i v e ,  
the res is t ance of  the vaccinated cats should be obvious.  I n  the 
f i r s t  e x p e r i m e n t  o f  t h i s  s t udy  ( C h a p t e r  4) not  a l l  o f  t he  
u n v a c c i n a t e d  c o n t r o l  ca t s  became v i r a e mi c  f o l l o w i n g  chal lenge.  
This was almost  c e r t a i n l y  due to chal lenge wi th  too low a dose of  
vi rus  since in the second and t h i r d  vacc i na t i on  exper iment s ,  the
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a d m i n i s t r a t i o n  of  o La r ger  dose (4.5 X 10^ -  1 X 10*  ^ F1 U) 
produced p e r s i s t e n t  v i raemia  in 6 / 6  cats in each case.
The a p p r o p r i a t e  FeLV c h a l l e n g e  dose was d e t e r m i ncd in an 
e x p e r i m e n t  d e s c r i b e d  in Chapt e r  6. The c h a l l e n g e  in t h e s e  
exper iments was given by the oronasal  route in order  to s i mu l a t e  
n a t u r a l  c o n t a c t  c h a l l e n g e .  I t  was shown f i r s t  by Hoover  e t  a l
(1972) t ha t  i n t r a n a s a l  i n s t i l l a t i o n  of  the Rickard s t r a i n  of  FeLV 
in newborn k i t t e n s  gave r i se  to a p e r s i s t e n t  v i r aemi a  and then to 
t he  d e v e l op me n t  o f  l ymphosarcoma.  The t i m e  course  of  t h e  
e s t a b l i s h m e n t  of  v i r a e m i a  in 8 - week  o l d  and 1 6 - we e k  o l d  c a t s  
f o l l o w i n g  oronasal  a d m i n i s t r a t i o n  was subsequent ly determined by 
J a r r e t t  aj  ^ (1982a) and t h e i r  technique was used here.  In t ha t  
study,  i t  was found t ha t  4 / 5  3-week old k i t t e n s  and 5 /10  16-week  
old k i t t e n s  became permanent ly v i raemi c  f o l l o w i n g  exposure to 10^ 
Fi l l  of  F eLV-A/G I a sgo w - 1 , I n  a d d i t i o n ,  t r a n s i e n t  v i r a e m i a  was 
f ound in a l m o s t  a l l  of  t he  k i t t e n s  which e v e n t u a l l y  r e c o v e r e d  
f rom t he  i n f e c t i o n .  I t  was found t h a t  k i t t e n s  w i t h  t r a n s i e n t  
v i r a e m i a  cou l d  be d e t e c t e d  3 weeks a f t e r  i n f e c t i o n .  Fol l owi ng  
cha l l enge ,  t h e r e f o r e ,  the k i t t e n s  in the present  exper iments were 
t e s t e d  at  3 weeks f o r  e v i d e n c e  of  t r a n s i e n t  v i r a e m i a  and l a t e r  
f o r  p e r s i s t e n t  v i r a e mi a .  In d i f f e r e n t  exper iments the t i m i n g  of  
the t e s t i n g  f o r  p e r s i s t e n t  v i raemi a  was s l i g h t l y  d i f f e r e n t .  I t  
was f o u n d ,  h o w e v e r ,  t h a t  t h e r e  was L i t t l e  change i n  the  v i r u s  
status of  the cat  from 12 weeks a f t e r  chal lenge.
In most other  s tudies  on FeLV v a c c i n a t i on ,  the chal l enge has 
been by subcut aneous  or i n t r a m u s c u l a r  i n o c u l a t i o n  of  FeLV o r ,  
more commonly ,  FeSV. A l t hough  the  t i m e  course and outcome of  
p a r e n t e r a l  i n o c u l a t i o n  of  FeLV is  s i m i l a r  t o  t h a t  f o l l o w i n g
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oronasal  a d m i n i s t r a t i o n ,  t h e r e  may be d i f f e r e n c e s  in  the  speed  
wi th which the v i r us  spreads to the bone marrow. I t  may be t hat  
v i r u s  g i v e n  by i n j e c t i o n  w i l l  i n f e c t  bone marrow c e l l s  more 
r a p i d l y  than i f  given o r o n a s a l l y ,  and might ,  t h e r e f o r e ,  be less  
s u s c e p t i b l e  t o  a n t i - v i r a l  i m m u n i t y  w h i c h  i s  p r o d u c e d  by 
v a c c i n a t i o n .  So f a r  the  o n l y  c a r e f u l l y  c o n t r o l l e d  s t udy  u s i n g  
n a t ur a l  contact  t r ansmi ss i on  was t h a t  of  Pedersen et_ ^  (1979) .  
I n  t h e i r  e x p e r i m e n t s ,  groups of  4 - 6  v a c c i n a t e d  or  u n v a c c i n a t e d  
cont ro l  k i t t e n s  which were appr ox i mat e l y  20 weeks o ld were housed 
w i t h  2 - 3  v i r a e m i c  c a t s .  Under  t h e s e  condi t i ons^ ,  1 0 / 2 5  (40%) of  
t he  u n v a c c i n a t e d  c a t s  became p e r s i s t e n t l y  v i r a e m i c .  Thus,  i n  
t h e s e  e x p e r i m e n t s ,  t h e  p r o p o r t i o n  o f  c a t s  w h i c h  b e came  
p e r s i s t e n t l y  v i r a e m i c  was much l es s  t han  i n  t he  p r e s e n t  
e x p e r i m e n t s .  I n  a n o t h e r  e x p e r i m e n t  i n v o l v i n g  c o n t a c t  
t r a n s m i s s i o n ,  Olsen eL ^  ( 1 9 8 0 a ) u s e d  t h e i r  s o l u b l e  t u m o u r -  
associated vaccine to vacc i nate  45 FeLV- f ree cats in a household 
of  pet  ca t s  i n  wh i ch  FellV was e n z o o t i c .  Of t h e s e  45 c a t s ,  . 12  
(27%) d e v e l op e d  p e r s i s t e n t  v i r a e m i a .  E i g h t  of  t hese  c a t s  
developed v i r a e mi a  dur ing the va c c i n a t i o n  procedure,  and i f  these  
are excluded from the r e s u l t s ,  only 4 / 37  (11%) appeared to become 
v i r aemi c  f o l l o w i n g  n a t u r a l  chal l enge.  This suggests a high l e v e l  
of  p r o t e c t i o n .  Howe v e r ,  a m a j o r  o b j e c t i o n  t o  t h i s . s t u d y  i s  t he  
l ack  o f  a g e -  and s e x - m a t c h e d ;  u n v a c c i n a t e d  c o n t r o l s .  The o n l y  
i n d i c a t i o n  o f  t h e  p r e v a l e n c e  o f  p e r s i s t e n t  v i r a e m i a  i n  
unvaccinated cats was t ha t  t ha t  29% of the cats in the house were 
FeLV- pos i t i ve  before the va c c i n a t i o n  programme began.
In sever a l  o t her  exper iments the chal lenge FeLV was given by
' i f
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i n j e c t i o n .  J a r r e t t  ( 1975 )  v a c c i n a t e d  k i t t e n s  w i t h  l i v e
FL74 c e l l s  and c h a l l e n g e d  by subcut aneous i n o c u l a t i o n  of  10^ 
i n f e c t i o u s  u n i t s  of  FeLV-AB/G l asgo w- 5 .  The c a t s  were  6 months  
o l d  when c h a l l e n g e d  and 3 / 1 0  of  t he  v a c c i n a t e d  and 9 / 1 0  o f  t he  
unvaccinated cats became p e r s i s t e n t l y  v i r a e mi c .  The reason f o r  
the success o f  t h i s  c h a l l e n g e  in p r o d u c i n g  v i r a e m i a  in such a 
h i gh  p r o p o r t i o n  o f  16 month o l d  a n i m a l s  i s  p r e s um a b l y  t h e  h i gh  
dose of  v i rus  which was used.
I n  a n o t h e r  e x p e r i m e n t  Hoover  e^ aij  ^ <1977b)  va c ci  n a t e d  
p r e g n a n t  queens w i t h  FeLV-ABC/ FL74 v i r u s  i n a c t i v a t e d  by UV-  
i r r a d i a t i o n .  Only one of  ten queens developed v i ru s  n e u t r a l i s i n g  
ant i bodi es .  The k i t t e n s  of  the vaccinated queens were inocul a t ed  
i n t r a p e r i t o n e a l l y  wi th  10^ PeLV-AB/Rickard when they were 2 days 
old  and 18/19 became p e r s i s t e n t l y  v i r a e mi c .  S i m i l a r  r e s u l t s  were 
obtained by Salerno _e  ^ ^  (1979) .
A l l  of  the  o t h e r  i n v e s t i g a t i o n s  of  FeLV v a c c i n a t i o n  have  
used c h a l l e n g e  by FeSV. T h e r e  are  t h r e e  main reasons why FeSV 
has been used r a t h e r  t han  FeLV. F i r s t ,  when e x p e r i m e n t s  on 
v a c c i n a t i o n  began,  i t  was b e l i e v e d  t h a t  a n t i - FOCMA a n t i b o d i e s  
were r e s p o n s i b l e  f o r ,  or  were a measure o f ,  i m m u n i t y  t o  FeLV 
(Essex ej^ a I ,  1975 ;).  Ant  i -FOC M A a n t i b o d i e s  c o u l d  be r a i s e d  i n  
cats a f t e r  v acc i na t i on  wi th  l i v e  FL74 c e l l s  or i n a c t i v a t e d  FL74 
c e l l s  ( J a r r e t t  e_^  a I ,  1975 ;  Peder sen  e_t_ a I ,  1979)  or  UV-  
i r r a d i a t e d  FeSV or  FeLV (Yohn et  a l ,  1 9 7 6 ) .  Essex et  a I ( 1971 )  
showed t ha t  the l e v e l  of anti -FOCMA ant i bod i es  was impor t ant  in 
i m m u n i t y  t o  FeSV. Hence many s t u d i e s  have used c h a l l e n g e  w i t h  
FeSV f o l l o w i n g  FeLV v a c c i na t i o n  and have used the development ,  or  
not ,  of sarcomas as an i n d i c a t i o n  of  the e f f i c a c y  of vacc i na t i o n .
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A second reason f o r  the use of FeSV is that  tumours occur in 
weeks r a t h e r  t han in months or y e ar s  as i s  the  case w i t h  FeLV.  
Ther e f or e ,  exper iments can be done much more r a p i d l y  wi t h  FeSV 
than wi t h  FeLV chal l enge.  In the exper iments descr ibed in t h i s  
t h e s i s ,  FeLV was used as the chal lenge since i t  was be l i eved  t ha t  
t he  b i o l o g y  of  FeSV and FeLV was q u i t e  d i f f e r e n t .  For e x a m p l e ,  
in tumour development by FeSV, the tumour is p o l y c l ona l  and the  
sarcoma v i rus  t ransfor ms many c e l l s  and spreads to f u r t h e r  c e l l s  
t o  r e c r u i t  them i n t o  t h e  t u mo u r .  On t h e  o t h e r  hand,  FeLV i s  
t h o u g h t  t o  t r a n s f o r m  a s i n g l e  c e l l  which t hen  grows i n t o  a 
tumour,  o f t en  a f t e r  a very long incubat ion per iod.
A no t h e r  reason why FeLV i s  c o n s i d e r e d  a more a p p r o p r i a t e  
c h a l l e n g e  v i r u s  i s  because  i t  was s u b s e q u e n t l y  shown t h a t  FeLV 
n e u t r a l i s i n g  a n t i b o d i e s  are more r e l a t e d  to res i s t ance  t o  FeLV 
i n f e c t i o n  than anti -FOCMA ant i bodi es  (Hardy et a l ,  1976; Russe l l  
and J a r r e t t ,  1973b) .
I n  f u t u r e  i t  would  be u s e f u l  t o  t e s t  t he  p r e s e n t  v a c c i n e  
under n a t u r a l  condi t i ons  of  chal l enge wi th  FeLV since i t  may be 
t h a t  n a t u r a l  c o n t a c t  t r a n s m i s s i o n  mi ght  not  be so severe a s t h e  
oronasal  chal lenge used in the present  exper iments.
3.  Response of  vacc inat ed cats to FeLV chal lenge
I t  was considered unnecessary in the present  exper iments to  
w a i t  f o r  l ymphosarcoma t o  d e v e l o p  i n  ca t s  in o r d e r  t o  t e s t  the  
e f f i c a c y  o f  a v a c c i n e .  The o n l y  e x p e r i m e n t  i n  whi ch  t h i s  has 
been done i s  i n  t h a t  of  Hoover  _et_ a_l ( 1 9 7 7 b ) .  I n s t e a d ;  t he  
development of  v i r a e m i a  was taken as a marker of FeLV i n f e c t i o n
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and freedom from v i r a e mi a  by vaccinated cats f o l l o w i n g  chal lenge  
was considered an i n d i c a t i o n  of  e f f i c a c y  of the vaccine.
There  i s  v e r y  good e v i d e n c e  t h a t  t he  v a s t  m a j o r i t y  o f  c a t s  
which are  F e L V - n e g a t i v e  do not  d e v e l op  d i s e a s e s  which are  
be l i eved  to be FeLV- r e l a t ed .  Hardy ^  d 976 ) showed t hat  by
e l i m i n a t i n g  FeLV c a r r i e r  c a t s  f rom househol ds  of  pe t  c a t s  in  
whi ch t h e  i n f e c t i o n  had been e n z o o t i c ,  t he  v i r u s  was a l s o  
e l i m i n a t e d .  I n  a d d i t i o n ,  t h e r e  was no o c c u r r e n c e  in t he  
sur v i v i ng  cats of  FeLV-associated diseases.  I n  a f o l l o w - u p  study 
of  t h e s e  c a t s ,  M c C l e l l a n d  (1980 )  showed t h a t  t he  f a t a l i t y
r a t e  o v e r  3,5 y e a r s  was 83% f o r  F e L V - i n f e c t e d  c a t s  but  o n l y  15% 
f o r  FeLV- negat  i ve ca t s  a f t e r  FeLV had been e l i m i n a t e d  f rom t he  
households.  From t h i s  evidence i t  was considered in the present  
exper iments t ha t  the e f f i c a c y  of  a FeLV vaccine could be assessed 
by the capac i t y  of  the vaccine to prevent  v i r aemi a .
Two t y p e s  o f  v i r a e m i a  w e r e  d e t e c t e d :  t r a n s i e n t  and  
p e r s i s t e n t .  P r o t ec t i o n  aga inst  p e r s i s t e n t  v i r a e mi a  was the most  
impor tant  i n d i c a t i o n  of  the e f f i c a c y  of  a vaccine.  I n the l a t e r  
exper iments descr ibed here,  cats were sampled 3,  6 and 12 weeks 
a f t e r  c h a l l e n g e .  I t  was f ound in the  e x p e r i m e n t s  d e s c r i b e d  i n  
C h a p t e r  7 t h a t  t he  v i r a e m i c  s t a t u s  of  a ca t  d i d  not  a l t e r  a f t e r  
12 weeks. The method used to detect  v i r us  in the blood was v i rus  
i s o l a t i o n  from the plasma since J a r r e t t  ej  ^ aj  ^ (1982a) showed t ha t  
t h i s  method was the most s e n s i t i v e  f o r  demonst rat ing v i r u s .
The c a t s  were  a l s o  t e s t e d  f o r  a t r a n s i e n t  v i r a e m i a  a t  3 
weeks a f t e r  i n f e c t i o n .  I n  a p r e v i o u s  s t ud y  in which t h i s  has 
been s t u d i e d ,  Pedersen ej^ _al_ ( 1979 )  found t h a t  a f o r m a l d e h y d e -  
i n a c t i v a t e d  FL74 v i r u s  v a c c i n e  d i d  not  p r o t e c t  ca t s  f rom
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t r a n s i e n t  v i r a e m i a  f o l l o w i n g  c o n t a c t  i n f e c t i o n ,  i n  t h a t  7 / 2 6  
(27%) of  v a c c i n a t e s  d e v e l o p e d  t r a n s i e n t  v i r a e m i a  which was 
s i m i l a r  to the p r opo r t i on  of  6 / 25 (24%) in the cont ro l s .  However 
o n l y  3 / 2 6  (12%) of  t he  v a c c i n a t e s  became p e r s i s t e n t l y  i n f e c t e d  
compared t o  1 0 / 2 5  (40%) of  t he  c o n t r o l s .  The r e s u l t s  i n  t h e  
p r e s e n t  e x p e r i m e n t s  were s i m i l a r  to t hose  of  Pedersen and 
c o l l e a g u e s .  I t  was found t h a t  more ca t s  became t r a n s i e n t l y  
v i r a e m i c  t h a n  became p e r m a n e n t l y  v i r a e m i c .  For e x a m p l e ,  t he  
r e s u l t s  i n  t he  l a s t  e x p e r i m e n t  of  FeLV v a c c i n a t i o n  ( C h a p t e r  8)  
were t h a t  i n  v a c c i n a t e d  groups C l ,  C2 and C3 t he  number of  
t r a n s i e n t l y  v i r a e m i c  c a t s  were  1,  2 and 3 o f  6 (1 7 ,  34 and 52%)  
r e s p e c t i v e l y  compared to the number of the permanent ly  v i r a e mi c  
ca t s  i n  t he  same groups whi ch  was 0 ,  1 and 2 ( 0 ,  17 and 34%) 
r e s p e c t i v e l y .  This was in cont rast  to groups C4 and C5 ( cu l t u r e  
f l u i d  c o n t r o l  and unvaccinated cats)  in which the r e s u l t  was t ha t  
6 of  6 (100%) became permanent ly  v i raemi c  in both cases.
I t  would be p r e f e r a b l e  i f  a vaccine could prevent  t r a n s i e n t  
v i r a e m i a  as w e l l  as pe r ma ne n t  v i r a e m i a  f o r  t wo main reasons .  
F i r s t ,  i t  was shown by J a r r e t t  e^  ( 1982a )  t h a t  k i t t e n s  
e x c r e t e d  v i r u s  f rom the mouth d u r i n g  the  s h o r t  t i m e  Of a 
t r a n s i e n t  v i ra e mi a .  They may be able to t r a n s mi t  v i r us  to other  
c a t s  d u r i n g  t h i s  s h o r t  p e r i o d .  S e c o n d l y ,  f o l l o w i n g  t r a n s i e n t  
v i r a e m i a  a l a t e n t  i n f e c t i o n  may be e s t a b l i s h e d ,  as d i s c u s s e d  
be l ow.  I t  would be u s e f u l  i f  both o f  t h e s e  s i t u a t i o n s  c ou l d  be 
prevented.
The o t h e r  measure of  the  e f f i c a c y  of  the v a c c i n e  was t he  
development of  v i r u s  n e u t r a l i s i n g  ant i bodi es  in vaccinat ed cats.
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None o f  t he  v a c c i n a t e d  c a t s  in t hese  e x p e r i m e n t s  produced  
ant i bodi es  a f t e r  va c c i na t i on  and before chal lenge.  This f i n d i n g  
agr ees  w i t h  t h e  r e s u l t s  of  o t h e r  s t u d i e s  in  whi ch k i t t e n s  were  
v a c c i n a t e d .  Only a f t e r  v a c c i n a t i n g  a d u l t s  w i t h  s i x  r e p e a t e d  
doses o f  U V - i r r a d i a t e d  FeSV,  d i d  Yohn ejt_ £l_ ( 1976 )  cons i s t  ent  l y  
f i n d  v i r u s  n e u t r a l i s i n g  a n t i b o d i e s ,  and o n l y  i n  low t i t r e s .  
However,  i t  appeared t h a t  the vaccinated k i t t e n s  were pr imed by 
v i r a l  ant igens since f o l l o w i n g  chal lenge most cats responded by 
making v i r u s  n e u t r a l i s i n g  a n t i b o d i e s .  Those c a t s  were FeLV-  
n e g a t i v e ,  whi ch i s  a s i m i l a r  s i t u a t i o n  t o  t h a t  i n  t he  f i e l d  
f o l l o w i n g  n a t u r a l  c h a l l e n g e  (Hardy et  a I ,  1976;  R u s s e l l  and 
J a r r e t t ,  1978b ) .  W h i l e  t h e  pr esence  of  v i r u s  n e u t r a l i s i n g  
ant i bod i es  i nd i c a t e s  that  a cat is l i k e l y  to be FeLV- f ree ,  i t  i s  
not c e r t a i n  t ha t  i t  i s these an t i bod i es  which are responsible  f o r  
s u p p r e s s i n g  t he  g r o w t h  o f  t he  v i r u s  in t he  c a t .  For e x a m p l e ,  
c e l l  mediated immuni ty may be very impor tant  in k i l l i n g  v i r u s -  
i n f e c t e d  c e l l s .  Ho we v e r ,  a n t i b o d i e s  can a l s o  k i l l  f e l i n e  
lymphosarcoma c e l l s  in the presence of  cat  complement (Grant et  
a I ,  1980 )  and r e c e n t l y  i t  was shown t h a t  mouse m o n o c l o n a l  
a n t i b o d i e s  whi ch were  c y t o t o x i c  were a l s o  v i r u s  n e u t r a l i s i n g  
(Grant et  a l ,  1983) .  I t  is l i k e l y ,  t h e r e f o r e ,  t ha t  n e u t r a l i s i n g  
a n t i b o d i e s  are  i m p o r t a n t  i n  s u p p r e s s i o n  of  v i r u s  and v i r u s -  
i n f e c t e d  c e l l s .
A n t i b o d y  to FOC MA was not  measured in t h e s e  e x p e r i m e n t s  
because i t s  presence does not i n d i c a t e  t hat  a cat  is r e s i s t a n t  to  
FeLV i n f e c t i o n  (Hardy e t  a l ,  1 9 7 6 ) .  The e x p e r i e n c e  of  o t h e r s  
using i n a c t i v a t e d  v i r u s  vaccines is tha t  anti -FOCMA ant i bodi es  do 
not appear in vaccinated cats before  chal lenge (Pedersen et. a I ,
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1979).  Anti-FOCMA ant ibody does appear,  however,  in cats which 
are vaccinated wi t h  Live FeLV or FeLV- inf ected c e l l s  ( J a r r e t t  et  
a l ,  1974;  Pedersen  _e^ a I ,  1979;  Grant  ^ I ,  1930)  or  w i th  
i n a c t i v a t e d  F e L V - i n f e c t e d  c e l l s  ( J a r r e t t  et  a I ,  1975;  Olsen et  
a l ,  1976;  Yohn et  a l ,  1976;  Pedersen et a l ,  1979) .
A scor ing system was used in the s tudies  descr ibed here in 
order  to a s s i s t  in grading the responses f o l l o w i n g  v a cc i na t i on .  
The aim of  t h i s  syst em was t o  g i v e  an i n d i c a t i o n  of  whi ch of  
s e v e r a l  v a c c i n e  t y p e s  was most  e f f i c i e n t .  As d e s c r i b e d  i n  
Cha pt e r  4 ,  both t h e  v i r a e m i c  s t a t u s  and a n t i b o d y  s t a t u s  of  t he  
ca t s  i n  a group were  t a k e n  i n t o  ac c o u n t ,  A summary o f  t h e  
resu l t s  of  the t hree  vaccine exper iments is shown in Table 11.1.  
From t h i s ,  i t  i s  seen t h a t  the scor ing system was a usefu l  a id  in 
s e l e c t i n g  vaccines f o r  f u r t h e r  development .  No other  studies on 
FeLV va c c i n a t i o n  have used such a system,  but a scor ing system,  
based on c l i n i c a l  s i g n s  f o l l o w i n g  c h a l l e n g e ,  was used i n  t he  
development  of  a vaccine against  f e l i n e  herpesvi rus  ( S l a t e r  and 
York,  1975 ) .
A t h i r d  response  of  ca t s  t o  FeLV c h a l l e n g e  was a l s o  
i nv e s t i g a t e d .  Whi le  t h i s  study was in progress the phenomenon of  
FeLV l atency was discovered (Post and Warren,  1980; Rojko et  a l ,  
1982; Madewel l  and J a r r e t t ,  1983) .  I t  was considered impor t ant  
to  d e t e r m i n e  wh e t he r  c a t s  which appear ed  t o  be p r o t e c t e d  f rom  
FeLV chal lenge by v a c c i na t i o n  were l a t en t  c a r r i e r s  of  the v i r u s .  
Cats which had r e s i s t e d  chal l enge in group Cl vacc i nat ed w i t h  PF-  
i n a c t i v a t e d  F422 v i r u s  as d e s c r i b e d  i n  C h a p t e r  3 were  exami ned  
and some were found to have l a t e n t  v i r u s .  I t  is i n t e r e s t i n g  t ha t
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TABLE 11. 1
Summary o f  E f f i c a c y  Scores i n  Vacc i nat i on  Experiments  
Group Score Rank
No. Vaccine Vi rus ■ Ant ibody Tot a l
A1 PF(1) 0 325 325 1
A2 PF(10) 75 300 375 2
A3 A E I ( I ) 225 600 825 6=
A4 AEI (10) 75 350 425 3
A5 DTNP/PF(1) 25 525 550 5
A6 DTNP/PF(10) 50 475 525 4
A7 F422 c e l l s 425 600 1025 8
AS Unvaccinated 225 600 825 6=
81 PF(ICFA) 232 . 550 782 1
82 PF(Saponin) 300 567 867 2
83 Unvaccinated 600 600 1200 3
Cl F422(1) 64 283 347 1
C2 F422 (10) 142 270 412 2
C3 FeLV-A(10) 382 549 931 3
C4 Cont rol  F l u i d 550 600 1150 4
05 Unvaccinated 600 600 1200 5
 _______________________________________:_________:____________  :________   :____________ : __________________________________________________________________   ■ ;  j
these cats did not show even a t r a n s i e n t  v i r aemi a  but had Latent  
v i rus .  This i nd i ca t es  t h a t  the vaccine did not p r e v e n t . i n i t i a l  
v i r u s  g r o w t h  or  s p r e a d  f r om t h e  o r o p h a r y n x  t o  t he  bone mar row.  
I t  i s  not  known how Long l a t e n t  v i r u s  i s  m a i n t a i n e d  in  the  bone 
marrow.  Recent  s t u d i e s  have i n d i c a t e d  t h a t  t h e  p r o p o r t i o n  o f  
ca t s  w i t h  l a t e n t  i n f e c t i o n  f o l l o w i n g  n a t u r a l  FeLV c h a l l e n g e  
decreases from about 60% at  20 weeks a f t e r  exposure,  to 25% a f t e r  
80 weeks CO, J a r r e t t ,  p e r s o n a l  c o m m u n i c a t i o n ) .  I t  w i l l  be 
i m p o r t a n t  i n  f u t u r e  t o  t e s t  v a c c i n a t e d  c a t s  w i t h  l a t e n t  
i n f e c t i o n s  over a longer per iod of t ime than the 12 weeks in the  
present  exper iment .  Another i mpor t ant  quest ion is whether  or not  
l a t en t  c a r r i e r s  of  FeLV can t r a n s m i t  the v i r us .  At present  t here  
i s  no evidence t h a t  they do (Madewe11 and J a r r e t t ,  1983).
4 .  Future Studies
For t he  f u t u r e  i t  would  seem to be i m p o r t a n t  t o  d e v e l o p  an 
improved vaccine which would induce v i r us  n e u t r a l i s i n g  ant i bodi es  
i n  young k i t t e n s  b e f o r e  c h a l l e n g e  w i t h  l i v e  FeLV. The p r e s e n t  
exper iments i n d i ca t e d  t ha t  t h i s  might  not be achieved Simply by 
i ncreas i ng  the dose of  ant i gen  in the vaccine.  Also the vaccine  
of  Peder sen ejt. ^  ( 1979 )  was even more c o n c e n t r a t e d  than t h o s e  
used in t he  p r e s e n t  e x p e r i m e n t  ( e q u i v a l e n t  to  2 0 - f o l d  g r e a t e r  
than the most concent rated vaccine used here)  and d id  not achieve  
b e t t e r  r e s u l t s .  I t  may be t h a t  the  use of  more e f f i c i e n t  
a d j u v a n t s  mi gh t  i n c r e a s e  t h e  i mmunogeni  c i t y  o f  t h e  v a c c i n e .  
However,  the development of  b e t t e r  adjuvants than those used here 
has been very slow.  The use of saponin in the present  study was 
not  successful .
v::i
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I t  would seem t h a t  one o f  the most e f f e c t i v e  ways of  
immunising against  FeLV would be by using a modi f i ed l i v e  v i rus  
vaccine.  J a r r e t t  e^ a_l, (1975) used l i v e  FL74 c e l l s  and protected  
5 / 3  ca t s  a g a i n s t  a c h a l l e n g e  of  FeLV which produced p e r s i s t e n t  
v i raemi a  in 9 / 10  unvaccinated cont ro l s .  In a s i m i l a r  exper iment ,  
G r a n t  ^  a_l ( 1980 )  p r o t e c t e d  a l l  of  11 ca t s  a g a i n s t  c h a l l e n g e  
w i t h  FeSV. Peder sen  2Ë. ( 1979 )  used l i v e  FL74 v i r u s  and
p r o t e c t e d  2 8 / 2 8  c a t s  f rom a n a t u r a l  c h a l l e n g e  w i t h  FeLV which  
produced p e r s i s t e n t  v i r a e mi a  in 15/37  cont ro ls .  None of the cats  
v a c c i n a t e d  w i t h  l i v e  FL74 c e l l s  or  v i r u s  showed any s i gns  of  
becoming v i r a e m i c  f o l l o w i n g  v a c c i n a t i o n .  T h i s  i s  because t he  
FL74 v i r u s  has a v e r y  low s p e c i f i c  i n f e c t  i v i  t y  which i s  o n l y  
about 1 t hat  of  FeLV grown in monolayer cu l t u r es .  Whi le the  
use of  t h i s  n a t u r a l l y  " a t t e n u a t e d "  v i r u s  is  s u p e r f i c i a l l y  
a t t r a c t i v e ,  i t  i s  u n l i k e l y  t h a t  such a v a c c i n e  cou l d  be used i n  
t he  f i e l d  s i n c e  FL74 v i r u s  caused e r y t h r o i d  h y p o p l a s i a  when 
i nocul a ted  i n t o  newborn k i t t e n s ,  presumably because of  i t s  FeLV-C 
component  (Hoover  e t  a l ,  1 9 7 4 ) .  The v a c c i n a t i o n  e x p e r i m e n t s  
d e s c r i b e d  above have a l l  been done i n  c a t s  whi ch were  s e v e r a l  
months o l d  and r e s i s t a n t  t o  FL74 v i r u s  i n f e c t i o n  (Hoove r e t  a I ,  
1976).  Even in 8 week old k i t t e n s  which arc normal l y  r e s i s t a n t  
t o  F e L V - C ,  t h i s  v i r u s  can be f a t a l  i f  t h e  a n i m a l s  a r e  
i m m u n o s u p p r e s s e d  f o r  some r e a s o n  ( 0 .  J a r r e t t ,  p e r s o n a l  
communi cat  i o n ) .
The type of  modi f i ed  l i v e  vaccine t ha t  would appear to o f f e r  
the best chance of  success is a temperature  s e n s i t i v e  ( ts)  mutant  
of FeLV which could be given i n t o  the upper r e s p i r a t o r y  t r a c t .  A 
s u c c e s s f u l  i n t r a n a s a l  v a c c i n e  has been d e v e l o p e d  u s i ng  a t s
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mutant of  f e l i n e  herpesvi rus  ( S l a t e r  and York,  1975) .  This v i r u s  
grows in t he  nose and i mmuni ses  the ca t  but  does not  become  
systemic .  R e t r o v i r u s  t s  mu t a n t s  can be o b t a i n e d  a l t h o u g h  one 
problem is t hat  they may r e v e r t  (Wyke, 1976).  However,  i t  would 
be i n t e r e s t i n g  t o  a t t e m p t  t o  produce  such a v a c c i n e  f o r  FeLV 
since i t  might prevent  the v i r us  spreading to the bone marrow and 
e s t ab l i s h i n g  a l a t e n t  i n f e c t i o n .
Recent l y ,  v i r a l  subuni t  and g e n e t i c a l l y  engineered vaccines  
have been pr oposed.  The e x p e r i e n c e  w i t h  FeLV gp70 v a c c i n a t i o n  
has not  been e n c o u r a g i n g  ( S a l e r n o  3 L/  1 9 7 8 ) .  A l t hough  
ant ibody was induced f o l l o w i n g  the i nocu l a t i on  of  20 ug of gp70 
i n t o  guinea p igs ,  t here was no response in cats given 40 ug. The 
v a c c i n e  d e v e l o p e d  by Ol sen  ^  ( 1980)  i s  a p p a r e n t l y  v i r u s -
f r ee  and contains ant igens which induce an t i bod i es  to FOCMA and 
gp70.  However ,  t h e  f l u i d  f rom FL74 c e l l s  r e q u i r e s  e x t e n s i v e  
c o n c e n t r a t i o n  and i t  i s  d o u b t f u l  i f  such a v a c c i n e  would be 
economic to produce f o r  genera l  use in the f i e l d .
By c o n t r a s t ,  t h e  i n a c t i v a t e d  v i r u s  v a c c i n e  which i s  
d e s c r i b e d  i n  t h i s  t h e s i s  woul d  be r e l a t i v e l y  i n e x p e n s i v e  t o  
manufacture.  I t  should now be possible  to t es t  t h i s  vaccine for  
i t s  capaci ty  to p r o t e c t  cats from n a t u r a l  contact  chal lenge as a 
f i n a l  step to developing i t  f o r  use in the f i e l d .
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